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Bone grafts are used to treat more than 300,000 fracture patients yearly [1], as 
well as patients with congenital defects, bone tumors, and those undergoing spinal fusion.  
Given the established limitations of autograft and allograft bone, there is a substantial 
need for bone graft substitutes.  Tissue engineering strategies employing the addition of 
osteogenic cells and/or osteoinductive factors to porous scaffolds represent a promising 
alternative to traditional bone grafts.  While many bone defects are in load-bearing sites, 
very little is known about the response of bone grafts and their substitutes to mechanical 
loading, despite vast documentation on the ability of normal bone to adapt to its 
mechanical environment.  The goal of this research was to quantify the effects of 
controlled in vivo mechanical stimulation on bone graft repair and bone graft substitutes 
and identify the local stress/strain environment associated with load-induced changes in 
bone formation.   
The global hypothesis that cyclic in vivo mechanical loading improves 
mineralized matrix formation within bone grafts and bone graft substitutes was addressed 
in this work using orthotopic and ectopic models specifically designed to facilitate 
modeling of local stresses and strains.  In the first study, a bone defect repair model 
utilizing an orthotopic implant capable of supplying a controlled mechanical stimulus to a 
trabecular allograft showed a significant reduction in new bone formation with controlled 
in vivo mechanical loading.  Although the reason remains unclear, loading conditions 
may not have been ideal for increased bone formation or potential micromotion may have 
influenced the results.  A second study demonstrated for the first time that controlled in 
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vivo mechanical stimulation enhances mineralized matrix production on a mesenchymal 
stem cell-seeded polymeric construct using a novel subcutaneous implant system.  In 
addition, the local stresses and strains associated with this adaptive response were 
predicted.  The novel subcutaneous implant represents technology which may be adapted 
for the preparation of tissue-engineered bone constructs, capitalizing on the benefits of 
mechanical loading and a vascularized in vivo environment.  Such an approach may 
produce larger, stronger, and more homogeneous constructs than could be developed in a 








Local bone loss from trauma or long-term degeneration is a major cause of patient 
disability.  Given an adequate local supply of osteoprogenitors, osteoinductive proteins, 
and vascularity, bone displays a remarkable capacity for repair and regeneration.  
Unfortunately, 5-10% of the six million fractures occurring in the United States yearly 
require bone grafting procedures to augment the natural regeneration process [1].  
Numerous other clinical applications, including spine fusion, bone tumors, metabolic 
bone disorders, and congenital defects, also commonly require some form of treatment.  
While commonly used clinically, autograft and allograft bone transplantation have well 
documented limitations that motivate the development of bone graft substitutes. 
Numerous strategies are being pursued to develop bone graft substitutes by combining 
osteoinductive factors or cells with porous scaffolds.  The goal of such efforts is typically 
to provide an initial structural framework along with bioactive factors that will stimulate 
rapid formation of new bone and restoration of local function.   
Two critical factors in bone repair and regeneration are vascularity and 
mechanical function.  An adequate local vascular supply is required for bone formation to 
occur.  Bone repair constructs developed in vitro, for example, are characterized by a 
non-physiologic distribution of mineralized matrix around the periphery of the construct. 
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An in vivo bone tissue engineering strategy that includes an integrated vascular supply 
may circumvent this limitation.  The mechanical loading environment also plays a key 
role in bone function.  Bone is an adaptive organ, capable of renewal, and responds to 
changes in its mechanical environment.  Vast documentation exists on bone atrophy 
caused by disuse and conditions of microgravity, as well as on the ability of bone to 
remodel in response to exercise [2-9].  Controlled studies of in vivo loading of whole 
bones show an adaptive response to compensate for the applied stimulus [10, 11].  Under 
repair conditions, the local mechanical environment of a repairing fracture callus 
contributes to tissue differentiation [12-16].  Consistent with these observations, 
osteoprogenitors and osteoblasts in culture are highly responsive to mechanical stimuli 
[17-21].  Given the sensitivity of bone to mechanical cues, it is reasonable to consider the 
use of controlled mechanical stimuli as a means to enhance bone repair or the 
development of bone graft substitutes. 
There are at least three possible settings in which mechanical loading may be 
employed to enhance the ability of a scaffold to repair a bone defect: 1) the in situ 
orthotopic environment, 2) the in vitro preparation of a bone replacement scaffold, and 3) 
finally, the in vivo ectopic preparation of a bone replacement construct.  A few therapies 
have capitalized on in vivo mechanical loading.  Distraction osteogenesis represents a 
successful application of in situ application of mechanical forces to enhance bone repair 
in the distraction gap [22].  However, the application of a controlled load to a scaffold 
filling a bone defect is a more challenging situation since the scaffold often has 
inadequate mechanical integrity and poor bone/implant stability initially.  It has also been 
postulated that the application of a low magnitude, high frequency vibration could be 
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used to prevent or possibly treat osteoporosis [23, 24].  In addition, control of the local 
mechanical environment can be used in vitro on monolayer or three-dimensional cultures 
to direct the differentiation of cells toward an osteoblastic phenotype and enhance 
mineralization of the secreted matrix [25-27].  Diffusional limitations however hamper 
the use of in vitro technologies to adequately prepare three-dimensional constructs for 
bone defect repair.  Finally, mechanical loading may potentially be employed ectopically 
in an in vivo “culture” environment to enhance the development of scaffolds intended for 
bone replacement.  Such an approach could capitalize on the presence of an adequate 
vascular supply to promote bone formation.  This third area represents an as yet 
unexplored avenue of research. 
While mechanical loading of normal bone has been extensively studied, the 
effects of mechanical loading on three-dimensional architectural bone grafts and bone 
graft substitutes have not been characterized.  Since the structure is distinctly different 
from normal bone in that cells simply line a three-dimensional structure without the 
benefit of an established canalicular network, the mechanism(s) by which the cells 
respond to mechanical signals may be altered or absent.  To gain a better understanding 
of mechanically-induced changes in bone formation for any three-dimensional structure, 
whether normal bone or a tissue-engineered construct, knowledge of the local stresses 
and strains at the trabecular level provide useful indices of mechanical signals associated 
with adaptive responses.  Unfortunately, this information has not been fully characterized 
for normal bone and no investigations have considered the local mechanical environment 
of a tissue-engineered bone substitute subject to a mechanical stimulus.  Examination of 
the local mechanical environment can currently only be performed using theoretical 
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models using finite element analysis and therefore require the use of specially designed 
testbeds which provide stringent control of the specimen’s boundary conditions.  A well-
defined knowledge of the local stresses and straines associated with adaptive changes in 
bone formation on a three-dimensional structure would provide useful design information 
for the production of future tissue-engineered bone substitutes.   
1.2 Goal & Global Hypothesis 
The goal of this dissertation work is to quantify the effects of controlled in 
vivo mechanical stimulation on bone graft repair and bone graft substitutes and 
identify the local stress/strain environment associated with load-induced changes in 
bone formation.  The global hypothesis that cyclic in vivo mechanical loading enhances 
mineralized matrix formation within bone grafts and bone graft substitutes was tested 
using experimental devices implanted at orthotopic and ectopic sites.    
1.3 Objectives 
The following three objectives were outlined to test the global hypothesis. 
Objective #1: To correlate the local mechanical stress/strain environment with patterns 
of bone formation on trabecular bone allografts subject to cyclic in vivo mechanical 
stimulation  in an orthotopic site. 
While others have investigated effects of mechanical compression on bone in 
vivo, the effect of in vivo mechanical compression on cell-populated matrix materials has 
not been determined.  Furthermore, correlation of the local trabecular mechanical 
environment to local patterns of bone formation has not been accomplished.  An 
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academic model of defect repair utilizing an orthotopic bone chamber capable of 
supplying a controlled mechanical stimulus to a repairing trabecular allograft within the 
implant was used to address this objective.  Although not a clinical model of bone defect 
repair, this model, when used to study loading of a scaffold with a known architecture 
such as traditional allografts, provides the necessary controlled environment to determine 
the local tissue strains and stresses that result in adaptive bone formation.  Knowledge of 
a specific adaptive mechanical environment will help define design criteria for more 
clinically relevant applications of mechanical loading for the development of tissue-
engineered bone replacement constructs.  It is hypothesized that cyclic in vivo mechanical 
loading will increase mineralization of the trabecular bone allografts in an orthotopic site 
and that areas of new bone formation will positively correlate with higher local trabecular 
strains. 
 
Objective #2: To design and develop a novel implantable bioreactor system to apply 
controlled mechanical stimuli to tissue-engineered constructs in a subcutaneous in vivo 
environment. 
An original implant system capable of applying a controlled mechanical stimulus 
to cylindrical scaffolds implanted subcutaneously in a rat was designed and created.  
Such a system may provide the ability to develop larger, stronger, and more 
homogeneous vascularized bone tissue replacements than could be developed in a 
diffusionally limited in vitro culture system.  Such pre-conditioned constructs may be 
better able to meet the functional demands of the bony environment. Furthermore, if 
 
 6 
constructs are developed in the final host, they may be populated with receptive host cells 
that will reduce the immunologic challenge presented to the patient when the bone defect 
is repaired.  Furthermore, such an implant would provide a well-controlled environment 
suitable for modeling tissue-level stresses and strains, allowing for characterization of 
adaptive mechanical signals. 
  
Objective #3: To quantify the effects of construct preculture time and controlled in vivo 
mechanical loading on mineralized matrix formation within cell-seeded scaffolds 
implanted into a subcutaneous bioreactor including characterization of the associated 
local mechanical stresses and strains. 
Finally, work was undertaken to demonstrate the ability of in vivo cyclic 
mechanical compression to improve bone formation on a tissue-engineered construct.  
However, the development of an ideal bone replacement product may also involve some 
form of in vitro preculture as well, so the influence of various amounts of exposure to 
osteogenic supplements in in vitro culture prior to implantation and loading was 
examined.  It is hypothesized that cyclic in vivo mechanical loading and longer times in 
in vitro preculture will increase mineralized matrix formed within tissue-engineered 
constructs implanted in a subcutaneous bioreactor.  It order to establish the local 
mechanical signals associated with potential load-induced changes in mineralization on 




While most fractures heal suitably, over 300,000 of these injuries experience 
complications that may be remedied by a tissue-engineered bone substitute [1].  
Currently, the market for bone grafts and bone substitutes represents more than a $270 
million industry [28].  Significant donor site morbidity, compromised structural integrity, 
and limited quantities of available bone restrict the clinical value of autograft bone and 
recent incidents of disease transmission from banked tissues have created increased 
interest in alternatives.  A tissue-engineered bone replacement product could find a 
substantial place in the bone graft and substitute market. 
Tissue engineering however is a field still quite in its infancy.  There are many 
challenges to be met in the design of tissue replacements.  They must not only meet the 
biological requirements of the tissue, but also must consider the biomechanical 
requirements of the tissue, especially for tissues that are normally mechanically 
challenged such as musculoskeletal tissues.  In September 2000, a group of engineers, 
biologists, and clinicians convened a Functional Tissue Engineering Workshop in which 
key target areas of future research for this emerging field were outlined.  One of the 
stated critical areas was to “determine how mechanical stimulation of cell-matrix 
implants modulates engineered tissue structure and function.”  Furthermore, a need was 
also expressed to “solve implant size issues by exceeding functional limitations of 
diffusion” [29].  The research presented in this body of work targets these two critical 
areas. 
This research seeks to translate knowledge about the mechanoresponsiveness of 
bone into a mechanism to improve cell-seeded constructs for bone defect repair.  While a 
 
 8 
great deal is known about the adaptive properties of bone to mechanical loading, there 
has been little translation of this knowledge into therapeutic applications for bone defect 
repair.  This work is the first research to demonstrate the ability of controlled in vivo 
mechanical stimulation to enhance mineralized matrix production on a polymeric scaffold 
seeded with osteogenic cells.  The use of mechanical loading during construct 
development may improve mineralization of such constructs allowing them to better 
support the mechanical demands of the orthotopic environment.  Combining mechanical 
preconditioning of cell-seeded constructs with the benefits of a vascular in vivo 
environment may be able to produce larger, more homogeneous, and potentially stronger 
constructs, circumventing the size and diffusional limitations of current tissue 
engineering approaches.  Furthermore, a set of tissue level stresses and strains 
experienced by the loaded tissue-engineered constructs were predicted to facilitate the 
design of future tissue-engineered constructs which may be subject to mechanical forces 






2.1 Bone Structure 
Bone serves many important roles including hematopoesis, mineral homeostasis, 
and several mechanical functions such as the protection of vital organs and provision of 
the necessary supportive framework for skeletal mobility.  It is the dynamic nature of a 
person’s mobility requirements that drives bone’s organization, making the structure and 
function of bone intimately intertwined.  A bone’s organization is typically classified as 
either cortical or trabecular.  The microstructural unit of cortical bone consists of many 
concentric layers of matrix that is penetrated by a single longitudinal canal and various 
transverse canals.  Many of these units placed longitudinally side-by-side make up the 
overall structure.  Cortical bone is therefore very dense and is found in areas requiring 
high strength and stiffness, typically the shafts of long bones.  While trabecular bone is 
comprised of a layered microstructural unit, the layers are not concentric and the overall 
structure is a porous network that may resemble either plates or rods.  The ratio of plates 
to rods is modulated by the mechanical demands placed on the tissue [30].  As a result of 
this porous network, trabecular bone is lightweight and effectively absorbs and distributes 
loads making it an ideal architecture for the epiphyseal region of long bones where load 
distribution across an articulating joint surface reduces the impact of loading on adjoining 
bone and cartilage. 
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2.2 Role of the Mechanical Environment 
Bone is an adaptive organ, capable of renewal and responds to changes in its 
mechanical environment.  While Wolff receives most credit for formally postulating in 
the late 19th century that bone’s architecture and function are inextricably linked [31, 32], 
Galileo had observed that the shape of a bone corresponded to its mechanical integrity as 
early at 1638.   After Lanyon first instrumented in vivo bone tissue with strain gages in 
1973 providing the first quantification of the mechanical signals that regulate adaptation 
[33], Frost presented his Mechanostat theory in 1987 which proposed that strain 
magnitude thresholds could predict the adaptive response of bone [34-36].  Observations 
of deteriorating properties of bone in naturally occurring instances of disuse such as 
bedrest [2, 37, 38], microgravity [3-5, 39],  paralysis [40], surgery recovery [41], and 
edentatation [42, 43] are plentiful.  Controlled research involving models of disuse such 
as tail-suspension of rats [44, 45] and limb immobilization [46-48] demonstrate both the 
changes in architecture and mechanical properties that result when mechanical loads on 
bone are reduced or removed.  Conversely, research involving exercise has demonstrated 
that sedentary individuals have less bone mass than those who exercise [6] and that 
exercise programs can increase bone mass at least temporarily [7, 8].  Furthermore, 
exercise programs have been shown to reduce bone loss in post-menopausal women [9, 
49]. 
While much research has focused on the role of mechanical factors in remodeling 
of normal bone, the mechanical environment of a fracture site also plays a direct role in 
repair of bone, directing tissue differentiation.  Both transmitted loads and 
interfragmentary motion can be used to predict the clinical outcome of a fracture.  The 
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removal of all transmitted loads such as occurs when a fracture is treated with rigid 
internal fixation will often result in intramembraneous ossification with delayed union 
accompanied by reduced final bone strength.  Conversely, if there is too much 
interfragmentary motion, cartilage or fibrous tissue will form rather than bone.  An 
intermediate level of mechanical stimulation where interfragmentary motion is restricted 
but not eliminated tends to enhance the inflammatory stage, encouraging greater 
vascularity, which promotes bone healing [12-16, 50].   
Given the important role of mechanical loading on bone formation, the potential 
to develop therapies utilizing mechanical loading to enhance bone repair and regeneration 
has been noted.  Much research has focused on determining the characteristics of an 
optimal loading regimen.  Overall, studies consistently show that bone formation is 
influenced by strain rate, frequency, amplitude, and duration of loading [51-55].   
Furthermore, cyclic loading is absolutely necessary to elicit an adaptive response.  Static 
loads simply do not invoke a significant amount of bone formation [56-58].  Furthermore, 
it has been shown that more bone will form if there are periods of rest between loading 
sessions [59].  It has recently been reported that shorter, more frequent bouts of loading 
produce greater increases in bone formation [60, 61].    
In recent years, the focus of much research has been elucidation of the mechanism 
wherein mechanical signals are sensed by cells and translated into a cellular response of 
matrix production and/or degradation.  The mechanism of mechanotransduction 
continues to be disputed.  While the apparent effect of mechanical strain overall is not in 
question, the strain the cell senses may or may not be the primary stimulator of 
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adaptation.  Some researchers postulate that fluid shear caused by matrix deformation 
may be able to explain bone’s adaptive properties [62-66], while others present evidence 
that electromagnetic fields may be the primary mechanism [67-69].   There has been 
other evidence to suggest that adaptation is triggered by accumulation of microdamage in 
the bone’s matrix [70-73].  Whether or not the true answer is any one of these options or 
even a combination of them, it is apparent that mechanical signals play an important role 
in the natural adaptive responses of bone.  Furthermore, the molecular signaling pathway 
mediating the response is also under investigation [74, 75]. 
There has also been a wide range of research performed in in vitro culture systems 
demonstrating the mechanosensitivity of bone cells.  Several types of in vitro monolayer 
culture systems have been devised to provide mechanical stimulation to bone-like cells 
based on flexible substrate deformation [18, 20, 76], application of vacuum pressure [18, 
20, 76], and oscillatory flow [17, 26, 77].   These studies have illustrated that mechanical 
stimulation results in cytoskeletal modulation, including upregulation of actin and 
vinculin and downregulation of tubulin [78].  Other work has demonstrated increased 
proliferation and changes in cellular alignment in response to deformation of the substrate 
supporting osteoblast-like cells [18].  Research has also shown a downregulation of 
osteocalcin [19, 79] and upregulation of prostaglandin E [65, 80], nitric oxide [66], and 
collagen type I [81].  Stretch on osteoblastic cells has been shown to increase the 




Evidence has been obtained from various cells sources containing 
osteoprogenitors that suggests mechanical stimulation may have an effect on bone 
lineage progression.  Much work has been done to characterize the effects of intermittent 
hydrostatic compression (IHC) on rat calvarial cells subcultured into two subpopulations, 
one exhibiting an osteoblastic-like phenotype and one with a more osteoprogenitor-like 
phenotype.  These studies show that mechanical stimulation may be necessary to 
maintain a differentiated phenotype in the osteoblast-like cells, but the osteoprogenitor 
cells act somewhat differently and were not as mechanosensitive as their differentiated 
counterparts for osteopontin upregulation [82] However, osteoprogenitor-like cells did 
upregulate alkaline phosphatase activity and TGF-β  secretion [27, 62].  Other research 
shows that mechanical strain downregulates the number of osteoclasts formed in murine 
stromal cell populations [83, 84].  Recently, Weyts has shown that the response of 
osteoblastic cells to mechanical stretch depends on the length of time the cells were 
exposed to dexamethasone, possibly indicating that mechanosensitivity varies with 
differentiation of osteoblastic cells [85]. 
2.3 Bone Chamber Systems 
To date, bone chamber technology has been utilized in the academic study of 
bone formation and chemical and physical regulators of that process.  An early 
predecessor of modern bone chambers are simple diffusion chambers which house a 
selected population of cells within cellulose acetate membranes and are placed either 
intraperitoneally, intramuscularly, or in the subcutaneous space of an animal.  The cells 
receive nutrition by diffusion from the surrounding host environment and are exposed to 
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endogeneous bioactive factors, while isolating the cell population so that any measured 
response can be attributed to the implanted cell population.  These systems have been 
used to investigate a variety of cells, primarily to investigate cell and tissue physiology as 
well as cell immunity and tumor growth.  These chambers have also been used to 
demonstrate the osteogenic capacity of a population of cells within the periosteum and 
bone marrow.   The scope of the investigations of bone formation that can be performed 
using diffusion chambers is limited however because nutrition is diffusionally mediated 
since a vascular network is absent from the chamber interior.  Because of size and 
nutritional limitations, fully structured bone cannot develop within a diffusion chamber.   
A wide range of chamber designs have been developed for studying orthotopic 
bone formation.  These chambers may reside in the cortex only or may transverse both 
the cortex and trabecular regions of a bone.  These chambers have been used to study 
both normal de novo bone ingrowth as well as the effect of many biological factors on 
bone growth [86-88].  The chambers have even been manufactured with different surface 
finishes to study bone/implant interactions [89, 90].  Some bone chamber systems have 
features to provide easy access to the chamber contents in a non-terminal procedure 
without disturbing the chamber itself [91, 92].  Bone chamber systems have been 
modified to supply an electrical stimulus to developing bone to study the induction 
effects of electrical current [93].  One transcutaneous bone chamber system even 
provides a translucent port to study developing bone in the chamber using an optical 
microscope in real-time [94].   
 
 15 
Only a few chamber systems have been designed to impart a mechanical stimulus 
to developing bone.  Aspenberg has developed a micromotion bone chamber system 
which applies a small micromotion to bone within the chamber via a rotating inner sleeve 
resulting in fibrous tissue formation and inhibition of bone [95, 96].  Tagil developed the 
rat bone conduction and load chamber which penetrates the bone cortex and allows bone 
growth into a chamber space sitting atop the cortex.  A subcutaneous piston is used to 
apply a known force to the tissue via an extracutaneous dynamometer.  Tagil found that 
when de novo bone formation was allowed in this chamber system for three weeks and 
then loaded for an additional seven weeks, a cartilage layer resulted next to the loading 
piston in four out of seven samples [97].  It should be noted however, that at the onset of 
loading the tissue within the chamber is mostly fibrous tissue next to the piston with a 
bony callus forming at the opposite end of the chamber.  Thus it may be postulated that 
loading of fibrous tissue in a potentially less vascular setting produced a cartilage layer, 
rather than concluding that loading of de novo bone produced cartilage.   Although not a 
true chamber system, Lamerigts developed the subcutaneous pressure implant to study 
how controlled loading would affect incorporation of morsellized bone graft into an 
orthotopic defect site in goats.  The system consists of a titanium rod which passes 
through the cortex and into the epiphysis of a long bone to serve as an actuating piston to 
compress the graft chips placed in the epiphysis.  A cap enclosing the exterior end of the 
rod and lying in the subcutaneous space over the cortex is connected to a subcutaneous 
air pressure cannula which conveys compressed air to actuate the piston.  Lamerigts 
found that after 12 weeks of loading, loaded graft chips exhibited greater incorporation, 
remodeling, and higher overall bone density [98].   
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The hydraulic bone chamber system developed by Guldberg was the first chamber 
system to apply a controlled cyclic compressive stimulus to repairing bone within the 
chamber.  The system resembles a hollow titanium screw with large tissue infiltration 
openings on the distal end which resides in the trabecular bone, while the opposite cap 
end remains in the subcutaneous space flush with the bone cortex.  Subcutaneous 
hydraulic tubing is connected to the cap end to supply pressurized saline to actuate a 
piston within the chamber to compress tissue within the chamber.  This system provides 
the ability to apply a controlled mechanical stimulus in vivo to a volume of tissue isolated 
from 98.6% of ambulatory loads [99].  The easily accessible subcutaneous cap allows for 
repeated non-terminal biopsy procedures.  This system was first used to investigate the 
effects of cyclic compression on de novo bone growth in a canine model.  Twelve weeks 
of loading resulted in bone samples with increased mineralization and decreased collagen 
fiber organization.  Architectural changes with loading included increased connectivity 
and trabecular plate thickness resulting in a 6-fold increase in the apparent modulus of 
loaded bone cores [100].   Although this study demonstrated the adaptive nature of 
regenerating bone to intermittent mechanical compression, it failed to demonstrate an 
adaptive set of local tissue strains resulting in new bone formation since the architecture 
of the developing bone scaffold was unknown. 
Moalli subsequently used the canine hydraulic bone chamber model to investigate 
early changes in cellular activity and gene expression resulting from short term 
mechanical loading of de novo bone growth.  This work illustrated a biphasic 
upregulation of c-fos and zif-268 gene expression within the first 24 hours following a 
single loading episode and increases in the synthesis of type I procollagen and alkaline 
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phosphatase after six consecutive days of loading [101].  In a separate experiment, Moalli 
also demonstrated load-induced activation of focal adhesion kinase (FAK) and its 
association with Src using the canine hydraulic bone chamber model [75].  Recently, the 
hydraulic chamber system has been modified for use in a rabbit model and was used to 
investigate the ability of tissue-engineered cartilage constructs to support bone formation 
under controlled mechanical loading conditions.  This work demonstrated a nine-fold 
increase in mineralized bone formation on cartilage constructs receiving a daily 
controlled intermittent mechanical stimulus [102].  
2.4 Bone Defect Repair 
Over six million fractures occur in the United States every year.  While most 
fractures heal suitably, between 5-10% of these injuries experience complications that 
may be remedied by a tissue-engineered bone substitute.  These situations may be 
subsequent to an osseous infection, improper alignment of bone fragments, excessive 
motion or periosteal stripping, as well as interfering soft tissue damage.  Further clinical 
uses for tissue-engineered bone substitutes include bone regeneration following or 
complicated by osteomyelitis, osteonecrosis, or the removal of a malignant or benign 
osteosarcoma [1].  The market for bone grafts and bone substitutes is experiencing 
tremendous growth, demonstrated by gains of 40% from 1997 to 1999 when the market 
represented a 270 million dollar industry [28].  While autograft bone is considered the 
gold standard for bone replacement therapies, its use is not without complication [103].  
Significant donor site morbidity, compromised structural integrity, and limited quantities 
of available bone restrict its clinical value.  Allografts are an option, but limited supply 
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and recent incidents of disease transmission from banked tissues have created increased 
medical and financial interest in alternatives.  Researchers are actively seeking bone 
replacement scaffolds and tissue-engineered bone substitutes. 
2.5 Bone Tissue Engineering 
2.5.1 Overview 
Bone formation requires osteogenic cells with an extracellular matrix in an 
appropriate chemical and physical environment [104].  Each element represents one piece 
of the complex puzzle that is the in vivo bone environment.  Exact recreation of the 
physiologic in vivo environment may or may not be necessary to develop an effective 
bone replacement.  Tissue engineering strategies attempt to mimic the natural bone 
formation process by exogenously providing one or more of the following: an 
osteoconductive scaffold, osteogenic cells, and chemical and physical inductors of bone 
formation.  The location, functional needs, and local cellular and vascular supplies of the 
defect site will determine how aggressive the tissue engineering approach must be and 
which of the aforementioned components must be incorporated in the replacement 
scaffold.   
Typically, tissue engineering approaches employ a scaffold material to serve as 
the framework for bone formation as well as a structural and potentially load-bearing 
intermediary until complete remodeling occurs.  These scaffolds may be augmented with 
osteogenic cells or resident host cells may be relied upon to mediate matrix secretion.   
The provision of additional osteogenic cells with a matrix is particularly important for 
patients with certain clinically challenging bone repair situations where the host wound 
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bed may have an impaired cellular supply such as older patients, smokers, patients 
receiving chemotherapy or radiation and patients with severely damaged wound beds 
[104].  Certain strategies employ the use of bioactive factors involved in induction or 
regulation of the bone formation process.  In certain instances, additional osteogenic cells 
may not need to be provided if such osteoinductive factors are supplied to cause the 
resident population of cells to form new bone.  Often the supplied cells are genetically 
engineered to overexpress such factors to overcome the challenges associated with 
delivering the actual soluble factor itself [105].  This approach has been used with some 
success to heal bone defects using cells expressing bone morphogenetic proteins [106] 
and the transcriptional factor Runx2 [107].  Although a less explored approach than 
chemical stimulation of bone formation, it may be possible to use mechanical loading as 
a stimulant of new bone formation on tissue-engineered constructs given bone’s native 
capacity to respond to local mechanical signals.   
2.5.2 Scaffold Selection 
Scaffold selection is critically important in the development of a bone 
replacement construct.  The scaffold must be biocompatible, osteoconductive, and be able 
to be sterilized.  Porous osteoconductive matrices have been shown to provide an 
excellent framework for new bone formation.  Ideally, the matrix would promote protein 
adsorption, cell adhesion, mitosis, and differentiation while providing initial mechanical 
stability, depending on the local loading requirements of the defect site.  While natural 
materials like collagen and hyaluronan are an option [108, 109], their lack of mechanical 
integrity makes them suitable only for certain non-loadbearing environments.  Calcium 
 
 20 
phosphate ceramics such as hydroxyapatite [110-113], tricalcium phosphate [110, 114, 
115], bioactive glass [116] and coralline materials [117] are a natural choice because of 
excellent osteoconduction on these surfaces.  However, the brittle nature of these 
materials and the lack of a completely interconnected pore structure limit their 
usefulness.  Polymers are gaining a great deal of attention as possible matrices for bone 
replacement constructs since their architecture and mechanical properties can often be 
tailored easily.  Polymers that have been investigated for use in bone tissue engineering 
include polypropylene fumarate (PPF) [118], polyurethane (PUR) [119, 120], 
polycaprolactone (PCL) [121, 122], and other poly ether esters [123], but the most 
commonly used polymer options are polylactides and polyglycolides and their 
copolymers [113, 124-126] due to their ability to rapidly degrade in the in vivo 
environment. 
2.5.3 Cell Sources 
The choice of cells to incorporate in a tissue-engineered bone construct is also 
crucial.  Options include terminally differentiated osteoblasts, osteoprogenitors, or cell 
populations containing stem cells capable of osteogenesis.  Cells expressing the 
osteoblast phenotype however are typically harvested in small numbers, demonstrate 
limited expansion capacity and are prone to phenotypic dedifferentiation [127].  Bone 
marrow stroma has been used in many instances to augment bone repair with some 
success [128-131].  Unfortunately, it is estimated that humans have only one 
osteoprogenitor per every 100,000 nucleated bone marrow cells [132].  Purified ex vivo 
expanded mesenchymal stem cells derived from a  variety of sources including marrow 
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[110, 127], muscle [133], and adipose tissue [134-136] represent a more concentrated 
source of osteogenic cells for bone replacement scaffolds.  Osteoprogenitors from fetal 
calvaria [126] and periosteal cells [106] may also be used. 
There are many advantages to using MSCs for tissue-engineered bone products 
including the ability for ex vivo expansion.  Since human MSCs are capable of a billion-
fold expansion over ten passages [132], this represents a commercially viable source for 
osteoprogenitor cells for tissue-engineered bone substitutes.  Furthermore, since 
mesenchymal stem cells are easily obtained from adult bone marrow aspirates, MSCs are 
a readily available cell source.  Preliminary work also shows that these cells may exhibit 
some immune tolerance, making an allogeneic off-the-shelf product more feasible.  
Research performed at Osiris Therapeutics has demonstrated that allogeneic canine stem 
cells implanted on a ceramic scaffold into a canine segmental gap defect model provide 
comparable healing of the defect when compared to an autologous product [137][138].  
Host response to the donor cells was evaluated in a mixed lymphocyte reaction and no 
adverse reactions were detected [139].  Further studies showed that rat MSCs do not 
stimulate alloreactive T cell responses [140].  Mesenchymal stem cells have shown 
strong osteogenic capacity in vitro when cultured in the presence of a standard set of 
osteogenic supplements including Na-β-glycerophosphate, L-ascorbic acid-2-phosphate, 
and the synthetic glucocorticoid dexamethasone for 14 to 21 days.  The osteoblastic 
phenotype is evidenced by a change from a fibroblastic to a cuboidal morphology, 
expression of alkaline phosphatase, reactivity with anti-osteogenic cell surface 
monoclonal antibodies, osteocalcin mRNA expression, and mineralized nodule formation 
[127, 141]. Excellent availability, ease of culturing, ability to use allogeneic cells, and 
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sensitivity to osteogenic stimuli make mesenchymal stem cells an excellent choice for 
clinical tissue-engineered bone products. 
2.5.4 Construct Preparation 
While most researchers recognize the critical nature of scaffold and cell selection 
for a bone replacement scaffold, the importance of construct preparation is somewhat less 
acknowledged.  Typical bone tissue engineering approaches simply seed primary or ex 
vivo expanded cells on a three-dimensional matrix and immediately implant it in the 
defect site [106, 110, 114, 131].  This approach does not allow for extracellular matrix 
formation prior to implantation or predifferentiation of osteoprogenitor cells.  While more 
common for cartilage [142], tendon [143], vascular tissue engineering [144], some 
researchers however have used three-dimensional in vitro culture to prepare constructs 
for bone replacement.  Such an approach allows for cellular differentiation and matrix 
secretion prior to implantation, often utilizing a set of media supplements to induce 
osteogenesis or accelerate matrix secretion [115, 117, 145, 146].  Yoshikawa has 
demonstrated that a two-week subculture in dexamethasone-containing media caused 
hydroxyapatite scaffolds seeded with bone marrow-derived cells to have increased bone 
formation once implanted subcutaneously in rats [147, 148].  Constructs developed in this 
manner were shown to have higher osteoblastic activity than autogeneous trabecular 
allograft [149].  Providing a construct in which the cells already have an established 
extracellular matrix may enhance cell retention after implantation.  Furthermore, a 
construct that already has a mineralized matrix may actually promote ensuing bone 
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formation as the resident mineral may provide nucleation sites for subsequent 
mineralization.   
In vitro preculture of bone constructs is limited however by diffusional 
limitations.  Scaffolds tend to have a necrotic core because of insufficient transport of 
nutrients into the scaffold and degradation products and metabolic waste out of the center 
of the scaffold.  Ingrowth limitations on cell-seeded scaffolds for tissue engineering have 
been observed [126, 150-152].  Research involving rat marrow cells and rat calvarial 
cells on PLGA in static in vitro culture for up to 56 days only showed osseous tissue 
penetrating to a depth of 200-300 microns [126, 150].  Additional studies have shown 
that cell-seeded constructs developed in static culture show preferential cell growth on 
the scaffold exterior [151-154].  Recently, researchers have begun to develop in vitro 
perfusion systems to culture three-dimensional constructs [25, 155-157].  The flow of 
medium not only enhances transport but applies a shear stress to the cells within the 
construct which has been shown to improve matrix deposition within constructs.  Wang 
has performed the only research in which cell-seeded scaffolds were prepared for in vivo 
implantation using a perfusion culture technique.  Wang perfused β-tricalcium phosphate 
scaffolds seeded with bone marrow derived cells for two weeks before subcutaneous 
implantation and found increase alkaline phosphatase and osteocalcin synthesis 
accompanied by increased bone formation compared to static controls after four and eight 
weeks in vivo [155].   
A few other researchers have also developed systems to capitalize on the 
stimulatory effect of mechanical loading on bone cells.  Jones has developed a 3-D cell 
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culture system capable of applying either a known strain or a known force to developing 
bone constructs [158].  Porter has developed an in vitro bioreactor system for the 
development of three-dimensional bone constructs that is capable of applying both 
perfusion and axial mechanical compression [159].  As yet neither of these systems have 
been used to mechanically precondition bone tissue engineering scaffolds prior to in vivo 
implantation, but such systems will undoubtedly be employed for such purposes in the 
near future [160].  Researchers are already employing in vitro mechanical conditioning to 
the development of tenogenic constructs for in vivo use [161].   
Another potential way to circumvent the complications arising from diffusional 
limitations associated with in vitro preculture is to utilize the in vivo environment as a 
bioreactor for the preparation of tissue-engineered bone replacements.  Ingrowth of blood 
vessels into the scaffold may provide adequate nutrient and metabolite transport, 
potentially resulting in larger, more homogeneous, and mechanically stable mineralized 
constructs.  While many cell-seeded constructs have been implanted into the 
subcutaneous space, the purpose of such experiments has primarily been evaluation of 
biocompatibility [162, 163], comparison of cell and scaffold technologies [114, 115, 
148], or the efficacy of bioactive factors to induce bone formation [164-166].  To date, 
the effects of controlled in vivo mechanical loading on a cell-seeded construct have not 
been investigated. 
The concept of using the in vivo environment to develop tissues is not altogether 
new, but to date use of the in vivo environment as a means of preparing bone replacement 
scaffolds has been explored only marginally.  In 1998, Tsukagoshi published work 
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describing the revascularization of autograft bone by embedding it in muscle and 
implanting it subcutaneously for several weeks before transplanting it to a cranial defect 
site.  Blood vessels from the muscle flap were anastomosed to temporal vessels to 
maintain a vascular supply to the graft [167].  Jingushi has proposed a similar approach 
using BMP2 to induce bone on β-tricalcium phosphate within muscle which could then 
be transplanted with the muscle pedicle to repair a bony defect [168].  Likewise, Pelissier 
has investigated the ectopic development of bone constructs using bone marrow-derived 
cells on a coralline scaffold with a vascular pedicle [169].  At this point however, the 
ability of constructs developed in this way to heal an actual bone defect has not yet been 
tested.  Furthermore, researchers have been developing shaped tissue-engineered 
constructs for bone replacement resembling the mandibular condyle and phalanges [117, 
170, 171].  Vacanti and Bonasser have proposed that such constructs developed in vivo 
could then be transplanted to repair large bone defects [172].  As yet, no one has 
employed mechanical stimulation in vivo to aid in the development of tissue-engineered 
constructs for bone replacement.  Given the evidence suggesting better bone formation 
occurs on tissue-engineered bone constructs developed in in vitro bioreactors [155] and 
the proven responsiveness to osteoblasts in vivo and in vitro, it is likely that mechanical 
stimulation in an in vivo bioreactor will improve bone construct development.  
Combining mechanical preconditioning with the vascular benefits of an in vivo 
environment may represent a successful approach for developing tissue-engineered 





EFFECTS OF CYCLIC MECHANICAL COMPRESSION ON THE REPAIR OF 
FROZEN ALLOGRAFTS IN A LAPINE BONE DEFECT MODEL 
3.1 Introduction 
3.1.1 Summary 
The ability of bone to adapt to its mechanical environment is undisputed.  
However, the effects of controlled in vivo mechanical loading on a repairing bone graft or 
bone graft substitute have not been investigated.  It is unknown whether new bone on a 
three-dimensional scaffold will show a positive adaptive response to an applied cyclic 
mechanical stimulus.  Although the adaptive ability of mature bone is well documented, 
the absence of a fully connected canalicular network, relative tissue immaturity, and other 
factors may impact the ability of the cells to respond to in vivo mechanical signals.   The 
effect of controlled in vivo mechanical loading on repairing trabecular allografts may also 
be indicative of the response of tissue-engineered bone replacement constructs since both 
systems are typically characterized by a three-dimensional scaffold populated by 
osteogenic cells and scant mineralized matrix. 
Of a practical nature, controlled mechanical stimulation may represent an 
attractive method of preconditioning tissue-engineered scaffolds to improve cellular 
distribution and mechanical properties for bone defect repair. Whether systems for 
mechanical preconditioning are utilized in an in vivo or an in vitro environment, 
determination of a regime of tissue strains resulting in a positive adaptive outcome will 
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provide a target level of deformation for these systems to achieve [173].  Foreknowledge 
of a target adaptive strain regime will aid in the design of mechanical preconditioning 
systems.  To date, the local mechanical stresses and strains resulting in bone adaptation 
have not been determined in either mature or regenerating bone.   
A bone chamber system capable of applying a controlled intermittent mechanical 
stimulus was utilized to study in vivo bone formation on rabbit trabecular allografts.  A 
similar system was used previously to investigate mechanical adaptation in canine de 
novo bone and found increased mineralization and adaptive architectural changes in 
loaded specimens [100].  However, this study was unable to predict an adaptive regime of 
tissue strains because the architecture of the de novo bone at the time of loading was 
unknown.  The work presented here involves trabecular allografts of a known 
architecture in a controlled environment with known boundary conditions to facilitate 
finite element modeling of the applied loading conditions.  Predictions of the tissue level 
stresses and strains can be compared to histological sections showing areas of new bone 
formation to estimate a set of adaptive tissue strains. 
After four weeks of de novo bone growth and four additional weeks of daily 
controlled in vivo loading, a significant decrease in bone formation was observed.  Since 
an increase in bone formation did not result from loading, an adaptive set of local tissue 
stresses and strains could not be determined.  Finite element models show that the 
average normal strains at the tissue level fell in the range of -1060 µå to +140 µå while 
the overall apparent strain was 8740 µå.  The decrease in bone formation may be a result 
of impaired vascularity resulting from micromotion between the implant and the 
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anchoring bone or it may reflect a true vulnerability of immature bone on a scaffold to in 
vivo mechanical stimulation.  This work demonstrated that cellular responsiveness to 
mechanical stimulation is complex and a positive adaptive response cannot be assumed.  
Furthermore, this research underscored the need for a stable vascular environment for 
bone repair. 
3.1.2 Specific Aims and Hypotheses 
Specific Aim #1: To quantify new bone formation on trabecular allografts in a rabbit 
bone chamber model applying cyclic mechanical compression. 
Hydraulic bone chambers were implanted in the distal metaphysis of male New 
Zealand rabbits.  After four weeks of bone formation on trabecular allografts implanted in 
the chambers, cyclic mechanical compression was applied for an additional four weeks.  
New bone formation was quantified using fluorochromes injected intravenously just prior 
to onset of loading and harvest.  It is hypothesized that cyclic mechanical compression 
will increase new bone formation on trabecular allografts implanted at an orthotopic site. 
 
Specific Aim #2: To predict trabecular strains employed by cyclic in vivo mechanical 
compression of trabecular allografts in a rabbit bone chamber system to identify an 
adaptive tissue strain regime. 
Micro-computed tomography images of implanted trabecular allografts were used to 
create a digital image based finite element mesh for the basis of finite element models 
representing the applied in vivo loading conditions.  Predicted tissue stresses and strains 
were generated.  It was hypothesized that larger local tissue strains will correlate with 
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greater bone formation induced by cyclic mechanical compression of a trabecular 
allograft implanted at an orthotopic site. 
 
Specific Aim #3: To compare early mRNA response for collagen type I and osteopontin 
from repairing trabecular allografts in a rabbit bone chamber model experiencing cyclic 
mechanical compression. 
Hydraulic bone chambers were implanted in the distal metaphyses of male New Zealand 
rabbits.  After four weeks of bone formation on trabecular allografts implanted in the 
chambers, cyclic mechanical compression was applied for an additional three days.  The 
harvested tissue was used to examine early gene expression using reverse-transcriptase 
polymerase chain reaction methods.  It was hypothesized that cyclic mechanical 
compression will increase early gene expression of bone-related proteins in trabecular 
allografts implanted at an orthotopic site. 
3.2 Methods and Materials 
3.2.1 Hydraulic Bone Chamber (HBC) System 
A bone chamber model capable of supplying a controlled intermittent mechanical 
stimulus to regenerating bone or bone scaffolds in vivo was developed.  The chamber can 
be biopsied repeatedly within a given animal without disturbing the implant to provide 
excellent within-animal controls and reduce the number of animals required in a given 
study.  While not a traditional clinical model, this system represents a hybridization of 
classical in vivo and in vitro models.  This three-dimensional system retains the relevant 
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in vivo environment, which provides appropriate growth factors, cytokines, hormones, 
and vascularity to the tissue.  This system also creates an environment for the tissue that 
is completely mechanically isolated from the surrounding tissue such that the local 
mechanical environment is tightly controlled [99]; a feature that is typically only obtained 
with in vitro cell culture systems.  Guldberg and colleagues at the University of Michigan 
originally developed the hydraulic bone chamber model for canine studies [100]. At 
Georgia Tech, several changes have been made to the hydraulic bone chamber system for 
use in rabbits.  To ensure the best chance of demonstrating differences between treatment 
conditions, a more challenging bone repair model was created by restricting vascular 
access to the regenerating tissue in the chamber.  In addition, the overall size was reduced 
and the cap design was significantly modified to lower the chamber’s profile, keeping it 
close to the bone’s surface. 
The basic rabbit hydraulic bone chamber can be represented as a hollow threaded 
titanium bolt with a removable cap (Figure 1).  The base of the bone chamber has an 
inner diameter of 0.25” and a depth of 0.25”.  Those chambers intended to supply a 
mechanical stimulus also have a flat piston inside separating a tissue space from a 
superior plenum.  The tissue space contains twelve regularly spaced holes to allow 
cellular invasion and new vascularization.  The superior plenum is filled with saline and 
has a barbed outlet to which polyurethane tubing is connected and routed subcutaneously 
to an exit site on the animal’s back.  The external end of this tubing can be connected to a 
solenoid-driven loading system (Figure 2).  This actuating system is capable of applying 
an intermittent compressive stimulus controlled by active pressure transducer feedback.  
The saline in the tubing is pressurized which displaces the piston within the bone 
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Figure 1.  Hydraulic Bone Chambers for Rabbits 
 
Figure 2.  External Solenoid-Driven Loading System 
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3.2.2 Surgical Procedures 
Hydraulic bone chambers were implanted bilaterally into the distal femoral 
metaphyses of 19 male New Zealand White rabbits using a sterile surgical technique.  
Each animal received one basic implant and one loaded  implant with a piston and barb to 
allow for compression of the tissue inside the chamber.  A detailed surgical procedure 
can be found in Appendix B.1 Procedure to Implant Rabbit Hydraulic Bone Chamber.  
The chambers were allowed to integrate into the bone for four or five weeks.  In a second 
surgical procedure, the chambers were opened, cleared of de novo tissue ingrowth using a 
thin-walled extraction tool.  This procedure is described in Appendix 
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B.2 Procedure for a Non-Terminal Biopsy of the Rabbit Hydraulic Bone Chamber.  
Trabecular bone allografts (0.25” diameter, 0.25” length) that had previously been 
sterilely harvested from the distal femoral metaphyses of other New Zealand White 
rabbits and then stored at -80C were thawed and placed inside the cleared bone chambers.  
During this surgical procedure, tubing was attached to the barb of the loaded chamber 
and routed subcutaneously to an exit site on the rabbit’s back between the shoulder 
blades.  Appendix B.3 Procedure to Implant Subcutaneous Loading Tubing in Rabbits 
contains a detailed description of the surgical procedure to implant this tubing. 
All animal procedures were approved by the Georgia Tech and Emory 
University’s Institutional Animal Care and Use Committees (Protocol # V043-98). 
3.2.3 Loading Procedure and Harvest 
New bone was allowed to form on the implanted trabecular allografts for four 
weeks before loading sessions began.  Each animal’s tubing was connected to the 
external solenoid-driven loading system so that the saline within the tubing and hydraulic 
bone chamber could be pressurized to apply a compressive load to the allograft within the 
loaded chamber.  Each loading session applied a compressive stimulus in a sinusoidal 
wave pattern applying 2.22 N to 22.2 N compression (upper limit of loading system) to 
the allograft.  The loading stimulus was applied at 1 Hz for 30 minutes similar to 
previous experimental work [100][81][79][75].  A detailed protocol for operating the 
hydraulic loading system can be found in Appendix C.  Each animal was loaded for three 
consecutive days.  The tissue was then extracted from the chamber in a sterile surgical 
procedure using a thin-walled biopsy extraction tool (Figure 81) for subsequent analysis 
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of gene expression.  A second trabecular allograft was placed in the chamber and new 
bone formation allowed for an additional four weeks prior to initiation of a four week 
loading regimen identical to the one described for the short-term loaded group.  This 
second allograft was then extracted from the chamber in a terminal surgical procedure.  
All biopsied tissue was fixed in 10% neutral buffered formalin for 48 hours then stored at 
4C in 70% ethanol. 
3.2.4 Fluorochrome Labeling 
Fluorochrome labels were administered intravenously to mark newly deposited 
calcium within the allograft during the long-term loading sessions.  Oxytetracycline was 
administered 1 day before the initial loading session at a dosage of 25 mg/kg, while 
calcein was given at a dosage of 10 mg/ml 1 day before the termination of the four week 
loading period.  Each dose was administered intravenously in a volume of 80-100ml over 
a thirty minute period.  Animals were given an injectible anesthetic of 
ketamine/xylazine/acepromazine (19/9/0.4 mg/kg) prior to the procedure. 
3.2.5 Animal Grouping and Infection Problems 
The study was conducted using three separate groups of animals since it would be 
prohibitive to perform the experiment with a large number of animals at one time.  The 
first group of seven animals (GW1-7, Spring 1999) was plagued with infection along the 
indwelling tubing and no useable data was collected.  The second group of six animals 
(GW8-13, Fall 1999) fared somewhat better, in part due to daily exit wound care and 
anchoring of the tubing with a felt cuff as described previously.  Four samples from the 
short-term loading segment were obtained and three from the long-term loading segment.  
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The third group of six animals (GW14-19, Spring 2000) had the lowest incidence of 
infection, primarily because the animal’s exposure to the tubing was minimized by 
implanting the tubing in a separate procedure just one week prior to the onset of loading.  
Additionally, the application of silver-impregnated glass powder to the exit wound 
improved the incidence of infection in the third group.  Six samples from the long-term 
loading group and four from the short term loading groups were successfully obtained 
from Group #3, making the overall number of usable biopsies for analysis from the long-
term loading group nine and eight for the short-term loading group.  It should be noted 
that unlike animals in Group #2, animals in Group #3 received the long-term loading 
treatment first and then the short-term loading in an effort to balance for any biopsy 
sequence effects.  
3.2.6 RNA Extraction  
Samples harvested after a four-week tissue formation period and a 3-day loading 
regimen were handled with RNase-free tools and immediately flash frozen in liquid 
nitrogen.  Samples were stored at -80C prior to RNA extraction.  Naïve rabbit trabecular 
bone and de novo clearout tissue from the HBC integration period were also examined as 
a control for the loaded and nonloaded allograft samples.   
RNA was isolated from samples in Group #2 using Promega’s RNAgents Total 
RNA Isolation System.  Briefly, 3ml of denaturing solution was added to each sample 
and homogenized using a rotor-stator homogenizer, and then 300 µl of sodium acetate 
was added and inverted to mix.  Next 3ml of Phenol:Chloroform:Isoamyl Alcohol was 
added and mixed then chilled.  Samples were centrifuged 30 minutes at 10,000g and 4C.  
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About 2/3 of the aqueous phase was aspirated and transferred to a clean tube.  Then a 
second volume of Phenol:Chloroform:Isoamyl Alcohol equal to the aspirated volume was 
mixed in and chilled.  Samples were again centrifuged 20 minutes at 10,000g and 4C.  
Again, about 2/3 of the aqueous phase was aspirated and transferred to a clean tube.  An 
equal volume of isopropanol was added and incubated 30 minutes at -20C then 
centrifuged at 10,000g and 4C.  The pelleted RNA at the base of the tube was 
resuspended in 1ml of chilled 75% RNase-free ethanol and centrifuged 10 minutes at 
10,000g and 4C.  The supernatant was discarded and any residual volume was dried in a 
speed vac being careful not to completely dry the pellet.  The RNA pellet was 
resuspended in 20ul RNase-free water and optical density measurements performed to 
determine the quantity and purity of RNA extracted. 
RNA was isolated from samples in Group #3 using Qiagen’s RNeasy Kit 
(#75163).  Briefly, samples were snipped with bone cutters and then homogenized using 
a rotor-stator homogenizer in the presence of 7.5 ml of Buffer RLT with β-
mercaptoethanol.  The mixture was placed in the Qiagen spin column and spun at 3800g 
for 10 minutes.  The supernatant was transferred to a clean spin column and 7.5 ml of 
70% ethanol was added before another spin for 5 minutes.  Then 7.5 ml of Buffer RW1 
was added and spun for 5 minutes.  A buffered DNase solution (Qiagen # 79254) was 
applied to the column for 30 minutes.  Additional Buffer RW1 was added to the column 
and spun for 5 minutes.  The membrane was washed twice with Buffer RPE and then 
spun until dry.  The column was placed in a clean elution tube and 500ul RNase-free 
water was applied directly to the membrane of each column.  The extracted RNA was 
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then collected in the elution tube in two consecutive spins.  Optical density measurements 
were performed to determine the quantity of RNA extracted.   
RNA samples from Group #2 were reverse-transcribed using a standard protocol 
involving Invitrogen’s SuperScript II Rnase H- RT enzyme on a 4 µg quantity of RNA 
primed with OligodT(12-18).  Please see Appendix D.1 Protocol Worksheet for Reverse 
Transcriptase Reaction to Convert RNA into cDNA for the complete RT procedure.  The 
resultant cDNA was amplified using PCR (see Appendix D.2  ) for a housekeeping gene 
hGAP.   
3.2.7 Microcomputed Tomography Imaging & Analysis 
Each chamber biopsy from the long-term loading group was subsequently 
scanned on a compact fan-beam-type tomograph (µCT 20, Scanco Medical, Bassersdorf, 
Switzerland) also referred to as a desktop micro-CT [174].  The system uses a microfocus 
X-ray tube with a focal spot of 10 µm as a source.  To perform a measurement, the 
specimen was mounted on a turntable with axial automation.  Six hundred projections 
were collected over 216° (180° plus half the fan angle on either side).  CT images in 512 
x 512 pixel matrices were reconstructed using a standard convolution-backprojection 
procedure with a Shepp and Logan filter.  A complete set of micro-tomographic slices, 
with a slice increment of 34 µm, was acquired per sample.  Measurements were stored in 
three-dimensional (3-D) image arrays with an isotropic voxel size of 34 µm.  Noise in the 
volumetric image data was partially suppressed using a constrained 3-D Gaussian filter.  
Mineralized tissue was segmented from surrounding soft tissue using a global 
thresholding procedure [174].  These high resolution images of the chamber biopsies 
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were used as input in finite element models described later to estimate the tissue level 
strains experienced by the allograft during compression. 
3.2.8 Histology 
After long-term loading specimens were scanned using micro-CT, they were cut 
longitudinally using a custom designed cutting jig and razor saw blades.  Half the sample 
was decalcified and embedded in paraffin and the other half was embedded in methyl-
methacrylate.  All biopsy samples were sectioned longitudinally for subsequent analysis.  
Paraffin biopsy sections were stained with H&E and a modified Mallory aniline blue 
stain (mMAB) [175], as well as a stain for tartrate-resistant acid phosphatase (TRAP).   
Immunohistochemistry was performed using a monoclonal antibody (Sigma A2547) for 
α-smooth muscle actin (α-SMA) on paraffin sections.  This stain was used to quantify 
the vascularity present in the samples.  Vascular structures were simply counted for the 
entire section at a magnification of 10X. Plastic biopsy sections were either left unstained 
for fluorochrome analysis or stained with Goldner’s trichrome stain.  
Immunohistochemical assays were also performed on paraffin sections of the chamber 
biopsies.  Assays utilized monoclonal antibodies for Type I procollagen (IgG M-38) and 
osteopontin (IgG1 MPIIIB101) obtained from the Developmental Studies Hybridoma 
Bank (The University of Iowa, Iowa City, IA). 
3.2.9 Fluorochrome Analysis 
Unstained plastic sections were viewed using a Nikon Eclipse TE300 microscope 
with a motorized stage and a Toshiba 3 CCD camera run by ImagePro Plus software.  
New bone formation was quantified using fluorescent microscopy of the calcein green 
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label which encompassed the earlier tetracycline red label and co-localized to areas of 
new bone formation seen using Goldner’s Trichrome staining.  The implanted graft bone 
picked up the label to a lesser extent than the new mineralizing bone.  Using a 
magnification of 4X, nine fields of view were analyzed for each specimen representing 
the regions diagrammed in Figure 3.  The total bone volume was measured as an area 
expressing a green fluorolabel.  Because this measurement included both the implanted 
graft bone and new bone, a higher threshold was also applied to eliminate the graft bone 
and provide a measure of the total new bone volume (NBV).  The difference between the 
total bone volume and the new bone volume gave a measure of the implanted graft bone 
volume (GBV) as well.  Furthermore, if the bone formed along the surface of the graft, it 
was designated as appositional bone formation, while bone forming within the pore 
spaces was designated as intramembraneous bone.  Both appositional bone volume 
(ABV) and intramembraneous bone volume (IBV) were quantified individually.  In 
addition, a linear measurement of all graft bone surfaces was made to approximate the 
graft surface area (GSA).  Regional comparisons were made by averaging scores for all 
sections in a given zone.  Two radial zones were defined such that the inner zone includes 
fields 2, 5, and 8 while the outer zone includes fields 1, 3, 4, 6, 7, and 9.  Three 
longitudinal zones (top/middle/bottom) were defined as well (Figure 3).  Variance was 
analyzed using a General Linear Model with two factors: Animal and Load, for the 
following parameters:  graft bone volume (GBV), graft surface area (GSA), total new 
bone volume (NBV), new intramembraneous bone volume (IBV), new appositional bone 
volume (ABV), total new bone volume/ graft bone volume (NBV/GBV), new bone 
volume/ graft surface area (NBV/GSA), and new appositional bone volume/ graft bone 
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volume (ABV/GBV), new appositional bone volume/ graft surface area (ABV/GSA).  All 
statistical analyses were performed for an alpha of 0.05. 
 
Figure 3.  Zones of Analysis for Fluorescent Microscopy. 
3.2.10 Finite Element Modeling & Analysis  
The accuracy of any finite element model depends on the accuracy of the material 
properties supplied to the model.  Therefore, a reasonable value for the tissue-level 
modulus of the rabbit trabecular bone exposed to one freeze/thaw cycle must first be 
determined.  By matching known force/displacement data of a representative allograft to 
the output of a finite element model based on that sample’s architecture, a reasonable 
estimate of the tissue-level modulus may be obtained. 
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Twelve bone cores were biopsied from the distal femoral metaphyses of New 
Zealand White rabbits and sized to fit the HBC (1/4” diameter x ¼” length) in a 
procedure identical to that used to obtain trabecular allografts for the in vivo study.  Like 
the long-term loaded chamber biopsies, these bone cores were also scanned using micro-
CT.  A newer desktop CT (µCT 40, Scanco Medical, Bassersdorf, Switzerland) was 
available providing a resolution of 16 microns.  The samples were then frozen at -80C, 
thawed and mechanically tested in a confined compression scenario to simulate the rabbit 
HBC environment.  A rabbit HBC (Figure 4a) was threaded through a table-top platform 
which was immersed in room temperature PBS (Figure 4b).  A MTS TestarIIm 858 Mini 
Bionix II hydraulic test frame (Figure 4d) with a 100lb load cell and LVDT with a 
working range of 100mm was used to test these specimens in cyclic compression.  A -
0.5N preload was applied and then ramped linearly to -2.24 N in 1 second and then 
cycled sinusoidally between -2.22 N and -22.2 N in force control at 1 Hz for 30 minutes 
simulating the daily loading regimen experienced by the allografts tested in the in vivo 





Figure 4.  Mechanical Testing Setup: a) Sample in HBC, b) HBC in Platform 




A representative bone core was chosen from among these samples to be modeled 
using finite element analysis to determine the tissue modulus of rabbit trabecular bone.  
Sample XII was chosen because its architecture most represented a right cylinder without 
holes and its bone volume fraction was close to the average of the actual in vivo samples.  
To create the input mesh, the microCT images were first filtered using a constrained 3-D 
Gaussian filter (sigma = 1.2, support = 2) to partially suppress noise in the volumetric 
image data, and then mineralized tissue was segmented from surrounding soft tissue by 
using a global thresholding procedure (threshold = 143).  Scanco Medical’s Finite 
Element-software v1.0 (Basserdorf, Switzerland) was employed to generate and solve a 
model based on the microCT image data.  To limit the size of the model, the voxel data 
was first coarsened to a resolution of 32 microns.  A volume of interest was selected that 
tightly encompassed the allograft.  Next, a component labeling technique was employed 
and only the largest component kept, ridding the model of unconnected structures which 
carry no load in the scaffold, but will complicate the solution of the model.  This single 
component represented over 99.5% of the voxels in the model.  Using a voxel conversion 
technique known as digital image-based finite element meshing (DIBFEM), a 32 micron 
brick element was created to represent each voxel in the microCT image for a total of 
1.84e6 elements.  A distributed compressive load of 18.17N was applied to the top 
surface of the model (z = 0) to match the actual force amplitude applied during cyclic 
mechanical testing of Sample XII.  In addition, the base (z = zmax) was constrained to 
have no displacement in the z direction and the walls of the cylinder were constrained to 
have no displacement in the x or y directions.  Figure 5 illustrates the coordinate system 
used and the distributed load across the top surface.   
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Like most finite element modeling software, this software package makes several 
a priori assumptions about the material being modeled.  It is assumed that the model 
represents a continuum.  Harrigan has shown that this assumption is valid for trabecular 
bone when the size of the model exceeds five intertrabecular lengths [176].  A set of 48 
trabecular bone grafts harvested from the distal metaphyses of New Zealand White 
rabbits were scanned  and the average trabecular spacing for this population of bone was 
determined to be 800 microns, suggesting that any sample size over 4 mm meets the 
continuum assumption.  The samples modeled were 6 mm in both diameter and length.  
The software also assumes the material is elastic.  Mechanical testing as described above 
confirms that the tissue responds in an elastic manner in the range of loads analyzed.  
Furthermore, the software assumes small deformations in the material.  Since the applied 
apparent strain is less than 1%, this assumption is also appropriate.  The software uses an 
iterative conjugate gradient solver in combination with an element-by-element matrix-
vector multiplication scheme [177].   
 







The model was solved using an initial guess of 5000 MPa for the tissue modulus and 0.3 
for Poisson’s ratio.  The actual tissue modulus was approximated by multiplying the 
initial guess by the ratio of the apparent strain in the z-direction from the model to the 
actual apparent strain measured in the mechanical test as shown in Equation 1.  The tissue 
modulus of rabbit cancellous bone from the distal femoral metaphysis was approximated 
as 6.48 GPa.  Although supporting data is not available for rabbit bone tissue, van 
Rietbergen has shown that the tissue modulus of human cancellous bone can range from 
2.23 to 10.1 GPa, with an average of 5.91 GPa [178].  Given this range for human 



















Two representative samples were chosen from the nine long-term loaded chamber 
biopsies obtained from the in vivo study.  Specimens GW19L and GW14R were chosen 
for their architecture and were then modeled in a fashion similar to the naïve rabbit bone 
cores.  Since the resolution of the original microCT images was 34 microns, no 
coarsening of the mesh was needed.  Each voxel was modeled as a 34 micron brick 
element.  Local errors associated with DIBFEM should be minimal at this resolution 
since the average trabecular thickness of allografts in the long-term loading study was 
194 microns allowing 5-6 elements across each trabecular strut on average [179, 180].  
The models were constrained as described earlier but the distributed load was increased 
to 22.24 N to represent the actual applied load in the in vivo loading procedure.  
Furthermore, the trabecular bone’s tissue modulus was modeled as 6.48 GPa.  The 
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interstitial marrow space was not represented in the model.  Again, Scanco Medical’s 
Finite Element-software v1.0 was used to determine the solution.  The models were 
considered converged when the force and displacement residuals were less than 1e-4.  
Four output parameters were examined including the normal compressive strain along the 
longitudinal axis of the sample, the largest principal strain, Von Mises Stress, and strain 
energy density.  An interpolation algorithm was employed during post-processing to 
smooth any oscillating stress/strain response on the surface produced from “jagged” 
edges produced by the DIBFEM technique.  In addition, histograms of each parameter 
were generated ignoring the top and bottom 5% of voxels since these voxels most likely 
represent artefactual surface responses.  Appendix F includes a step-by-step guide to the 
necessary Image Processing Language (IPL, ©Andres Laib, Scanco Medical AG) 
commands required for pre-processing, solving, and post-processing these models. 
3.3 Results 
The overall number of usable biopsies obtained for analysis was eight pairs from 
the short-term loading group and nine pairs from the long-term loading group.  Five 
rabbits were euthanized prematurely due to infections along the indwelling tubing or 
complications unrelated to surgery.  One loaded sample was excluded from analysis due 
to implant instability that was discovered at the time of final harvest. 
3.3.1 RNA Extraction & RT-PCR 
While sufficient quantities of relatively pure RNA were extracted from the short-
term loading samples in Group #2, the expression of the housekeeping gene hGAP as 
determined using RT-PCR techniques was undetectable, indicating that the RNA 
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obtained was significantly degraded.  Therefore no gene expression data could be 
gathered from Group #2 specimens.  In Group #3, the purity of RNA was excellent, but 
only one nonloaded sample and three loaded samples had sufficient RNA to perform an 
RT reaction.  With such a low sample size, it was decided not to proceed with the 
subsequent investigation of early gene expression changes with a short-term loading. 
3.3.2 Qualitative Histology Results 
The analysis of the paraffin and plastic histological sections provided qualitative 
information about the tissue regeneration that occurred on the trabecular allografts in the 
hydraulic bone chamber model.  Histology confirmed that osteoblasts repopulated the 
allograft and began lining the graft surfaces as clearly shown along the bottom surface of 
the trabecula in Figure 6.   
 
Figure 6.  Osteoblasts Line Trabecular Allograft Surface of a Loaded Allograft; 
H&E at 40x 
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Three types of new bone formation were observed.  The majority of new bone was 
appositional new bone formation along surfaces of the implanted allograft (Figure 7).  
There were also fewer areas of new de novo intramembraneous bone not associated with 
an allograft surface (Figure 8).  Furthermore, one loaded sample showed large amounts of 
endochondral bone formation (Figure 9).  A few instances of osteoclastic remodeling 
through new bone into the implanted allograft were also observed.  H&E stained samples 
visually confirmed the existence of less new bone formation in the loaded experimental 
treatment group as seen in the panels below.  Immunohistochemical staining confirmed 
that areas of new bone formation were expressing the bone-associated proteins pro-
collagen type I and osteopontin.  Gross observation of loaded versus nonloaded samples 
indicated a reduction in new bone formation in loaded samples as depicted in Figure 10. 
 




Figure 8.  Intramembraneous New Bone Formation within a Loaded Sample; 
Goldner’s Trichrome at 20x 
 




Figure 10.  Typical New Bone Formation on Allografts without Loading (Left) and 
with Four Weeks of Load (Right); A = Allograft, NB = New Bone; 20x 
Similar patterns of bone formation were seen in both the paraffin and plastic 
sections.  Comparisons of serial plastic sections either unstained for fluorescence 
detection or stained with Goldner’s Trichrome illustrated that the fluorescent labels were 
diffusely spread throughout areas of new woven bone with some background labeling of 
the implanted allograft, unlike typical sequential fluorescent labeling of cortical bone.  





Figure 11.  Photomicrographs of allografts:  A,B) Goldner’s Trichrome;  C,D) 




3.3.3 Quantitative Results of Fluorochrome Label 
New bone formation was quantified using fluorescent microscopy of the calcein 
green label on unstained plastic sections which encompassed the earlier tetracycline red 
label and co-localized to areas of new bone formation seen using Goldner’s Trichrome 
staining as seen in Figure 11.  Of the nine pairs of samples obtained from the long-term 
loading study, seven pairs were considered for analysis.  Samples from animal #16 were 
excluded due to a lack of fluorescent signal in the loaded biopsy.  The loaded chamber 
never securely integrated into the surrounding bone in this animal.  The subsequent 
motion probably prevented vascularization of the graft since no fluorescent signal (even 
background) was seen in the loaded specimen only.  The nonloaded specimen showed 
typical results, but including it in the models would cause the sample to exert unusually 
high leverage since the sample is unpaired.  After an initial analysis of the remaining 
eight pairs of data, the specimen pair from animal #17 was removed from the data set as 
an outlier.  The DFITS values for these samples were ±3.42 and ±4.20 for new bone 
volume/graft surface area and new appositional bone/graft surface area respectively.  
Belseley [181] suggests considering any observation to be unusual with abs(DFITS) > 
2(p/n) or 1.41 for this model.  Upon review of this animal’s history, the loading piston 
was extremely difficult to position during surgery which may indicate that load 
transmission was compromised in this animal.  New bone volume averaged 8.20 mm2 in 
the nonloaded group and 5.88 mm2 in  the loaded group. 
Models of the graft bone volume and surface area confirmed that the assignment 
of rabbit trabecular allografts was random between the nonloaded and loaded groups 
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since there were no significant differences in graft properties between the groups.  An 
initial model of total new bone volume showed a trend toward a significant difference 
(p=0.060) between loading groups.  Ignoring the intramembraneous bone formation and 
considering just new appositional bone formation, the effect becomes significant 
(p=0.047).  Volumes of intramembraneous bone were small and exhibited no differences 
between loading groups. 
In an effort to normalize the new bone formation to the graft properties, general 
linear models were also performed on total new bone volume (NBV) and new 
appositional bone volume (ABV) normalized by either the graft volume (GBV) or graft 
surface area (GSA).  Normalization of NBV and ABV by the graft bone volume did not 
help explain the variability in the data but normalization by the graft surface area did 
improve the model.  Loading resulted in a significant change in NBV/GSA (p=0.017) and 
ABV/GSA (p=0.010).  Figure 12 shows new bone volume for each pair normalized by 
that graft’s surface area illustrating a consistent decrease in bone formation with loading 
for each biopsy pair.  
The mean and standard error for each of the statistical groups is listed in Table 1 
along with the p-values for each output parameter for a General Linear Model with Load 
and Animal used as factors to explain the variance in the data.  An analysis of regional 
zones showed no significant differences between radial or longitudinal zones as defined 





Figure 12.  New Bone Volume Normalized by the Available Graft Surface Area for 
Each Biopsy Pair from the Long-Term Loading Study of Rabbit Trabecular 
Allografts and the Overall Average for the Group (p=0.009). 























No Load 11.68 74.55 8.20 0.88 7.31 0.73 0.64 0.112 0.099 Mean 
Load 10.12 81.98 5.88 0.86 5.02 0.58 0.50 0.072 0.062 
No Load 0.85 8.95 1.26 0.20 1.18 0.12 0.11 0.014 0.014 SE 
Load 0.89 7.61 1.29 0.54 0.80 0.12 0.07 0.015 0.009 
Animal 0.077 0.413 0.060 0.555 0.047 0.126 0.103 0.017 0.010 p-




In an effort to explain the observed reduction in bone formation with loading, the 
vascularity within each construct was investigated.  An initial qualitative assessment 
suggested there might be more new blood vessels in the nonloaded samples. 
Representative samples for both a loaded and nonloaded construct are shown in Figure 
13.   
 
Figure 13.  Representative sections of a loaded (left) and nonloaded (right) sample 
stained for α -SMA (bright pink) at 10X. 
A subsequent quantitative analysis was performed by counting the number of 
vessels staining positive for α-SMA at 10X.    illustrates the number of apparent vessels 
in a given section for each sample within the long-term study.  Both a two-way General 
Linear Model using load and animal as factors and a paired t-test reported p=.68, 























Figure 14.  Number of vessels per section as identified by positive α -SMA staining 
for each loaded and nonloaded sample in the long-term study. 
3.3.5 Micro-CT and Finite Element Model Output 
A general analysis of the micro-CT images of samples from the long-term loading 
studies showed that the overall average bone volume fraction (BVF) was 37.5%.  While 
comparisons of morphology parameters do not provide meaningful data on the effect of 
loading since new bone can not be thresholded from the implanted allograft bone, these 
images do provide a useful basis for finite element models of the loaded samples.  Since 
relatively little new bone was formed overall, the endpoint image is a reasonable 
approximation of the geometry of the sample throughout the loading period.  Table 2 lists 




Table 2.  Bone Volume Fraction of Biopsies from Long-Term Loading Group 
ANIMAL ID LOADED BVF NONLOADED BVF 
10 20.70 41.11 
11 35.58 34.99 
13 43.97 43.84 
14 43.92 43.92 
15 42.43 48.98 
16 32.66 52.40 
17 44.48 26.07 
18 23.36 25.46 
19 39.73 31.79 
 
Finite element analysis of two representative samples from the long-term loading 
group was performed with reasonable agreement in the predicted tissue response between 
both samples.  At the apparent level, the average predicted normal strain in the z-
direction was 8740 µå and the average predicted normal stress in the z-direction was 0.55 
MPa.  Normal tissue strains in the z-direction range from -1060 µå to +140 µå with the 
peak of the histogram near zero strain (Figure 15).  The profile of the predicted largest 
principal strains was similar to the normal strain in the z-direction but covered a wider 
range from -1420 µå to +480 µå (Figure 16).  Von Mises stress ranged from 0 to 11.9 
MPa with the most common value being 1.2 MPa (Figure 17).  The predicted strain 
energy density ranged from 0 to 0.0115 MPa (Figure 18).  The average predicted value of 
each of the four tissue parameters is given in Table 3 for each representative sample 
along with the overall average.  Figure 19 shows a representative cross-section from the 
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center of each of the models with its architecture color-coded for largest principal strain 
and Von Mises Stress.  To better delineate patterns in the schematic, the only voxels 
represented are those ranging from the mean value minus one standard deviation to the 





Figure 15.  Histogram of Normal Strain in the Z-direction 
 




Figure 17.  Histogram for Von Mises Stress 
 
Figure 18.  Histogram for Strain Energy Density 
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Table 3.  Average Predicted Tissue Level Response of Long-Term Loaded Samples 
  14R 19L Average Std. Dev. 
åzz, µå -246.1 -246.7 -246.4 0.42 
åpl, µå -306.4 -285.8 -296.1 14.57 
VMS, MPa 4.98 3.45 4.21 1.08 






Figure 19.  Representative Cross-Sections (Central 340 microns) of Finite 






The first specific aim of this study was to characterize and quantify new bone 
formation in response to in vivo mechanical loading of trabecular bone allografts in an 
orthotopic site.  This objective was successfully met.  Several patterns of de novo bone 
formation were apparent in histological sections of the rabbit trabecular allografts in the 
long-term loading experiment.  De novo bone formation in the canine hydraulic bone 
chamber study [100] followed an intramembraneous bone formation pathway, and while 
intramembraneous bone was observed in the rabbit trabecular allografts, the majority of 
new bone formation occurred by direct apposition to the allograft.  The mineralized 
allograft provides an ideal surface for osteoconduction supporting such appositional bone 
formation.   
Unlike studies performed in most bone chamber models including the canine 
hydraulic bone chamber, endochondral bone formation was also observed.  Tagil 
however did report cartilage formation in a loaded bone chamber study of de novo tissue 
formed in a chamber resting atop the bone cortex.  The tissue in this conduction chamber 
at the time of loading represented a layered arrangement of tissues that varied from bone 
and marrow components away from the loading platen to fibrous tissue in direct contact 
with the loading platen.  Upon loading, a cartilage layer was observed only at the top of 
the biopsy near the platen [97].  For Tagil’s study, it is reasonable to postulate that 
loading of fibrous tissue in a potentially restricted vascular setting produced a cartilage 
layer, rather than concluding that loading of de novo bone formation produced cartilage.  
 
 65 
In healing fracture calluses, cartilage tissue differentiation is commonly noted in areas of 
poor vascularity and/or areas of unstable interfragmentary micromotion [13, 14, 16].  
Probst describes how spreading capillaries are disrupted by shear forces in mechanical 
unstable fractures causing a hypoxic environment favoring chondrogenic differentiation 
[15].  Furthermore, it has been demonstrated that preosseous tissue will be diverted to a 
condrogenic fate in regions of low oxygen tension [50].  One loaded hydraulic bone 
chamber in the long-term loading study never fully integrated into the femoral bone, 
allowing free rotation of the implant in the host bone.  Micromotion on a much smaller 
scale may have occurred in other loaded implants as well explaining the observance of 
cartilage and endochondral bone formation.  Either the motion itself and/or subsequent 
disruption in vascularity may have predisposed cartilage formation.  However, a 
disruption in vascularity could not be confirmed from an analysis of histologic sections 
stained for α-SMA. 
General histological observation of loaded and nonloaded samples indicated a 
reduction in new bone formation with loading.  Quantification of the fluorescent signal 
from injected bone labels confirmed a significant reduction in new bone volume per graft 
surface area available for bone formation.  Intuitively, this result seems unexpected given 
the positive results of similar experiments on de novo bone formation in canines [100] as 
well as the abundance of literature supporting enhanced bone formation with mechanical 
loading.  There are a few possible explanations.  First, in vivo compression of 
regenerating bone formation on a three-dimensional scaffold has never been investigated.  
While previous work in the rabbit hydraulic bone chamber confirmed the presence of 
osteoblasts lining trabecular surfaces and a thin layer of mineralized tissue on allografts 
 
 66 
implanted in the chamber for four weeks, the number of responsive cells and the quality 
of matrix present at the time of load onset was probably inferior to that in the canine 
hydraulic bone study of de novo bone formation in which loading was delayed for eight 
weeks.  No studies at present have been conducted to examine the impact of a connected 
matrix network on conduction of mechanically induced molecular signals, but results 
may have been different if loading had been delayed further allowing additional de novo 
bone formation prior to initiating mechanical loading.  Furthermore, it is possible that the 
loading stimulus chosen was not significant enough to induce bone formation.  The 
normal compressive strains predicted by finite element analysis in the trabecular tissue 
ranged from +140 µå to -1060 µå.  Frost’s Mechanostat Theory predicts that strains in 
this range would fall in the physiological range of loading and are therefore suitable for 
the maintenance of bone mass [34].  However, Frost’s strain guidelines are based roughly 
on apparent strains which might suggest that tissue level strains in this range may actually 
fall toward more of a disuse regime.  Interestingly, Guo modeled compression of rat tail 
vertebra using a set of loading parameters known to induce bone formation and predicted 
normal compressive tissue strains ranging from +380 µå to -1994 µå for a 100 N load 
[182].  While this range is broader than the strain range predicted for this study, the 
difference does not seem large enough to separate resorptive from formative regimes. 
However these theories more likely explain the absence of an effect of loading on 
new bone formation, when in fact a significant reduction in new bone was observed in 
loaded trabecular allografts.  Given that one loaded chamber never stably integrated with 
the femoral bone and another loaded sample demonstrated signs of chondrogenesis 
suggests that unexpected micromotion between the bone and the implant may have 
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occurred in other samples as well.  While cartilage was not observed in all loaded 
samples, micromotion may still have been significant enough to disturb the vascular 
supply such that bone formation was impeded in loaded specimens.  Given the small 
apparent deformation of 8740 µå in the axial direction, it seems possible but unlikely that 
the motion of the loading piston resulted in disrupted vascularity since local 
displacements would be even smaller and apparent deformation of 2-5% in the canine 
hydraulic bone chamber did not seem to disturb the vascular supply.  However, it is also 
possible that radial micromotion of the implant occurred due to the presence and 
pressurization of the attached indwelling tubing.  Since the tubing is transcutaneous, the 
tubing was subject to disturbances caused by the animal’s motion even though 
precautions were taken to minimize this eventuality.  Furthermore, the required pressure 
in the tubing to adequately deform the trabecular allograft was 100 psi which is the 
recommended maximum working pressure for the polyurethane tubing used.  This 
pressure was large enough to cause significant motions of the unrestricted connecting 
tubing external to the animal and palpable vibrations through the skin from the 
indwelling tubing.  Given the perpendicular orientation of the tubing attachment to the 
chamber, such vibrations may have resulted in a net moment on the chamber causing 
radial micromotion.  Such micromotion may have disturbed the vascular supply to the 
regenerating allograft through the radial infiltration ports, however a disruption in 
vascularity could not be confirmed from the histology.   Currently, no single explanation 




The second specific aim of this study was to use finite element modeling to 
predict tissue strains in the loaded trabecular allografts for comparison with patterns of 
local bone formation in order to determine a regime of adaptive tissue strains.  
Predictions of tissue level strains ranged from -1420 µå to +480 µå for the largest 
principal strain with most of the bone experiencing strains near -300 µå.  Because a 
positive adaptive response in bone formation on rabbit trabecular allografts was not 
achieved however, it was impossible to meet the primary objective of the study to 
determine a set of local tissue strains resulting in mechanical adaptation.   
The third specific aim of the study was examination of early gene response to 
mechanical loading of trabecular allografts in vivo.  Investigation of early gene 
expression using RT-PCR methods of trabecular allografts loaded for three days proved 
unsuccessful.  While others have analyzed mRNA expression in de novo bone formation 
regenerating in an empty defect [101], RNA extraction from bone forming on a trabecular 
allograft proved difficult.  Obstacles included a low ratio of metabolically active cells to 
the overall mineralized matrix present.  The trabecular allograft represents a large volume 
of devitalized matrix with only a small number of active cells on its surface.  The 
presence of an abundant mineralized matrix also interferes with and acts as a contaminant 
in the RNA extraction process. 
The outcomes of this study, although unexpected, do not suggest that pursuit of an 
in vivo bioreactor employing mechanical preconditioning of cell-seeded polymeric 
constructs should be abandoned.  The vast majority of literature supports the 
enhancement of mineralization through mechanical loading.  However, a large number of 
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factors play a role in tissue differentiation and mineralization of mesenchymal tissue 
including cellularity, vascularity, and a host of mechanical loading parameters.  Disrupted 
vascularity from micromotion, is less of a concern in a subcutaneous system because, 
unlike the rigid environment around an orthotopic chamber, the compliant nature of the 
subcutaneous environment is more likely to move with the chamber even if micromotion 
of the implant occurs.  In fact, the protocol for using the in vivo bioreactor developed 
avoided the use of transcutaneous tubing, reducing the likelihood of animal disturbance 
to the tubing which might disrupt blood supply to the regenerating scaffolds enclosed in 
the in vivo bioreactor.   In addition, the forces required to deform polymeric constructs 
are much lower due to their lower moduli, reducing the likelihood of micromotion 
associated with the actuation mechanism.  Moreover, an in vivo bioreactor may be 
employed to accomplish the same task of identifying a regime of local tissue strains 
resulting in bone formation on a three-dimensional scaffold as intended by the present 
study.  The results reported here even suggest that loading of a more cellular scaffold 






DESIGN AND DEVELOPMENT OF A NOVEL MECHANICAL LOADING DEVICE 
FOR USE AS A SUBCUTANEOUS IN VIVO BIOREACTOR IN A RODENT MODEL 
4.1 Introduction 
4.1.1 Summary 
Technology for construct development is a crucial area for tissue engineering.  
Cell-seeded scaffolds may benefit from chemical or physical preconditioning before 
implantation.  Such preconditioning may allow the construct to better meet the functional 
demands of its environment.  Most current tissue-engineered bone replacements typically 
do not utilize such preconditioning strategies, but researchers are beginning to examine 
the benefits of in vitro preculture of three-dimensional scaffolds.  This preculture period 
may promote cellular proliferation, differentiation, and/or matrix mineralization, usually 
from exposure to an array of tissue culture supplements including dexamethasone, bone 
morphogenetic proteins, and Na-β-glycerophosphate.  Wang has demonstrated the 
additional benefit of in vitro preculture to final in vivo mineralization [155].  However, 
current in vitro development of three-dimensional cell-seeded scaffolds for bone defect 
repair is limited by poor transport in and out of the scaffold of nutrients, degradation 
products, and metabolic wastes.  Construct development in vivo may be able to avoid 
such complications due to the presence of invading blood vessels into the construct.  
Others have used the in vivo environment to revascularize bone autografts and prepare 
other vascularized tissue engineering constructs [155, 167, 168].   
 
 71 
The development of an in vivo bioreactor system capable of applying a controlled 
mechanical stimulus to developing bone tissue-engineered constructs may be able to 
capitalize on the mechanoresponsiveness of osteoprogenitors to produce constructs with 
greater mineralization.  Such constructs may have greater amounts of more evenly 
distributed mineralization, possible suited for loadbearing situations.  Because of 
improved transport in an in vivo system, larger constructs may be produced with cells 
present throughout the scaffold.  For certain constructs, it may be possible to maintain the 
developed vascular structure to the orthopedic defect site, anastomosing the construct’s 
vasculature to the bone’s blood supply.  A tissue chamber system was designed and 
developed for use in the subcutaneous space of a rat.  This system is capable of applying 
a controlled intermittent stimulus via a hydraulically actuated piston to the three-
dimensional scaffold developing inside the chamber.  This chapter describes not only the 
system design, but feasibility and pilot experiments associated with the system 
development. 
4.1.2 Specific Aims 
Specific Aim #1: To verify that enclosure of a cell-seeded scaffold in a titanium chamber 
does not impede subcutaneous bone formation. 
An initial prerequisite for a subcutaneous in vivo mechanical loading system was 
assurance that bone formation could occur on cell-seeded scaffolds placed within 
titanium chambers in the subcutaneous space of rats.  A variety of cell/polymer and 
cell/ceramic combinations were placed within titanium bone chambers and implanted in 
the subcutaneous space.  Bone formation was quantified by micro-computed tomography 
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after six weeks.  It was demonstrated that enclosing a construct within a titanium 
chamber did not reduce bone formation compared to control specimens implanted 
directly into the subcutaneous space. 
 
Specific Aim #2: To design and develop a novel system to apply mechanical compression 
to tissue-engineered scaffolds prepared in a subcutaneous in vivo environment. 
An original implant system capable of applying a controlled mechanical stimulus 
to cylindrical scaffolds implanted subcutaneously in a rat was designed and created.  
Such a system may provide the ability to develop larger, stronger, and more 
homogeneous bone tissue replacements than could be developed in a diffusionally limited 
in vitro culture system.  Such pre-conditioned constructs may be better able to meet the 
functional demands of the bony environment. Furthermore, if constructs are developed in 
the final host, they may be populated with receptive host cells that will reduce the 
immunologic challenge presented to the patient when the bone defect is repaired.   
 
Specific Aim #3: To verify the functionality of new subcutaneous loading system 
hardware in vivo. 
Finally, an initial test of the performance of the newly designed subcutaneous 
tissue loading system was performed.  These experiments gave key insight into 




4.2 Subcutaneous Pilot Experiments 
4.2.1 Introduction 
Before proceeding with the idea of a subcutaneous in vivo bioreactor capable of 
applying a controlled compressive load in vivo, it was necessary to determine the 
feasibility of such an idea.  The first goal of the feasibility experiments was to determine 
if enclosing a tissue-engineered bone construct within a titanium chamber would hinder 
bone formation on the construct when implanted subcutaneously on a rat’s back.  The 
second goal of the feasibility experiments was to determine the best possible choice of 
scaffold material, cells, and culture conditions for the implanted constructs.  Therefore a 
variety of materials and cell preparation conditions were employed in these experiments. 
4.2.2 Methods  
Seventy-six scaffolds were prepared for the experiment.  Each scaffold had a 
cylindrical shape 0.25” in diameter and 0.25” in length.  Twenty-eight 60:40 
hydroxyapatite/tricalcium phosphate (Ha/TCP) samples were purchased from Berkeley 
Advanced Biomaterials (San Leandro, CA) with an average pore size of 250 microns and 
then sterilized with a 2.5 Mrad dose of gamma irradiation.  Eight polycaprolactone (PCL) 
were manufactured by a fused deposition modeling technique compliments of Dr. 
Dietmar Hutmacher at the National University of Singapore and were disinfected in 





Figure 20.  Polycaprolactone Microarchitecture  
Forty poly(L-lactide-co-D,L-lactide 70:30) (PLDL) samples were manufactured 
as published previously [183].  Briefly, PLDL was combined with 30% 
azodicarbonamide solvated in acetone and then repeatedly coated on 316 stainless steel 
wires.  Wires were bundled in heat shrink tubing and heated 20 minutes at 60C to fuse 
them together before the bundles were heated to 260C in peanut oil to decompose the 
porogen.  The wires were then removed and the bundles rinsed in hexane.  Bundles were 
cut to 0.25” lengths and rinsed in ethanol and allowed to dry.  PLDL samples were also 
sterilized with a 2.5 Mrad dose of gamma irradiation.   Scaffolds were incubated in a 20-
25 µg/ml suspension of rat plasma fibronectin (Sigma #F0635) for 16 hours at 4C, then 
rinsed three times with PBS and remained hydrated in PBS until seeded with cells.  Some 
scaffolds received a coating of rhBMP2 prior to fibronectin coating.  These samples were 
immersed in 100 µl of a 24 µg/ml solution of rhBMP2 (Sigma) and allowed to dry at 




Rat mesenchymal stem cells were obtained from Osiris Therapeutics and were 
isolated from the pooled marrow of seventeen Fisher rats and then frozen after the initial 
confluence.  Cells were expanded in alpha-MEM (Invitrogen #32561-037) with 10% fetal 
bovine serum (FBS) (Valley Biomedical lot # L7938) and 1% antibiotic/antimycotic 
(Invitrogen #15240-062).  Passaging was performed every fourth day with 0.05% trypsin, 
.53 mM EDTA-4Na (Invitrogen #15400-054) and replated at 10,000 cells/cm2.  Some 
cells were expanded in the standard media supplemented with 50 µM ascorbic acid 2-
phosphate (AsAp) and 10 nM dexamethasone to predifferentiate the cells toward an 
osteoblastic phenotype.  Since these cells were actively secreting extracellular matrix, 
treatment with a collagenase solution (150 U/ml collagenase type I and 50 U/ml 
collagenase type II (Worthington #LS004196) in serum-free alpha-MEM) was required 
prior to trypsinization to lift the cells to passage them. 
Scaffolds were seeded with a 7.5e6/ml or 9e6/ml cell suspension using a vacuum 
syringe technique.  Scaffolds were sterilely placed in the barrel of a 3ml syringe with a 3 
way stopcock on the syringe luer.  A 500 µl volume of the cell suspension was added to 
the syringe through the stopcock.  The valve was closed and a vacuum was pulled and 
released at least five times to help pull the cell suspension within the scaffold pores.  
Scaffolds were incubated at 37C for two hours before 1.5 ml media was added to nourish 
the cells.  Scaffolds were kept in a 37C incubator overnight until in vivo implantation.  
Table 4 lists the various scaffolds and cell treatments investigated in this pilot experiment 
and the number of samples used for each group.  A few extra scaffolds were prepared for 
analysis of cell viability using a Live/Dead fluorescent staining kit (Molecular Probes L-
3224) employing calcein and an ethidium homodimer.  After overnight incubation, 
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samples were rinsed three times in PBS, stained with a solution containing 4 µM 
concentrations of calcein and ethidium homodimer each, rinsed in PBS three more times 
and imaged using confocal microscopy.  Confocal images were taken at multiple depths 
and stacked to create a three dimensional representation of the scaffold using a Zeiss 
LSM 510 Confocal Microscope (Carl Zeiss, Inc.).  Additional samples were analyzed for 
double stranded DNA content using PicoGreen dsDNA Quantitation Kit (Molecular 
Probes P-11496).  See Appendix E for a detailed protocol employed to analyze DNA 
content from cells seeded on a three-dimensional scaffold. 
Table 4.  Various Tissue-Engineered Scaffolds Tested in Feasibility Experiments 
Material Dex Passage BMP2 
# 
Scaffolds  
Ha/TCP No P2 No 16 
Ha/TCP No P4 No 6 
Ha/TCP No P4 Yes 6 
PCL No P2 No 8 
PLDL No P2 No 8 
PLDL No P4 No 6 
PLDL No P4 Yes 6 
PLDL Yes P1 No 4 
PLDL Yes P1 Yes 4 
PLDL Yes P4 No 6 




Scaffolds were implanted subcutaneously into the backs of 19 male Fisher rats, 
each weighing more than 175 g, using a blunt dissection technique.  Four scaffolds were 
implanted in each animal at each of the four positions shown in Figure 21.  Two of the 
scaffolds were implanted in titanium chambers identical to the nonloaded chambers used 
in the experiments described in Chapter 2 (Figure 1).  Each scaffold/cell combination 
outlined in Table 4 had half the samples implanted within chambers and half were 
implanted directly into the subcutaneous space.  Scaffolds implanted in chambers were 
always positioned diagonally at either positions A and D or B and C. 
 
Figure 21.  Positions for Scaffold Implantation 
Anesthesia was induced using 4% isoflurane and maintained on 1-2% isoflurane 
by mask. The rat’s back was shaved and scrubbed.  The site was draped and covered in 
Ioban, a sterile antimicrobial film.  A 1.5 cm incision was made through the skin between 
positions A and B on the dorsal side of the rat parallel and slightly offset from the spine.  
Blunt scissors were used to make small pouches in the subcutaneous space on either side 
 
 78 
of the incision away from the midline as shown in Figure 22.  A single scaffold or a 
scaffold enclosed in a titanium chamber was placed in each pouch.  The incision was 
closed with wound clips.  The process was repeated for scaffolds implanted at positions C 
and D. 
 
Figure 22.  Subcutaneous Implantation of a Tissue-Engineered Bone Scaffold within 
a Titanium Chamber 
After six weeks, animals were euthanized via carbon dioxide overdose and 
scaffolds were harvested.  Scaffolds enclosed in chambers were retrieved using a thin-
walled kerchunker as shown in Figure 81.  All samples were fixed in 10% neutral 
buffered formalin for 48 hours and then stored in 70% alcohol.   
All animal procedures involving subcutaneous implants in rats without applied in 
vivo loading were approved by Georgia Tech’s Institutional Animal Care and Use 
Committee in Protocol #A02003. 
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Scaffolds were imaged using a microCT 40 in a process similar to that described 
in Section 2.2.6.  The microCT 40 differs from the microCT 20 in that serial tomograms 
are reconstructed from the raw data using a cone-beam filtered backprojection algorithm 
adapted from Feldkamp et al [184] rather than a fan-beam approach.  These samples were 
scanned at a resolution of 16 microns with the scanner operating at a voltage of 50 kVp 
and a current of 160 µA.  MicroCT images were first filtered using a constrained 3-D 
Gaussian filter (sigma = 1.2, support = 2) to partially suppress noise in the volumetric 
image data prior to segmentation to reveal the mineralized tissue from the surrounding 
soft tissue using a global thresholding procedure.  A threshold of 45 was selected for all 
PCL and PLDL samples in this experiment.  For the Ha/TCP samples, a double 
thresholding technique was attempted to isolate new bone formation from the implanted 
ceramic phase but was unsuccessful.   
For subsequent statistical analysis of PCL and PLDL bone formation, a 
normalized bone volume parameter (BVP) was examined.  Since sample diameters were 
very consistent, BVP was defined to be the bone volume per unit length of the sample 
minus the background bone volume per unit length if the polymer.  PCL had no 
background noise, but PLDL had a very small level of background noise that might 
appear as an additional 0.00228 mm2 of bone volume per unit length.   One observation 
out of 48 was removed from the data set as an outlier since is BVP was more than four 
times larger than any other sample and its corresponding DFITS value was almost eight 
times larger than the recommended maximum by Belesley [181].  General Linear Models 
were performed to search for patterns in the variance that may be attributable to the cell 
type or passage, scaffold material, BMP treatment, or enclosure in the titanium chamber.  
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Models also looked at animal, implantation position, and harvest date to further account 
for variability in the data.  All analyses per performed with alpha of 0.05.   
After scanning, samples were cut in half longitudinally using an Isomet 1000 
Precision saw (Beuhler).  If the scaffold material was PCL or PLDL, one half the sample 
was processed in paraffin and sectioned at 10 microns.  Sections were stained with H&E, 
Safranin-O, mMAB, or Goldner’s Trichrome.  Ha/TCP samples were processed in plastic 
and stained with either Sanderson’s Rapid Bone Stain [185] or Toluidine Blue. 
4.2.3 Results 
Confocal microscopy of representative PLDL samples stained with calcein and 
ethidium homodimer 24 hours after seeding revealed reasonable quantities of live cells.  
The longitudinal macroporosity allowed for deep penetration of the cells within the 
scaffold.  Of the four PLDL samples examined, the depth of penetration recorded ranged 
from 1.0 mm to 1.7 mm.  Figure 23 shows confocal images of a Live/Dead stained PLDL 
sample.  These images were acquired from the top of the cylinder looking along the 
longitudinal axis.  The side projection in Figure 23C illustrates that the cells were 




Figure 23.  A Representative Cell-Seeded PLDL Scaffold Labeled for Live (Green) 
and Dead (Red) Cells; A) Single Slice, B) Normal Projection of All Confocal Slices, 
C) Side Projection of All Confocal Slices 
Double-stranded DNA was quantified on four representative PLDL samples using 
a relatively untested protocol employing Pico-Green.  These results indicate that only 0.7-
1.2e6 cells attached to the scaffolds out of an original 4.5e6 cells in the cell-seeding 
suspension.  This represents cell-seeding efficiencies between 16-28%. 
All in vivo scaffolds appeared to be vascularized at time of harvest and did not 
appear to have initiated a significant foreign body reaction.  Such vascularization is 
apparent in Figure 24.  By visual observation, scaffolds implanted inside titanium 





Figure 24.  Representatives of Each Scaffold Material at Time of Harvest; A) 
Ha/TCP, B) PLDL, C) PCL 
Analysis of new bone formation from microCT images revealed that small 
volumes of new bone formed on PCL and PLDL.  New bone formation was evident 




Figure 25.  MicroCT Images of Cell-Seeded Scaffolds Implanted Subcutaneously for 
Six Weeks.  These Samples had No rhBMP-2 Treatment. 
Enclosed Implant Open Implant 
PCL, P2 rMSCs 
PLDL, P2 rMSCs 
PLDL, P4 rMSCs 
PLDL, P4 rMOPs 
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BVP values ranged from 0 to 0.08 mm3/mm.  Although data was collected on 48 
samples, sample sizes per ranged from 2 to 4 per treatment group due to a wide variety of 
treatments investigated.  The mean, standard error, and sample size of each treatment 
group is reported in Table 5.   
Table 5.  Mean Bone Volume Parameter, Standard Error of the Mean, and Sample 
Size for Each Treatment Condition Tested 





1 PLDL P4 MSC NO NO 0.0453 0.0058 3 
2 PLDL P4 MSC NO YES 0.0232 0.0081 3 
3 PLDL P4 MSC YES NO 0.0088 0.0023 3 
4 PLDL P4 MSC YES YES 0.0343 0.0194 3 
5 PLDL P4 MOP NO NO 0.0180 0.0019 3 
6 PLDL P4 MOP NO YES 0.0222 0.0047 3 
7 PLDL P4 MOP YES NO 0.0346 0.0044 3 
8 PLDL P4 MOP YES YES 0.0108 0.0074 3 
9 PLDL P1 MOP NO NO 0.0079 0.0001 2 
10 PLDL P1 MOP NO YES 0.0032 0.0038 2 
11 PLDL P1 MOP YES NO 0.0182 0.0088 2 
12 PLDL P1 MOP YES YES 0.0314 0.0209 2 
13 PLDL P2 MSC NO NO 0.0269 0.0179 4 
14 PLDL P2 MSC NO YES 0.0186 0.0052 3 
15 PCL P2 MSC NO NO 0.0019 0.0010 4 
16 PCL P2 MSC NO YES 0.0134 0.0043 4 
 
Figure 26 compares the mean bone volume parameter for the major factor groups.  
General Linear Models of the BVP did not show a significant difference between MSCs 
with or without predifferentiation to an osteoblastic phenotype.  Furthermore, there was 
no significant difference in BVP due to passage number or pretreatment of the scaffold 
with rhBMP2.  There was little variability from animal to animal or between implant 
position assignments.  Overall, the models could not show a significant difference 
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between bone formation on a scaffold implanted inside a titanium chamber versus on a 
scaffold implanted directly into the subcutaneous space.  However, in PCL, there was a 
significant (p=0.040) increase in BVP when the sample is enclosed in a titanium chamber 
(Figure 27).  Despite the increase in BVP for PCL when enclosed in a chamber, PLDL 





Figure 26.  Mean BVP Comparisons Based on Material Type, Enclosure in a 























































































































Figure 27.  Mean BVP Comparison for PCL Samples Implanted Within a Titanium 
Chamber of Directly in the Subcutaneous Space 
While histological processing was performed for many of these samples, 
techniques for processing tissue on polymeric scaffolds are highly experimental at this 
point, and consequently most of the results were unusable.  However, the tissue was used 
to try many different processing, sectioning and staining techniques, providing crucial 
experience which added in the successful histologic processing of polymeric scaffolds in 
future experiments.  A section of a Ha/TCP scaffold seeded with Passage 4 rat MSCs and 
implanted subcutaneously for six weeks is shown in Figure 28 to illustrate the osteogenic 
capacity of this cell source.  While the section shown is a BMP-treated scaffold, similar 




























Figure 28.  New Bone Formation on BMP2-Pretreated Ha/TCP Seeded with P4 
rMSCs and Implanted Subcutaneously in a Titanium Chamber; Plastic Sections 
with Sanderson’s Rapid Bone Stain viewed at 20x 
4.2.4 Discussion 
With a sample size of 24 pairs of scaffolds implanted subcutaneously in chambers 
or directly into the subcutaneous space, this work clearly demonstrates that enclosing 
PLDL seeded with MSCs in a titanium chamber does not impede subcutaneous bone 
formation in rats (statistical power = 0.95).  Such results indicate that the development of 
a subcutaneous in vivo bioreactor applying controlled mechanical loads to tissues 
developing within a loading device in vivo is a feasible option.  It also suggests that 
tissue-engineered constructs could be developed in vivo in shapes specified by titanium 
chambers.  Implanted titanium systems may also be used to deliver bioactive factors to 
constructs developing subcutaneously as well.  In light of visual observations of 
increased vascularity in enclosed chambers and the significant increase in bone formation 
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on PCL when enclosed in a chamber, a study quantifying the vascularization between 
enclosed and direct subcutaneous implantation may be worthwhile. 
This work also provides direction toward a cell/scaffold combination which might 
respond favorably to loading in an in vivo bioreactor.  While scaffolds with any of the 
experimental conditions tested may respond to mechanical compression, these data 
prescreened scaffold materials and several treatment options which may improve the 
ability of bone to form on the scaffold in vivo.  Few significant differences between 
treatment conditions were demonstrated but this may simply be a result of a small sample 
size.  Because many different treatments were considered, sample sizes ranged from only 
two to four samples per group.  The absence of a difference in bone formation on 
scaffolds seeded with MSCs expanded in standard versus osteogenic media was 
somewhat unexpected since the polymeric scaffold materials themselves are not 
necessarily osteoinductive.  However, since 20 scaffolds were tested using 
predifferentiated cells and 28 using undifferentiated MSCs, it may suggest that the cell 
population used was not completely undifferentiated but may have contained some 
committed osteoprogenitors.  Treatment of the polymers with rhBMP2 was employed in 
the hopes of showing an upper limit of achievable bone formation in a titanium chamber 
implanted subcutaneously for six weeks.  Unexpectedly, no benefit was gained from 
treating the scaffolds with rhBMP2.  Although the BMP was applied to the scaffolds 
using a previously published technique [166], the subsequent application of rat plasma 
fibronectin may have competed with the BMP and obscured the ability of the BMP to 
induce bone formation in surrounding cells.  Furthermore, the dosage (2.4 µg/implant or 
3.82 mg per cm3 of scaffold material) may have been inadequate.  While the dosage was 
 
 90 
based on research involving a ceramic scaffold material, recent evidence suggests that 
proper dosing of BMP2 may vary with species and carrier material [186].  While 
scaffolds seeded with Passage 4 cells performed better than those seeded with Passage 1 
or Passage 2 cells, the difference was not significant.  However, these data do 
demonstrate that bone forms more readily on PLDL seeded with rMSCs than PCL.   
4.3 System Design 
4.3.1 Design Requirements 
Several features were considered requirements for the system design.  First, a rat 
model was chosen for the availability of cells, molecular markers, and ease of animal 
handling.  Because of this choice, the system design must be small enough to be 
comfortably situated subcutaneously.  The implant would be designed for subcutaneous 
implantation on the rat’s back since this location would provide a large amount of 
workable space while minimizing the obstruction to the animal.  Furthermore, any 
transcutaneous access needs to be on the back to minimize the animal’s interference with 
the tubing or port.  Furthermore, the design must allow for adequate vascular infiltration 
to the chamber sample.  By definition, the design must incorporate a mechanism to 
deliver a controlled, compressive mechanical stimulus to the chamber sample, preferably 
in a manner compatible with our existing external solenoid-driven actuation system.  
Finally, the design must also provide for a convenient way to nondestructively remove 
the sample from the device at the time of harvest. 
Several other features were considered advantageous but not critical to the design.  
The design should allow for multiple samples to be loaded simultaneously maximizing 
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the experimental conditions that can be examined in a given animal.  As much as 
possible, the design should consider the animals comfort and minimize the implant 
profile.  The design of the system should also consider maximizing the flexibility of the 
system to test a variety of tissue scaffolds and perhaps apply a variety of both mechanical 
and biologic stimulants of tissue differentiation.  Furthermore, when possible, 
commercial components should be utilized for repeatability, supply, and reduced cost. 
A few features of the rabbit HBC system were not considered necessary for the 
design of this new system, including the ability to repeatedly biopsy the scaffold contents 
in a non-terminal procedure.  Since the design of the system may allow several samples 
per animal and is not necessarily constrained to two samples per animal, a variety of 
experimental conditions may be tested in a single animal simultaneously.  Therefore, the 
need for repeated biopsy was not considered great. 
4.3.2 Preliminary Ideas 
Many options were considered ranging from the basic chamber with a single 
transcutaneous tubing line similar to the rabbit hydraulic bone chamber to more complex 
systems involving manifolds to load many chambers and potentially completely 
implantable loading systems.  For the chamber itself, the main design challenges were 
vascularization, hydraulic access, the ability to easily biopsy the sample, and achieving 
watertight seals.  In addition, the overall profile of the chamber should allow for close 
contact between the subcutaneous tissue and the vascular ports of the chamber.  Several 
designs with suture holes were considered to pull the subcutaneous tissue close to the 
implant.  For vascular access, several hole patterns in the chamber walls were considered.  
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Hydraulic access could be achieved either through barbs and tubing similar to the rabbit 
HBC system or fixed metal ports through the skin similar to those used for electrical lead 
access in neurological studies.  Since the design requirements do not specify non-terminal 
repeated biopsies, easy sample retrieval can occur after the chamber is removed from the 
animal by either removable caps on both ends or plunger type designs. 
While the decision about hydraulic access to the chamber involves barbs or other 
metal ports, the challenge of hydraulic access to the animal is a more complicated one.  A 
fully implantable design would be optimal in which no external access is required and the 
actuating mechanism is implanted alongside the chamber.  Such designs might include 
radio controlled motors or piezoelectric materials or even the use of shape memory 
alloys.  However, the design of such a system would be complex, requiring electrical and 
controls background beyond the scope of this work.  Furthermore, the design would 
require miniaturization to fit in a rat’s back.  The components to create this design at this 
scale are not readily available.  One possible design might even include a fluid-filled 
diaphragm just under the skin that could be physically deformed through the skin, but 
obtaining feedback from the system to actively control the pressure applied would be 
problematic.  An intermediate concept might include a vascular assess port just under the 
skin that could be repeatedly pierced transcutaneously for hydraulic access.  The problem 
with this design is obtaining a water-tight seal in this diaphragm under the required high 
pressures. 
Due to the complications involved with creating a fully implantable system, it was 
chosen to create a design that could work easily with the existing external solenoid-
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driven system with active pressure feedback control (Figure 34).  Therefore during 
loading sessions, there must be some transcutaneous access to the implanted chamber.  
However, any transcutaneous access involves increased risk of infection.  Since one of 
our design requirements is a system that allows for loading of several samples per animal, 
an implanted manifold to connect all chambers to a single transcutaneous port will reduce 
the risk of infection to the animal.  Manifolds could be custom-designed to accommodate 
as many chambers as the animal can tolerate.  A manifold design should also consider the 
animal’s comfort and have a profile that keeps the chambers close to the underlying 
tissue.  To facilitate the removal of air bubbles from the system, the manifold must also 
include a bleed port. 
4.3.3 First Prototype Design 
The first prototype design that was manufactured and tested includes a custom 
manufactured manifold capable of linking four rat subcutaneous loading chambers (SLC) 
that are connected via commercial connectors (Beswick, Inc.).  A 3D rendered schematic 
of the custom pieces is shown in Figure 29 and the assembled manufactured prototype in 
Figure 30.  Complete machine drawings can be found in Appendix A.3 Rat Subcutaneous 






Figure 29.  Assembly of Initial Prototype for Manifold and Rat Subcutaneous 
Loading Chambers 
 




The rat subcutaneous loading chamber design resembles the nonloaded rabbit 
HBC with several substantial changes.  Overall, the chamber is much smaller having an 
inner diameter of 4mm.  No external threads on the chamber are needed since the 
chamber is not anchored in bone and instead of a cap the chamber has internal threads to 
mate with a standard 10-32 male connector.  Hole pattern designs were created for 
vascular access involving 2 or 3 rows of portals.  Machining complications ruled out the 
3-row design as shown in Figure 29 in favor of a 2-row design with larger diameter holes 
(Figure 30).  The design features a thin platen that sits in the bottom of the chamber.  A 
small diameter hole in the base of the chamber allows for a rod passed through the hole to 
lift the base platen, acting as a plunger to conveniently lift the sample residing in the 
chamber out during harvest procedures.  This feature was chosen over a removable end 
cap to minimize the chamber’s profile keeping the underlying tissue in close apposition 
to the chamber’s vascularization ports.  The chambers are assembled by first inserting the 
base platen, then the experimental scaffold, and finally a small piston with a .085x.036" 
Buna-N o-rings (custom order from Apple Rubber, Inc.) as diagrammed in Figure 31. 
 




The custom manifold allows for simultaneous loading of four SLCs.  The 
contoured shape creates smooth edges that are unlikely to cause lesions on the animal’s 
skin.  The SLCs mate to the manifold on 60° angled faces on either side.  When the 
manifold is aligned parallel to the vertebra, the chambers and manifold create an arcing 
shape that resembles the curvature of the rat’s back.  This allows the chambers to lie 
closer to the underlying tissue without creating as large empty tissue pockets as would be 
created if the chambers mated against an orthogonal manifold.  The manifold features a 
small flange on the bottom at the front and back of the manifold with small holes 
intended to be used for suturing anchor points to attach the manifold to the underlying 
tissue.  The manifold features a central longitudinal hole along the length with two angled 
holes intersecting from either side.  All holes have 10-32 internal threads.  Chambers can 
be mated using 10-32 male nipples and a 10-32 male connector with a hose barb is used 
on the front face to connect hydraulic loading tubing to the manifold.  Finally a 10-32 
male cap can be placed on the back face and used as a bleed valve. 
The largest perceived disadvantage of the manifold design is its large size and 
weight.  A long slot was added to the base and small through holes along the length of the 
manifold in the upper corners in an attempt to remove material and reduce the weight of 
the manifold.  This primary disadvantage spurred a second smaller design that could be 
used in the event the large manifold is too heavy for a rat. 
4.3.4 Second Design Prototype  
To create a smaller overall implant, a second design was made incorporating a 
small commercially available manifold (Beswick #MX-1010-303).  The manifold is 
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simply a small metal block with female 10-32 ports on all four sides.  Two SLCs as 
described earlier can be attached on opposite sides of the manifold using 10-32 male 
threaded nipples.  One of the remaining ports serves as a bleed valve and can be capped 
with a 10-32 plug, while the final remaining port receives an adjustable elbow barb with 
10-32 threads to a 1/16” hose barb (Beswick # SMLS-1012-303) to connect the hydraulic 
loading tubing to the manifold (Figure 32).  The miniature elbow barb keeps the overall 
size of the design small and allows the tubing to approach the chamber parallel to the 
implant.  This feature is very important since the overall design is somewhat long and 
linear, requiring the implant to lie parallel but offset to the rat’s vertebra.  The tubing 
must exit between the rat’s shoulder blades to minimize the chances of the animal 
interfering with the tubing.  In nonloaded controls, the elbow barb may simply be 
replaced by another 10-32 plug as shown in Figure 32.  Complete instructions for 
assembling this implant can be found in Appendix B.4.2 Assembly Instructions for 
Subcutaneous Rat Loading Device. 
The advantages of this design include its small size and weight as well as the use 
of a commercially available manifold, avoiding the expense and delay associated with a 
custom-machined manifold.  Unfortunately, this design is strictly limited to two 
chambers per manifold, restricting the number of experimental treatment conditions that 
can be investigated in a given animal.  The length and linearity of the design may also 




Figure 32.  Assembly of Standard Manifold with Subcutaneous Rat Chambers for 
Loading Experiments; Top (Loaded), Bottom (Nonloaded) 
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4.4 Tubing & Loading Pilot Experiments 
Several small pilot experiments were performed to decide procedural details about 
conducting loading experiments subcutaneously in rats.  Although, rats are considered 
relatively infection resistant, given our previous experience with infection along 
indwelling transcutaneous tubing in rabbits, the risk of infection was ascertained in 
several small pilot experiments meant to find a suitable tubing diameter and the 
appropriate surgical techniques and post-operative care to minimize infection and animal 
discomfort.  Since this work was performed in parallel with the design of the rat 
subcutaneous chamber and manifold system, the initial work was performed using the 
larger rabbit hydraulic bone chambers simply implanted subcutaneously with attached 
transcutaneous tubing for six weeks.   
The work investigated both 1/16” and 1/32” ID tubing with the hopes that smaller 
tubing may reduce the incidence of infection; however, no difference was seen in the 
occurrence of infection.  Although smaller tubing seemed more comfortable for the 
animal, hardware for 1/32” ID tubing is difficult to obtain and proved less effective at 
creating a watertight seal.  Anchoring the tubing to the underlying tissue by suturing a 
polyester cuff attached to the tubing with medical grade silicone glue was also attempted 
similar to the procedure described in Appendix B.3 Procedure to Implant Subcutaneous 
Loading Tubing in Rabbits (see Figure 82).  This approach reduced the incidence of 
infection in the rabbit hydraulic bone chamber model, but was not found useful in the rat 
model.  Often infection was found between the tubing and the polyester cuff itself.  The 
use of silver-impregnated glass powder to treat the exit wound was also employed and 
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provided some improvement in the rat of infection along the tubing, but did not prove as 
beneficial in rats as it did in the rabbit hydraulic bone chamber model.  Given the high 
rate of infection due to the open transcutaneous tubing, it was decided to minimize the 
amount of time the exit wound would remain open.  Pilot experiments were performed in 
which the transcutaneous tubing was clipped at the skin level and the exit wound closed 
after seven to ten days.  This action greatly improved the rate of infection.  Although it 
would have been more desirable to avoid the use of a pharmacologic agent, the use of 
prophylactic antibiotics was also employed.  A course of antibiotics (Cefazolin) 
corresponding to the length of time the tubing remained transcutaneous proved to be as 
effective as a course of antibiotics that lasted the entire six week period.  Additionally, 
this work demonstrated the need for the rat to wear an Elizabethan collar when the tubing 
is exposed to prevent the animal from chewing through the tubing. 
Two more pilot experiments were performed once the rat subcutaneous loading 
chambers and manifolds were designed and manufactured.  These experiments employed 
loading of PLDL enclosed in the rat SLC.  The purpose of these experiments was to 1) 
ensure the animal could physically tolerate the manifold/chamber assembly, 2) test the 
implanted hardware connections for leakage, 3) troubleshoot the overhauled external 
hydraulic loading system (Figure 34), 4) choose between manifold designs, and 5) choose 
between polyurethane and PTFE for the implanted loading tubing.  The first experiment 
pointed out several mechanical hardware revisions that had to be made to the external 
loading system.  The choice between manifold designs was made very clear.  Although 
the larger custom manifold had previously been successfully implanted and tolerated by a 
test rat, it was clear that the addition of loading tubing and SLCs made the implant much 
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too uncomfortable for the animal.  Each of the four animals receiving the large custom 
manifold exhibited signs of pain and anorexia and had to be euthanized within a few 
days.  Furthermore, surgical implantation of the larger custom manifold is more difficult.  
The overall design allows several empty tissue pockets that must be sutured close to both 
reduce infection and keep the tissue close to the SLC.  The small commercial manifold 
was tolerated better by the rats, but the animals still appeared uncomfortable, probably 
because of the external tubing and the need for the animals to wear Elizabethan collars.  
Simply wearing the collar is stressful for the rats and prevents grooming.  These animals 
exhibit red secretions around the eyes and nose, a typical reaction to stress in rats.  The 
stiff transcutaneous tubing may also cause the animal some pain as it ambulates. 
Following our veterinarian’s suggestion, a second loading experiment featured a 
loading protocol in which the implanted tubing remains beneath the skin at all times, 
except for a short period of time surrounding each loading session.  A minor surgical 
technique was performed in each animal immediately before the loading session to 
expose the tubing.  Immediately after the 30-minute loading session, the tubing was 
placed beneath the skin and the incision closed with wound clips.  A more detailed 
description of the procedure can be found in Appendix B.5 Procedure for Exposing 
Implanted Tubing for Loading Sessions in Rats.  Although this procedure greatly 
complicates loading sessions, it reduces the risk of infection along the indwelling tubing 
and improves the animal’s comfort by removing the exposed tubing and accompanying 
Elizabethan collar, both improving the animal’s chances of survival.  In addition, this 
final loading experiment demonstrated that polyurethane, which is more flexible than 
PTFE, could withstand pressures of 200 psi in our loading system without bursting or 
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leaking.  A leak occurred in one animal with PTFE tubing because the barb loosened 
from the manifold suggesting that PTFE tubing maybe too stiff to allow bending and 
motion of the tubing during the loading procedure.  Polyurethane tubing was chosen for 
successive loading experiments. 
4.5 Discussion 
The first objective of examining the effect of enclosing a cell-seeded scaffold in a 
titanium chamber on bone formation on the scaffold was successfully completed.  This 
work conclusively demonstrated that enclosure of a scaffold within a titanium chamber 
does not impede the formation of bone.  This was an important prerequisite for the design 
of a subcutaneous bioreactor employing mechanical stimulation of constructs.  
Interestingly, bone formation on polycaprolactone scaffolds significantly increased when 
scaffolds were implanted within a titanium chamber rather than directly in the 
subcutaneous space.  The reason for this is unclear, but studies investigating vascular 
ingrowth in the chambers may be worthwhile given gross visual observations of 
enhanced vascularity in loaded samples. 
The second stated objective of designing a mechanical loading system for the in 
vivo preconditioning of tissue-engineered scaffolds was also completed.  The final design 
joins a pair of custom-made scaffold chambers with a commercially available miniature 
manifold.  Hydraulic tubing connected to the manifold via an angled adjustable barb can 
be connected to an external loading system with active pressure feedback control.   
Attractive features include its relatively small size, the ability to load more than one 
scaffold at a time, and its use of readily available commercial parts. 
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Finally, the functionality of the subcutaneous mechanical loading system was 
verified in pilot experiments.  These experiments demonstrated the tremendous infection 
risk associated with the use of indwelling transcutaneous tubing, despite monumental 
effects to reduce the potential for infection.  Because this threat could significantly 
jeopardize studies employing the subcutaneous mechanical loading system, a protocol 
was developed in which the hydraulic loading tubing removes subcutaneous except 
during a brief period surrounding each loading session, rather than continuous 
transcutaneous exposure of the tubing.  Using this protocol, the novel in vivo bioreactor 
implant designed represents a robust system to mechanically precondition an array of 




CYCLIC MECHANICAL COMPRESSION ENHANCES THE DEVELOPMENT OF 




In an effort to produce tissue-engineered constructs capable of meeting the 
functional demand of bone defect sites, a novel in vivo bioreactor capable of imparting a 
cyclic mechanical stimulus to developing constructs has been designed to capitalize on 
both the vascular in vivo environment and the responsiveness of osteoprogenitors to their 
local mechanical environment.  To determine the ability of this novel system to enhance 
bone construct development, a study was performed to investigate bone formation on 
polymeric constructs seeded with mesenchymal stem cells.  Given that a successful tissue 
engineering strategy may need to employ several scaffold preparation techniques and that 
mechanoresponsiveness may depend on the level of cell and tissue maturity, the effect of 
in vitro preculture of the cell-seeded constructs prior to in vivo implantation in the loaded 
subcutaneous chamber system on load-induced changes in bone formation was also 
investigated.  Scaffold preparations included a no preculture group to represent the 
simplest approach of seeding cells on a scaffold and directly implanting the scaffold, a 1-
week preculture group to represent minimal in vitro preparation but which may commit 
the cells to an osteoblastic phenotype, and an 8-week preculture group with pre-existing 
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mineralized nodules.  While the data suggests a significant effect of preculture time on 
matrix mineralization, an experimental complication with cell-seeding prevents any 
conclusion concerning preculture time.  Overall the data show that cyclic in vivo 
mechanical loading results in a significant increase in matrix mineralization.  
Furthermore, the data suggest that cyclic in vivo mechanical loading may be necessary to 
prevent resorption of mineral deposited during in vitro preculture. 
5.1.2 Specific Aims and Hypotheses 
Specific Aim #1: To quantify the effect of controlled in vivo mechanical compression on 
new bone formation within tissue-engineered constructs for bone defect repair prepared 
in a subcutaneous in vivo bioreactor.   
Subcutaneous loading chambers (SLCs) containing polymeric scaffolds seeded 
with rat mesenchymal stem cells were implanted in the subcutaneous space on the back 
of male Fisher rats.  Cyclic mechanical compression was applied to the developing 
constructs three times per week for two weeks and samples were harvested at the end of 
six weeks.  New bone formation was quantified using micro-computed tomography 
imaging.  It is hypothesized that cyclic mechanical compression will increase new bone 
formation within cell-seeded polymeric constructed developed subcutaneously. 
 
Specific Aim #2: To quantify the effect of length of in vitro preculture on load-induced 
changes in new bone formation within tissue-engineered scaffolds prepared in a 
subcutaneous in vivo bioreactor. 
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Polymeric scaffolds were seeded with rat mesenchymal stem cells and then cultured in 
media containing osteogenic supplements for one week or eight weeks.  These scaffolds, 
along with no preculture and cell-free controls, were implanted into subcutaneous loading 
chambers in the backs of male Fisher rats.  A portion of these scaffolds also received 
mechanical loading treatments for three times a day for two weeks.  Samples were 
harvested after six weeks in vivo.  New bone formation was quantified using micro-
computed tomography imaging.  Given the presence of pre-existing mineral may act as 
nucleation sites for further mineralization, it is hypothesized that load-induced changes in 
bone formation will be amplified with longer preculture preparation of cell-seeded 
constructs.   
 
Specific Aim #3: To predict tissue-level strains and stresses resulting from cyclic 
compressive loading of polymeric constructs developed in the subcutaneous loading 
chamber system. 
Micro-computed tomography images of representative polymer scaffolds were used to 
create a digital image based finite element mesh for the basis of finite element models 
representing the applied in vivo loading conditions.  Predicted tissue stresses and strains 
were generated.   
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5.2 Methods and Materials 
5.2.1 Scaffold Choice and Manufacture  
The decision of which scaffold material to use for the study was a critical one.  
While the ideal matrix would necessarily be osteoconductive, it should also promote cell 
adhesion, mitosis, and differentiation while providing some initial mechanical stability.  
A critical requirement for this study is sufficient mechanical integrity to resist a moderate 
cyclic mechanical stimulus without permanent deformation or brittle failure.  Previous 
work performed in the hydraulic bone chamber model suggests that apparent 
deformations in the range of 2-5% should result in differences in new bone formation 
[100, 102] and thus represent the target apparent deformation for this study.  Even though 
there may be other explanations, apparent deformations of 0.8% did not result in 
differences in new bone formation on frozen allografts in the rabbit hydraulic bone 
chamber model (see Section 2.3.4).  It is imperative that greater deformations are applied 
to the scaffold in this work. 
PLDL was chosen to be the scaffold material for the tissue-engineered bone 
constructs for several reasons.  It has adequate elasticity to recover from repeated 
compressive loads sufficient to have the material deform within a 2-5% range.  
Furthermore, the stiffness of PLDL when manufactured with 30% porogen (E = 43.50 
MPa) [183] is neither too stiff nor too compliant such that the loading system can 
perform in its designated pressure range and still deform the tissue 2-5%.  Furthermore, 
PLDL samples offer more architectural consistency than natural scaffold materials such 
as bone or coral products.  It has no native osteoinductive capacity like demineralized 
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bone that could obscure differences in treatment groups.  PLDL performed well in the 
previous pilot experiments without eliciting a significant foreign body reaction. 
Other materials were considered and deemed less desirable, including 
demineralized bone matrix, polycaprolactone (PCL), and CollaGraft.  Although 
demineralized bone represents an attractive bone scaffold material clinically because of 
its osteoinductive properties, that same property could obscure bone formation caused by 
the addition of cells, in vitro pre-treatment of those cells, and/or loading.  Furthermore, 
finite element analysis of the tissue level stresses and strains experienced during loading 
treatments requires that the scaffold be imaged using microCT.  It would be impossible to 
adequately image the bone matrix after demineralization.  The consistent and repeatable 
architecture of PCL created by a fused deposition modeling technique was very attractive 
and therefore examined during the pilot work described in Chapter 4.  However, 
significantly more bone formed on PLDL than PCL in those experiments.  PLDL was 
also more readily available since it could be manufactured in our laboratory.  CollaGraft 
was excluded from consideration because of the high structural variability in natural 
materials and because the architecture could not be imaged using microCT.  
PLDL samples were manufactured as published previously [183].  Briefly, PLDL 
was combined with 30% azodicarbonamide solvated in acetone and then repeatedly 
coated on 316 stainless steel wires.  Wires were bundled in heat shrink tubing (100 wires 
per bundle) and heated 20 minutes at 60C to fuse them together before the bundles were 
heated to 260C in peanut oil to decompose the porogen.  The wires were then removed 
and the bundles rinsed in hexane.  Bundles were cut to 5 mm lengths and then punched 
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with a 4 mm skin biopsy punch to ensure a consistent diameter.  Finally, samples were 
rinsed in ethanol and allowed to dry.   
5.2.2 Mechanical Testing of PLDL 
Mechanical tests were performed on a set of PLDL samples (4 mm diameter by 5 
mm length) to determine if the compressive modulus changes after sterilization by 
gamma irradiation and after extended exposure to an aqueous environment.  These two 
processes may affect the mechanical properties due to cross-linking of the polymer 
during gamma irradiation or degradation of polymer chains with exposure to a saline 
environment.  Lin et al [183] reports the compressive modulus for PLDL manufactured 
with 30% azodicarbonamide to be 43.50 MPa, but these samples had not been exposed to 
gamma irradiation or extended exposure to an aqueous environment, even though the 
tests were performed in a saline bath.  Three treatment groups were considered including 
no gamma/no soak, gamma/no soak, and gamma/soak with 6 scaffolds per group.  
Samples in the gamma groups were exposed to 2.5 Mrad gamma irradiation and those 
samples that were soaked were exposed to Ca-free, Mg-free Dulbecco’s PBS (Invitrogen 
#14190136) at 37 C for 46-48 days.  The samples were mechanically tested in a confined 
compression scenario simulating the rat subcutaneous chamber environment.  A 4 mm 
internal diameter titanium rat chamber was threaded through a table-top platform which 
was immersed in room temperature PBS.  Samples were placed in the chamber with a 1 
mm thick smooth platen placed on top of the scaffold to distribute the applied load.  A 
MTS TestarIIm 858 Mini Bionix II hydraulic test frame (Figure 4d) with a 100lb load 
cell operating in the 100 N range and LVDT with a working range of 10 mm was used to 
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test these specimens to failure in displacement control.  A -1 N preload was applied and 
then ramped linearly to -0.1% displacement at 1 mm/min.  The sample was 
preconditioned by loading sinusoidally from 0.1% to 1.0% displacement ten times at 0.5 
Hz before ramping to 15% displacement at 1 mm/min resulting in failure.   
Stress-strain data was calculated from recorded load and displacement 
measurements.  Figure 33 shows representative stress-strain curves for each of the three 
treatment groups tested.  The compressive modulus was determined by the slope of the 
linear elastic region of the stress-strain curve.  The yield point was defined by a standard 
0.2% offset method.  One sample in the group exposed to gamma irradiation seemed to 
be an outlier.  This was the only sample tested that was also microCTed prior to 
mechanical testing.  This sample was excluded from statistical analysis.  The average and 
standard deviation of the yield strain, yield stress, and compressive modulus are reported 





















Figure 33.  Representative Stress-Strain Curves for Failure Tests of PLDL Made 
with 30% Porogen 
 
Table 6.  Failure Test Results for PLDL with 30% Porogen 












NO GAMMA/NO SOAK -0.068 0.018 -3.81 0.87 80.0 22.2 
GAMMA/NO SOAK -0.054 0.013 -3.84 0.47 96.8 17.9 




Analyses of variance were performed with alpha = 0.05 for all three of these 
parameters using all data points except the one outlier described above.  These analyses 
show that neither gamma irradiation nor extended exposure to an aqueous environment 
affect the yield strain.  Gamma irradiation did not affect the yield stress, but a one-way 
analysis of variance (ANOVA) shows that extended exposure to an aqueous environment 
did significantly (p = 0.034) reduce the yield stress of PLDL.  Compressive modulus 
showed a similar trend in that gamma irradiation had no effect, but exposure to saline 
significantly (p = 0.022) reduces the compressive modulus. 
Cyclic tests were also performed to ensure that samples prepared in an identical 
manner to those to be implanted in the in vivo study could tolerate repeated loading 
similar to that planned for the in vivo rat loading experiment.  Eight PLDL samples were 
prepared using 30% porogen, then exposed to 2.5 Mrad gamma irradiation, and then 
soaked in PBS at 37C for 48-50 days.  Samples were cyclically tested in confined 
compression using the same hardware described for the failure tests.  The force signal on 
the test frame was first tuned to a sine wave (P = 88, I = 8.5, D = 0).  A preload of -0.5 N 
was applied and the force then ramped to -1.42 N.  Under force control, the applied force 
was then cycled from -1.42 N to -14.2 N at 1 Hz for 3 hours (10800 cycles).  This load 
was chosen because early calibration data of the hydraulic loading system suggested the 
maximum load that could be applied by the system to a scaffold in the 4 mm rat chamber 




5.2.3 MicroCT Imaging & Analysis of Representative PLDL Samples 
In order to characterize the architecture of the scaffold material for the in vivo 
loading experiment, 12 naïve PLDL samples manufactured at the same time as those used 
for the in vivo experiment were imaged using Scanco’s MicroCT 20 as described in 
Section 3.2.7 at a resolution of 30 microns with the scanner set to a voltage of 50 kVp 
and a current of 160 µA using an integration time of 150 ms.  A volume of interest was 
selected to tightly encompass each sample.  MicroCT images were first filtered using a 
constrained 3-D Gaussian filter (sigma = 0.8, support = 1) to partially suppress noise in 
the volumetric image data prior to segmentation to reveal the polymer from the 
surrounding background using a global thresholding procedure.  A threshold of 28 was 
selected and used to evaluate all twelve PLDL specimens.  The thresholded 3D volumes 
were evaluated for histomorphometric parameters using direct distance transformation 
methods which, unlike many previous methods used to analyze trabecular bone, does not 
assume a specific plate or rod-like architecture [187, 188].  Table 7 outlines these 
parameters and their average values for the PLDL used in this study.  Three of the twelve 
samples imaged were subsequently soaked in PBS at 37 C for 8 weeks, scanned again, 
and histomorphometric parameters evaluated to determine if extended exposure to a 
saline environment changes the architecture of PLDL.  No differences in properties with 
soaking were apparent but the number of samples considered was very small. 
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Table 7.  Microarchitectural Parameters for PLDL Produced for In vivo Loading 
Experiment; Average ± Standard Error 
Volume Fraction (%) 29.7+1.0 
Strut Density (mm-1) 2.68+0.09 
Strut Thickness (µm) 134.8+3.3 
Strut Spacing (µm) 397.8+16.0 
Degree of Anisotropy 1.57+0.04 
 
5.2.4 Scaffold Seeding and Preculture  
Samples were sterilized with a 2.5 Mrad dose of gamma irradiation.  Five to six 
scaffolds were placed within the barrel of a 1 ml syringe with a 3-way stopcock on the tip 
and then covered with a 25 µg/ml solution of rat plasma fibronectin (Sigma #F0635).  A 
vacuum was drawn on the syringe by extending the syringe plunger with the stopcock 
closed 5-6 times to help the fibronectin penetrate the PLDL pores.  Scaffolds were 
incubated in the fibronectin solution overnight at 4C, then rinsed three times with Ca-
free, Mg-free PBS in 24-well plates.  Scaffolds remained hydrated in Ca-free, Mg-free 
PBS at 37C until seeded with cells.   
Scaffolds were seeded at three different times depending on the length of pre-
culture time assigned to each treatment group.  Seedings were timed such that all 
scaffolds would be ready for in vivo implantation on the same day to allow for a balanced 
design of treatment assignments among the rats.  Because mechanical testing of PLDL 
showed a reduction in compressive modulus with exposure to saline, it was imperative 
that all scaffolds were exposed to an aqueous environment for an equal time prior to 
implantation.  All scaffolds were coated in fibronectin at the same time but had varying 
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periods of time in PBS afterward before seeding with cells such that the total time in PBS 
and pre-culture equaled eight weeks for all scaffolds.  This means that the 8-week 
preculture group spent eight weeks in culture prior to implantation while the 1-week 
preculture group spent seven weeks in PBS and 1 week in culture, and finally the no 
preculture group spent eight weeks in PBS prior to seeding with cells and in vivo 
implantation.  Consequently, Seeding #1 for the 8-week preculture group occurred 24 
hours after the scaffolds were coated with fibronectin.  Seeding #2 for the 1-week 
preculture group occurred seven weeks later and Seeding #3 for the no preculture group 
occurred one week after Seeding #2.  Cell-free PLDL samples remained in PBS for the 
entire eight weeks after fibronectin coating prior to implantation.  Scaffolds from all 
groups were implanted within 48 hours of Seeding #3. 
Rat mesenchymal stem cells were obtained from Osiris Therapeutics and were 
isolated from the pooled marrow of seventeen Fisher rats and then frozen after the initial 
confluence.  Cells were expanded in alpha-MEM (Invitrogen #32561-037) with 10% FBS 
(Valley Biomedical lot # L7938) and 1% antibiotic/antimycotic (Invitrogen #15240-062).  
Passaging was performed every fourth day with 0.05% trypsin, 0.53 mM EDTA-4Na 
(Invitrogen #15400-054) and replated at 10,000 cells/cm2 for a total of four passages.  
Cells were passaged in this way separately for each preculture group starting from the 
same frozen lot of P0 rMSCs from Osiris.   
Scaffolds were seeded with a 20e6/ml suspension of freshly expanded P4 rMSCs 
in serum-free media using the vacuum syringe technique described above.  A 100 µl 
volume of the cell suspension was added to the syringe through the stopcock.  Scaffolds 
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were incubated at 37C for two hours before 1.5 ml serum-free media was added to 
nourish the cells.  Scaffolds were kept in a 37C incubator overnight.  After Seeding #1 
and #2, scaffolds were moved to 12-well non-tissue culture treated plates and cultured in 
5ml of the standard media described above supplemented with 10 nM dexamethasone, 50 
µM ascorbic acid-2-phosphate, and 3 mM Na-β-glycerophosphate.  Media was changed 
twice weekly until the specified preculture time ended and samples were implanted in 
vivo.  Scaffolds in the no-preculture group were implanted within 48 hours of cell-
seeding.   
Three extra scaffolds at each seeding were prepared for analysis of cell viability 
using a Live/Dead fluorescent staining kit (Molecular Probes L-3224) employing calcein 
and an ethidium homodimer.  After overnight incubation, samples were rinsed three times 
in PBS, stained with a solution containing 4 µM concentrations of calcein and ethidium 
homodimer each, rinsed in PBS three more times, and imaged using confocal 
microscopy.  Confocal images were taken at multiple depths and stacked to create a three 
dimensional representation of the scaffold using a Zeiss LSM 510 Confocal Microscope 
(Carl Zeiss, Inc.).  Three additional samples were analyzed for double stranded DNA 
content using PicoGreen dsDNA Quantitation Kit (Molecular Probes P-11496) from each 
preculture group.  See Appendix E for a detailed protocol to analyze DNA content from 
cells seeded on a three-dimensional scaffold. 
5.2.5 Parallel In vitro Assays 
Eighteen extra PLDL samples seeded with P4 rMSCs at Seeding #1 and Seeding 
#3 were cultured in vitro in 5 ml of the standard media described above supplemented 
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with 10 nM dexamethasone, 50 µM ascorbic acid-2-phosphate, and 3 mM Na-β-
glycerophosphate.  Media was changed twice weekly.  In addition, six cell-free PLDL 
scaffolds were cultured alongside those from Seeding #1 in supplemented media.  
Samples from each seeding group were harvested after 1, 7, 8, and 14 weeks for microCT 
imaging and quantification of mineralized volume.  Samples were harvested at weeks 1 
and 8 to determine an average amount of mineralization at the time of in vivo 
implantation for samples in the 1-week and 8-week preculture groups.  Samples were 
harvested at weeks 7 and 14 to determine the equivalent amount of mineral that could 
have been obtained by the 1-week and 8-week preculture samples if they had been 
cultured in vitro the entire time rather than implanted in vivo for six weeks.  Additionally, 
samples from each seeding group were also harvested at weeks 1 and 8 for RNA 
extraction.  The intent was to look for gene expression of osteonectin and bone 
sialoprotein, but the samples were never processed.  For each assay, three samples were 
taken both seeding groups.  It was felt that there was greater statistical power in having a 
small n, but repeating the experiment at two different seeding times rather than taking a 
large n for each assay all from the same seeding group. 
5.2.6 Surgical Procedure 
All animal procedures involving subcutaneous implants in rats with applied in 
vivo loading were approved by Georgia Tech’s Institutional Animal Care and Use 
Committee in Protocol #A02023.  Animals received antibiotic (Cefazolin) treatment for 
the first three weeks of the experiment and pain medication (Buprenex) for 48 hours after 
any new incision. 
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One rat subcutaneous loading device was implanted under the skin on the backs 
of 35 male Fisher rats (175-250g) using a blunt dissection technique described in 
Appendix B.4 Procedure for Implantation of Subcutaneous Rat Loading Device.  Each 
device consists of two chambers, each containing one prepared tissue-engineered 
construct.  A two-inch piece of polyurethane tubing (Cole-Parmer #95625-00) was 
attached to the implant and remained under the skin except during periods of loading 
when the tubing was exposed and attached to the external loading system to apply a 
controlled compressive stimulus to the constructs inside the two chambers of the loading 
device.  Twenty of the rats received loading treatments and fifteen did not.   
A total of 70 constructs were implanted.  The sample size per treatment group is 
listed in Table 8.  A nominal sample size of eight was chosen.  A larger sample size was 
assigned to loaded treatment groups because of the greater risk of losing these animals to 
infection or complications arising from anesthesia during the course of the experiment.  A 
smaller sample size was employed for the cell-free groups since little variability is 
anticipated in these samples.  Treatment assignments balanced the number of samples 
within a given treatment that were placed in either the top or the bottom chamber of the 
implant.  Time restraints prevented all scaffolds from being implanted the day after 
Seeding #3.  Two samples from each treatment were implanted in the final eight rats on 
the second day after Seeding #3.  Furthermore, two samples from each of the loaded 1-
week and 8-week preculture groups were not originally planned into the study but were 
added to help compensate for the loss of four animals due to complications with 
anesthesia during the first few days of loading.  Therefore, these four samples were 
implanted into two rats a week later.   
 
 119 
Table 8.  Treatment Groups and Number of Each Implanted 
Preculture Loading Sample Size 
No Preculture No 8 
No Preculture Yes 10 
1 Week Preculture No 8 
1 Week Preculture Yes 12 
8 Week Preculture No 8 
8 Week Preculture Yes 12 
Cell-Free No 6 
Cell-Free Yes 6 
 
5.2.7 Loading Regimen 
Constructs in the rat subcutaneous loading device were compressed by connecting 
the polyurethane tubing attached to the loading device to an external solenoid-driven 
loading system with active pressure feedback.  The external system shown in Figure 34 is 
the same system used in the loading study of frozen trabecular allografts in rabbits 
described in Chapter 2 (see Figure 2), except the system was remanufactured with a more 
powerful solenoid increasing the maximum pressure capability of the system to 200-250 
psi.  Consequently, many of the connectors and the manifold on the system also had to be 
replaced to accommodate the higher pressures.  The new stainless steel manifold is 
shown in Figure 35 and was angled as such to aid in the removal of bubbles from the 
system.  Although not useful for this study, the system remodel also allowed the system 
to operate at frequencies as high as 30 Hz. 
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Figure 34.  Solenoid-driven Loading System used to Compressively Load Constructs 




Figure 35.  Stainless Steel Manifold on External Loading System 
Calibration of the system pressure to the applied load in a mock chamber set-up 
(Figure 36) was performed to determine the extent of frictional losses occurring in the 
chamber due to the friction of the piston o-ring.  A pressure of 200 psi on the external 
system correlates to 0.64 V on the load cell attached to the mock chamber setup.  A 
separate calibration of the load cell with known weights indicated a force/voltage 
relationship of 4.61 V for the load cell.  Therefore, when the system operates at 200 psi, 
the tissue in the chamber (4 mm diameter) experiences 13.3 N force and an average 




Figure 36.  Mock Chamber Setup for Calibration of the External Solenoid-Driven 
Loading System 
Loading sessions began 3-4 days after implantation of the constructs.  Just prior to 
the initial loading treatment, anesthesia was induced in the rat and a small incision made 
over the free end of the tubing on the rat’s back.  The tubing was exposed, a luer 
connector added, and the device was connected via the tubing to the external solenoid-
driven loading system.  Once the animal was sternally recumbent, it was placed in a thin 
plastic restraining cone and loading performed.  After the loading session was complete, 
anesthesia was again induced in each rat while the loading tubing was placed back under 
the skin and the incision closed with wound clips.  During subsequent loading sessions, 
these wound clips were simply removed from the anesthetized animal and the tubing 
pulled back out without further incision since the wound margins do not have sufficient 
time to heal between loading sessions.  A more detailed protocol may be found in 
Appendix B.5 Procedure for Exposing Implanted Tubing for Loading Sessions in Rats. 
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Each device was loaded three times per week for 2 weeks.  This brief loading 
window was selected to minimize the risk of infection and trauma for the animal.  Other 
studies have shown that even a single load application can result in changes in gene 
expression of bone-related transcription factors and cell-signalling pathways [75, 101]  
Since a target of 2% strain was selected, each loading session applied a cyclic sinusoidal 
pressure ranging from 1.33 N to 13.3 N at 1 Hz for 30 minutes similar to previous 
experimental work [100][81][79][75] and the allograft study described in Chapter 3.  In 
order to apply this load range to the constructs within the chambers, the external loading 
system was required to operate at 20-200 psi. 
5.2.8 Harvest 
Six weeks after the in vivo implantation of the subcutaneous hardware and tissue-
engineered bone constructs, the rats were euthanized by carbon dioxide overdose.  The 
entire device was carefully dissected from the subcutaneous space and the chambers 
unscrewed from the manifold.  Constructs were retrieved from the chambers by pushing 
the base platen up with a thin rod inserted in the hole on the base of the chamber, lifting 
the scaffold out of the chamber.  Each construct was immediately placed in 10% neutral 
buffered formalin for 48 hours to fix the tissue.  Constructs were rinsed for 15 minutes in 
running deionized water, then transferred to 70% reagent alcohol for storage at 4 C. 
5.2.9 MicroCT Imaging & Analysis 
All constructs from the in vivo study, both loaded and nonloaded, were imaged 
using micro-computed tomography as well as samples from the parallel in vitro study 
harvested at 1, 6, 7, or 14 weeks.  Three samples at a time were stacked inside the barrel 
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of a 1 ml syringe with Teflon spacers separating the samples.  Samples were immersed in 
70% alcohol.  The syringe assembly was wrapped in foam and secured inside a 16.4 mm 
scanning tube.  Scaffolds were imaged using a desktop microCT scanner (µCT 40, 
Scanco Medical, Bassersdorf, Switzerland) in a process similar to that described in 
Section 4.2.2.  These samples were scanned at a resolution of 16 microns with the 
scanner operating at a voltage of 45 kVp, a current of 177 µA, and an integration time of 
150 ms.  A volume of interest was selected to tightly encompass each sample.  MicroCT 
images were filtered using a constrained 3-D Gaussian filter (sigma = 1.0, support = 1) to 
partially suppress noise in the volumetric image data prior to segmentation to reveal the 
mineralized tissue from the surrounding soft tissue using a global thresholding procedure.  
A threshold of 59 was selected for all samples in this experiment.  This value represents 
the average of 16 different visual observations of the appropriate 2D threshold across all 
the in vivo and in vitro treatment groups demonstrating substantial bone formation.  New 
bone volume (BV) was determined by the number of voxels attenuating x-rays above this 
defined threshold level (Obj#) multiplied by the volume of each voxel (4.41e-6 mm3).  To 
better represent the amount of available pore space in the PLDL that was actually filled 
with bone (% pore fill, %PF), the new bone volume was normalized by the PLDL pore 






















While exact measurements of the PLDL pore volume could not be made because 
PLDL attenuates x-rays in a manner very similar to the alcohol the sample was 
submerged in, the pore volume was estimated to be the total scaffold volume multiplied 
by the average PLDL porosity as determined from representative naïve PLDL scaffolds 
(Section 5.2.3).  The average porosity was determined to be 0.7028.  Subsequent 
statistical analyses were made of the percentage of pore space filled with new bone 
(%PF).  Analyses of variance were conducted using an alpha of 0.05.  %PF was 
determined for each sample as a whole as well as by longitudinal region for samples in 
the 8-week preculture loaded group.  Each sample was subdivided into three longitudinal 
regions representing the top and bottom 25% and the middle 50% of the sample.  The top 
was arbitrarily defined by the end of the scaffold having more mineral since no markers 
were placed on the scaffolds at the time of harvest to differentiate top from bottom.   
5.2.10 Histology 
A representative subset of samples from both the in vivo study and the parallel in 
vitro mineralization study was chosen for histological analysis after microCT imaging 
and analysis.  One scaffold from each of the cell-free groups was selected as well as two 
samples from each of the in vitro mineralization groups, and three samples from each of 
the in vivo groups.  More scaffolds were analyzed from the in vivo groups because more 
variability was expected in these samples.  The two scaffolds selected from each in vitro 
group were the samples with the most and least mineralized volume as determined by 
microCT analysis within their treatment group.  Likewise, the three scaffolds selected 
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from each in vivo group were the samples that represented the maximum, median, and 
minimum mineralized volume within its treatment group.   
Samples were cut in half longitudinally using an Isomet 1000 Precision saw 
(Beuhler).  One half of the sample was processed in paraffin without decalcification and 
sectioned at approximately 5 microns using a tape transfer technique (Instrumedics, 
Hackensack, NJ).  The other half was reserved for optional plastic processing, but was 
never utilized for that purpose.  Sections were stained with H&E, Von Kossa, and 
modified Mallory’s Aniline Blue.   
5.2.11 Finite Element Modeling & Analysis 
The accuracy of any finite element model depends on the accuracy of the material 
properties supplied to the model.  Therefore, a reasonable value for the tissue-level 
modulus of the PLDL scaffold material used in the in vivo loading study must first be 
determined.  By matching known force/displacement data of a representative PLDL 
scaffold to the output of a finite element model based on that sample’s architecture, a 
reasonable estimate of the tissue-level modulus may be obtained.  A representative naïve 
PLDL sample from the set previously imaged by microCT (Section 5.2.3) was chosen to 
be modeled using finite element analysis to determine the tissue modulus of the PLDL.  
Only two of the naïve samples scanned were also among the samples mechanically tested 
under cyclic compression (Section 5.2.2) after receiving 2.5 Mrad gamma irradiation and 
extended exposure to saline at 37 C.  Since the apparent modulus of PLDL changes with 
extended exposure to physiologic conditions, it was important to choose a sample from 
the gamma/soak group.  Of these two samples, sample p25 was chosen because its 
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architecture most represented a right cylinder without holes.  The mechanical testing data 
revealed that this sample experiences a strain of -0.0204 when a distributed load of 11.89 
N is applied to the top surface.   
To create the input mesh for p25, the microCT images were first filtered using a 
constrained 3-D Gaussian filter (sigma = 0.8, support = 1) to partially suppress noise in 
the volumetric image data, and then mineralized tissue was segmented from surrounding 
soft tissue by using a global thresholding procedure with the threshold set at 28.  The 
image was then rotated -9° about the x-axis and -5° about the y-axis to make the long axis 
of the cylinder line up with the global z-axis.  A volume of interest was selected that 
tightly encompassed the PLDL sample.  Next, a component labeling technique was 
employed and only the largest component kept, ridding the model of unconnected 
structures which carry no load in the scaffold, but will complicate the solution of the 
model.  This single component represented over 99.9% of the voxels in the model.  
Scanco Medical’s Finite Element-software v1.0 (Basserdorf, Switzerland) was employed 
to generate and solve the model based on the microCT image data.  Using a voxel 
conversion technique known as digital image-based finite element meshing (DIBFEM), a 
30 micron brick element was created to represent each voxel in the microCT image.  A 
distributed compressive load of 11.89 N was applied to the top surface of the model (z = 
0) to match the actual force applied during cyclic mechanical testing of Sample p25.  In 
addition, the base (z = zmax) was constrained to have no displacement in the z direction 
and the walls of the cylinder were constrained to have no displacement in the x or y 
directions.  Figure 5 illustrates the coordinate system used and the distributed load across 
the top surface.   
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Scanco Medical’s Finite Element-software v1.0 was used to determine the 
solution.  As discussed in Section 3.2.10, the software assumes a continuum sample with 
elastic properties experiencing small deformations.  Translating the rule of thumb for 
continuity of trabecular bone to the polymer would suggest that any sample larger than 
five times the trabecular spacing, or in this case, 5 x 400 microns or 2 mm, satisfies the 
continuum assumption [176].  The samples modeled were 4 mm diameter by 5 mm 
length.  Furthermore, mechanical testing as described above confirms that the tissue 
responds in an elastic manner in the range of loads analyzed.  Finally, the apparent strain 
applied is less than 2%, within the bounds of the small deformation assumption.  The 
software uses an iterative conjugate gradient solver in combination with an element-by-
element matrix-vector multiplication scheme [177].   
The model was solved using an initial guess of 5000 MPa for the tissue modulus 
and 0.3 for Poisson’s ratio.  Convergence tolerances were set to 1e-4.  The actual tissue 
modulus was approximated by multiplying the initial guess by the ratio of the apparent 
strain in the z-direction from the model to the actual apparent strain measured in the 
mechanical test as shown in Equation 1.  The result shows that the tissue modulus of 
PLDL manufactured with 30% porogen and exposed to 2.5 Mrad gamma irradiation and 
8 weeks exposure to an aqueous environment is approximately 849 MPa.  This value is 
much smaller than that calculated for rabbit trabecular bone, consistent with the lower 





















Three representative samples were chosen from the twelve naïve PLDL samples 
scanned for finite element modeling of the loading conditions employed during the in 
vivo loading study of tissue-engineered constructs in the rat subcutaneous model.  PLDL 
scaffolds from the in vivo study were not used for the architectural basis for the finite 
element models because unpublished data from our laboratory suggests there may be a 
reduction in subsequent in vitro mineralization of PLDL scaffolds after exposure to 
microCT scans.  Therefore, naïve representatitive samples p25, p26, and p93 were chosen 
for their architecture and then modeled in a fashion similar to that described above to 
determine the tissue modulus of PLDL.  Each voxel of the microCT images was again 
modeled as a 30 micron brick element.  Local boundary errors associated with DIBFEM 
should be reasonable at this resolution since the average strut thickness of the PLDL was 
135 microns allowing 4-5 elements across each trabecular strut on average [179, 180].  
An additional layer of elements was added to the top of the cylindrical model to represent 
the titanium loading platen used in vivo.  The models were constrained as described 
earlier but the distributed load was increased to 13.3 N to represent the actual applied 
load in the rat in vivo loading procedure.  Furthermore, the PLDL was assigned the 
estimated tissue modulus of 849 MPa and a Poisson’s ratio of 0.3.  The interstitial tissue 
space was modeled with a stiffness of 0.1 MPa and Poisson’s ratio of 0.3.  This stiffness 
value is similar to the Young’s Modulus  used by Loboa for mesenchymal tissue [189]  
The marrow is not intended to be a structural member of the model but is included to 
determine strain responses within the pore spaces.  The plate was assumed to be perfectly 
stiff and assigned a value of 1e7 MPa.  Modeling the stiff plate guards against large 
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deformation errors associated with having a load applied directly to two materials with 
very disparate moduli.   
The models were considered converged when the force and displacement 
residuals were less than 1e-4.  Four output parameters were examined for both the 
polymer and the interstitial space including the largest principal strain, Von Mises Stress 
(VMS), and strain energy density (SED).  Von Mises Stress provides an individual 
parameter reflective of both the hydrostatic and distortional stresses experienced in the 
tissue will strain energy density is a parameter often evaluated for its overall integration 
of both stress and strain responses.  To exclude end artifacts, the data representing output 
responses above the 95th percentile were excluded from analysis of VMS and SED 
(range: 0,∞).  In addition, the data below the 5th percentile and above the 95th percentile 
were excluded from analysis for the largest principal strain (range: -∞,∞).  In addition, 
the variation in these parameters was also observed among the top 25% of the model, the 
middle 50%, and the bottom 25% of the model to examine regional differences in the 
tissue response to the applied loading scenario.  Appendix G includes a step-by-step 
guide to the necessary Image Processing Language (IPL, ©Andres Laib, Scanco Medical 
AG) commands required for pre-processing, solving, and post-processing these models. 
5.3  Results 
5.3.1 Viability of Representative PLDL Scaffolds  
At each of the three seeding sessions, three samples were stained with calcein and 
ethidium homodimer 24 hours later to determine the viability of the cells present.  Figure 
37 shows a representative view along the longitudinal axis of the scaffold for each of the 
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nine scaffolds analyzed.  The PLDL scaffold material autofluoresces red, which 
unfortunately makes distinguishing dead cells from the scaffold difficult, but also allows 
you to see how the cells line the PLDL surfaces especially along the longitudinal 
macroporosity of the structure.  There is a marked reduction in the number of viable cells 
and possibly overall number of cells present in Seeding Groups #2 and #3 compared to 
Seeding Group #1.  In general, the overall number of cells present in Seeding Group #1 




Figure 37.  Representative Cell-Seeded PLDL Scaffolds from Each of the Three 
Seeding Groups Labeled for Live (Green) and Dead (Red) Cells; View Shown is 
Along the Longitudinal Axis  
 
 133 
5.3.2 Cell-Seeding Quantification 
The number of cells attached to the PLDL scaffold was quantified for three 
samples from each of the three seeding groups using PicoGreen fluorescent dye for 
double-stranded DNA.  The average number of cells attached was 122,000 for Seeding 
Group #1, 51,100 for Seeding Group #2 and 34,500 for Seeding Group #3 as shown in 
Figure 38.  These numbers represent seeding efficiencies ranging from 3.5% to 12.2%.  
Although there appears to exist a trend toward a significant decrease in the number of 
cells with each successive seeding, a one-way analysis of variance (α = 0.05) did not 
show any significant difference among seeding groups (p = 0.119). 
 
Figure 38.  Average Number of Cells Attached to Cell-Seeded Scaffold for Each 
Seeding Group, (Mean + Standard Error, n=3) 
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5.3.3 Mineral Quantification in Parallel In vitro Scaffolds  
Scaffolds seeded with rMSCs at Seeding #1 and Seeding #3 were maintained in 
osteogenic supplements for 1, 7, 8, or 14 weeks and then scanned using microCT to 
determine the overall mineral content of each scaffold.  There was a significant difference 
(p=0.007) between scaffolds seeded during Group #1 versus scaffolds seeded during 
Group #3 as illustrated by Figure 39, a plot of all samples from each seeding regardless 
of time in culture.  Because there was no variation in samples seeded during Seeding #3, 
only those samples in Seeding #1 were included in a subsequent analysis of variance to 
determine the impact of time in culture.  MicroCT images of the scaffolds in Seeding 
Group #1 and their cell-free controls are shown in Figure 40. 
 
Figure 39.  Mineralization on PLDL Scaffolds Cultured in vitro for 1, 7, 8, or 14 






















Figure 40.  Select MicroCT Images of Each of the In Scaffolds in Parallel Osteogenic 
In vitro Culture for 1, 7, 8, or 14 Weeks 
While the data from Seeding Group #1 was limited, a two-way ANOVA model 
involving scaffolds seeded with and without cells and then cultured for either 1 week or 8 
weeks shows a significant effect of both cells (p=0.022) and time in culture (p=0.001).  
Figure 41 reflects the increase in mineralization associated with both these parameters. 






Figure 41.  Mineralization on PLDL Scaffolds Cultured in vitro for 1, 7, 8, or 14 
weeks as a Function of Time in Culture (Mean + Standard Error, n=3) 
5.3.4 Histology of In vitro Samples 
MSC seeded PLDL scaffolds were cultured in osteogenic supplements and 
harvested after either one week or 8 weeks in vitro.  Cells were present both on polymer 
surfaces and within interior pore spaces.  Surfaces near the periphery were almost 
continuously lined with cells, but cells were still present in fewer numbers toward the 
interior of the scaffold.  While cells on near the periphery tended to be exclusively on 
polymer surfaces, cells in the interior could be found both on surfaces and within the pore 
space.  Cells on outer surfaces were flatter and associated with more secreted 
extracellular matrix than their counterparts on more interior surfaces.  This pattern was 
present both at 1 week and 8 weeks, however there were greater cell numbers and 
additional matrix present at 8 weeks.  At eight weeks there also seemed to be a greater 





















interior and exterior surfaces.  Round nodules of von Kossa positive staining indicating 
the presence of phosphates appeared at 8 weeks (Figure 43A) but were not present after 
only 1 week of culture.  These areas were typically confined to polymer surfaces and 
were not found within the interior of pores. 
Cell-free controls were naturally devoid of any cells or matrix staining.  At eight 
weeks, cell-free controls stained with von Kossa did however show some diffuse positive 
staining that appears to be dystrophic phosphate deposition from the culture medium 
(Figure 43B).  These diffuse staining is distinct from that occurring from true cell-
mediated phosphate deposition which occurs in discrete nodules directly associated with 
cells.  No areas suggestive of dystrophic mineralization were present in the constructs 
containing cells. 
  
Figure 42.  MSC-seeded PLDL cultured in osteogenic supplements for 8 weeks; A) 





Figure 43.  Von Kossa staining of PLDL cultured in osteogenic media for 8 weeks 





5.3.5 Harvest Observations  
All in vivo constructs were harvested six weeks after implantation and appeared 
viable at time of harvest with tissue filling the pore spaces.  Several samples showed 
signs of titanium debris particles on the scaffolds, especially on the ends.  Four rats died 
prematurely due to complications associated with anesthesia during the first week of 
loading treatments.  On a separate animal, the incision over the implant pulled apart, 
requiring the subcutaneous pouch to be widened and the incision reclosed.  After harvest 
however, it was determined that the vascular supply to the bottom chamber had most 
likely been disrupted during that process, so the sample was excluded from further 
analysis.  Otherwise, all harvested scaffolds seemed very vascular and often capillaries 
were observed entering the chambers through the vascular port holes.  Implants were 
encapsulated in subcutaneous tissue as seen in Figure 44.   Table 9 outlines the number of 
samples collected from each in vivo treatment group. 
 




Table 9.  Number of Samples Harvested per In vivo Treatment Group 
Preculture Loading Sample Size 
No Preculture No 8 
No Preculture Yes 8 
1 Week Preculture No 8 
1 Week Preculture Yes 10 
8 Week Preculture No 8 
8 Week Preculture Yes 8 
Cell-Free No 6 
Cell-Free Yes 6 
 
5.3.6 Histology of In vivo Samples 
In general, there were more cells and matrix on the sides of the cylindrical 
scaffold than the top and bottom surfaces.  Likewise, there was more tissue on the ends 
than in the very center of the scaffold.  There tended to be more matrix filling the pores 
of the 8-week preculture group (Figure 45), with much less in the 1-week preculture 
group, followed by the no preculture group.  However, the pores were better filled with 
tissue in the cell-free group than either the 1-week or no preculture groups, but less than 
the 8-week preculture group.  Cells could be seen both lining polymer surfaces and 
within the pores space as shown in Figure 46.  Vascular and marrow elements were 




Figure 45.  Nonloaded 8-Week Preculture Sample With H&E Staining Showing 
Tissue Filling Pore Spaces; 4x 
 
Figure 46.  Cuboidal Shaped Cells Lining Polymer Pore In An 8-Week 




Von Kossa staining for phosphates and modified Mallory’s Aniline Blue showing 
new bone and/or osteoid are useful for pinpointing areas of mineralization.  However, 
given the small volume of mineral present, the absence of either histological indicators of 
bone formation does not preclude the presence of mineral.  However, areas of positive 
von Kossa staining were found in the 1-week preculture nonloaded group, and both the 
loaded and nonloaded 8-week preculture groups.  Some areas of orange/yellow in the 
mMAB stain indicating new bone and/or osteoid like those present in Figure 47 were 
present in nearly all samples.  Since the mMAB stain also stains unmineralized osteoid, it 
is not surprising that there are more areas of new bone/osteoid than von Kossa positive 
areas for phosphate deposition.  The 8-week preculture group had much more mineral 
present than any other group with a noticeable increase in mineralized nodules present in 
the loaded group over the nonloaded group.  These nodules are present both along 
polymer surfaces and in the pore spaces as shown in Figure 48.  Mineral extends to the 
interior of the scaffolds along the longitudinal macropores.  Inspection of the mineral 
deposits at high magnification confirms that the deposits were cell-mediated as witnessed 
by cytoplasmic staining of the cells and matrix vesicles (Figure 48).  In the loaded group, 
there appears to be more mineral present on one end rather than the other end of the 





Figure 47.  Reddish-Orange Areas Indicating New Bone Formation In An 8-Week 
Loaded Specimen; mMAB 20x 
 
     
Figure 48.  Examples Of Positive Von Kossa Staining (Black) Both On A Polymer 
Surface And Within The Pore Space For An 8-Week Preculture Loaded Sample; 






Figure 49.  Loaded 8-Week Preculture Sample With Positive Von Kossa Staining  




5.3.7 MicroCT Results for In vivo Samples 
Bone volume formed within the scaffolds ranged from 0 to 0.67 mm3, indicating 
that 0-1.6% of the available pore space in the scaffold was filled.  Figure 50 shows a 
representative set of loaded and nonloaded scaffolds from the 8-week preculture group.  
Like these examples, most of the scaffolds exhibited mineral throughout the construct 
rather than just on the periphery of the scaffold.  Seven samples attenuated the x-rays 
from the microCT at an extraordinarily high level.  These samples were traced back to 
those noted as having titanium wear debris during harvest.  All of these samples came 
exclusively from nonloaded treatment groups.  The particles were most likely generated 
at the time of chamber assembly during implantation surgeries because machining 
variations made these chambers slightly more difficult to assemble.  Since the titanium 
particles could not be thresholded from the mineral, these seven samples were not 
included in analysis of mineral formation.  Incidentally, these samples were also excluded 
from histological processing.  Table 10 outlines the number of samples remaining for 




Figure 50.  Representative MicroCT Images of Mineral Formed on PLDL in the 8-
Week Preculture Group Without In vivo Loading (Left) and With In vivo Loading 
(Right) 
Table 10.  Number of Samples Included in Statistical Analysis per In vivo Treatment 
Group 
Preculture Loading Sample Size 
No Preculture No 8 
No Preculture Yes 7 
1 Week Preculture No 5 
1 Week Preculture Yes 10 
8 Week Preculture No 6 
8 Week Preculture Yes 7 
Cell-Free No 5 




Using the remaining in vivo samples, the percent pore fill was determined for each 
of the treatment groups.  Figure 51 shows the difference between the loaded and 
nonloaded groups for each scaffold preparation group (i.e. cell-free, no preculture, 1-
week preculture, and 8-week preculture).  A one-factor General Linear Model (GLM) of 
the entire data shows a significant effect of load (p=0.043) and a two-factor GLM 
predicts a significant impact of both load (p=0.034) and scaffold preparation group 
(p=0.026).  However, given the differences between Seeding Group #1 and Seeding 
Groups #2 & #3 demonstrated by DNA analysis, cell viability, and in vitro 
mineralization, the effect of scaffold preparation group may be either due to time in 
preculture or differences in cell number and viability.  Given this uncertainty, just the 
cell-free and 8-week preculture groups were again considered for analysis of variance.  
Even with this reduced data set, a two-factor GLM still shows a significant effect of both 
load (p=0.047) and scaffold preparation (p=0.041).  Neither the animal nor the position 




Figure 51.  Mineralization after Six Weeks In vivo with or without Two Weeks 
Loading of PLDL with Different Scaffold Preparations (A: Cell-free, B: Cell-Seeded 
with No Preculture, C: Cell-Seeded with 1 Week Preculture, D: Cell-Seeded with 8 
Weeks Preculture, E: All Preparation Groups); (Mean + Standard Error, 5n10) 
Since histological observations of the loaded samples in the 8-week preculture 
group included the presence of more mineral on one end of the scaffold than the other, a 
regional analysis of longitudinal bone distribution was performed for samples in this 
group.  The end of the scaffold with more mineral was arbitrarily defined “top” and the 
opposite end the “bottom.”  Percent pore fill was compared between the top 25%, middle 
50%, and bottom 25% of each loaded scaffold in the 8-week preculture group.  In the 
absence of accurate labeling of top versus bottom, all that can be safely concluded is that 
one end of each sample consistently shows more mineral than the opposite end of the 

















































































consistently either the true top or bottom of the sample, it is impossible to make this 
conclusion.  A two-factor GLM with region and animal as factors showed both factors to 
have a significant effect (p=0.038 and p=0.005 respectively).  Tukey pairwise 
comparisons confirm that regional differences only exist between the top and bottom and 
not between top and middle or bottom and middle.  These data demonstrate a significant 
pattern of increasing bone formation from one end of the sample to the other.   
 
Figure 52.  Longitudinal Differences in Bone Formation in 8-week Preculture 
Samples Loaded in vivo 
5.3.8 Finite Element Analysis of Loading Scenario 
Finite element models were based on the architecture of three different 
representative PLDL scaffolds and simulated the loading conditions applied during in 
vivo loading.  The average apparent strain of these models was 1.8% for the applied 13.3 
























trabeculae experienced largest principal strains ranging from +0.03% to -1.86%; 
however, the largest percentage of voxels saw strains in the region of -0.24% as shown 
by the histogram in Figure 53.  Strains within the interstitial tissue were much higher and 
ranged from +0.10% to -12.61% with most of the interstitial tissue experiencing strains 
around -1.20% as illustrated by Figure 54.  Although Von Mises Stress in the polymer 
phase reached as high as 10.15 MPa or about ten times the apparent stress, the majority of 
the polymer was subject to stresses around 1.60 MPa.  Since the interstitial pore space 
does not really carry much of the applied loads, the Von Mises Stress in the interstitial 
tissue was substantially lower, centered around 0.0014 MPa even though a few voxels 
reported stresses as high as 2.33 MPa.  Histograms for the Von Mises Stress in both the 
polymer (Figure 55) and the interstitial tissue (Figure 56) reflect these patterns.  
Histograms for strain energy density in the polymer (Figure 57) and in the interstitial 
tissue (Figure 58) appear to peak at zero, but close inspection of the data shows a very 
small non-zero number for each since the parameter reflects a product of very small 
values.  A detailed summary of each of these parameters can be found in Table 11, 














Figure 53.  Histogram of the Largest Principal Strain within the Polymer 









Figure 54.  Histograms of Largest Principal Strain within the Interstitial Tissue 
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Figure 55.  Histogram of the Von Mises Stress within the Polymer 
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Figure 56.  Histogram of the Von Mises Stress within the Interstitial Tissue  
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Figure 57.  Histograms of the Strain Energy Density within the Polymer 
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Figure 58.  Histograms of the Strain Energy Density within the Interstitial Tissue  
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Table 11.  Summary of the Mechanical Response Predicted by Finite Element 
Models for Both Polymer and Interstitial Tissue  
    Mean SEM Peak Avg. Min. Avg. Max. 
Polymer -0.56% 0.04% -0.24% -1.86% 0.03% Largest Principal 
Strain Interstitial Tissue -2.17% 0.27% -1.20% -12.61% 0.10% 
Polymer 3.450 0.135 1.595 0.000 10.147 Von Mises Stress, 
MPa Interstitial Tissue 0.197 0.017 0.0014 0.0000 2.3263 
Polymer 0.0136 0.0006 1.44e-4 0.0000 0.0746 Strain Energy Density, 
MPa Interstitial Tissue 0.0008 0.0001 8.30e-6 0.0000 0.0110 
 
Figure 59 shows a representative cross-section from the center of sample p26 with 
its architecture color-coded for largest principal strain and Von Mises Stress for both the 




Figure 59.  Representative Cross-Sections (150 microns) of Finite Element Model 
Coded for the Tissue Level Largest Principal Strain and Von Mises Stress in Both 
the Polymer and the Interstitial Tissue  
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Since microCT analysis of the 8-week preculture group loaded in vivo revealed a 
significant difference between bone formation on opposite ends of the scaffolds, a 
regional analysis of the stress/strain response as predicted by our finite element models 
was also performed in search of a similar trend in one of the response variables.  Each 
sample was divided into the top 25%, the middle 50%, and the bottom 25% 
longitudinally and åpl, VMS, and SED were calculated for each region of each of the 
three finite element models for both the polymer and interstitial tissue.  The mean value 
of each parameter for each region was averaged for the three samples and then divided by 
the result for the top region and plotted in Figure 60 for the polymer phase and in Figure 
61 for the interstitial tissue phase to demonstrate patterns in the data from region to 
region.  To then determine if these patterns were significant, a General Linear Model with 
sample and region was performed with alpha of 0.05 along with Tukey’s pairwise 
comparisons for each of the regions for each parameter.  The only significant difference 
detected between regions was between the top and middle sections for the strain energy 
density in the interstitial tissue.  No significant differences were found in any of the 




































Figure 60.  Longitudinal Variation in Stress/Strain Response in PLDL 
 








































The first specific aim of this study was to characterize and quantify new bone 
formation in response to in vivo mechanical loading of cell-seeded polymeric constructs 
in the novel subcutaneous loading system.  Overall, loading resulted in a significant 
increase in mineralization present in constructs developed in the subcutaneous system as 
quantified by microCT.  To our knowledge, this is the first demonstration of the ability of 
controlled in vivo mechanical stimulation to increase mineralized matrix production on a 
tissue-engineered bone construct.   
Except for the no preculture samples, when each scaffold preparation group is 
considered individually loaded samples have more bone on average, but t-tests fail to 
detect significant differences.  Consider the 8-week preculture group independently and 
although there is an increase of more than 300% in the mean value with loading, the large 
variance in the loaded group and unequal variance in the residuals between groups 
contribute to an inability to conclude a statistically significant difference due to loading, 
even though a trend (p=0.08) is observed.  A post-hoc power analysis of the 8-week 
preculture data shows the power of the test to only be 0.345, indicating a 65% chance that 
the null hypothesis is accepted when in fact it is false (i.e. that significant differences 
remain undetected).  Since taken as a whole, the effect of load is significant, individual 
comparisons of loading effect within groups would likely be significant given a larger 
sample size.  The post-hoc power analysis of the 8-week preculture group suggests that a 
sample size of 26 in the loaded group and 8 in the nonloaded group would give a power 
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of .90 which would one to reasonably say there are no differences between groups if the 
general linear model fails to reject the null hypothesis.   
Furthermore, the effect of load might be noticeably more dramatic in a tissue-
engineered system more suited to mineralization.  If the study were performed with a 
different polymer and seeded in a manner that delivers a large number of viable cells, the 
effect of loading may have been more detectable within each scaffold preparation group.  
The effect of loading was significant despite the suboptimal cell/scaffold conditions 
investigated within this work suggesting the robust impact that loading may have on the 
development of tissue-engineered constructs.  In fact, the data showed less mineral in 
samples implanted for six weeks with no loading after an eight-week preculture period 
than scaffolds receiving just the eight-week preculture, while quite the opposite was true 
for their loaded counterparts.  This observation suggests that in the absence of loading, 
simply implanting the construct in a vascularized in vivo environment was not sufficient 
to increase the mineralization formed in vivo.  
Although the volume of bone formed in the loaded groups was statistically 
significant, it may not be clinically relevant.  Due to the small volume of mineral present 
and the difficulties with obtaining full histological section of polymeric scaffolds, it is 
difficult to draw conclusions between groups based solely on histological observation.  
While it was not possible to see entire layers of newly secreted bone similar to that seen 
in the orthotopic study of rabbit trabecular allografts, given the subcutaneous location and 
scarcity of osteoprogenitors provided, the presence of mineralized nodules, cuboidal cells 
lining surfaces, and tissue that appears osteoid-like in nature are all noteworthy 
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observations.  Furthermore, a general observation of greater mineralized nodules on one 
end of scaffolds within the 8-week preculture group spurred an analysis of longitudinal 
regions in the microCT date revealing that indeed there is significantly more mineral on 
one end of the scaffolds versus the other.  Since a longitudinal analysis was 
unanticipated, the ends were unfortunately not labeled, making it unclear whether the end 
with more mineral is the end close to the piston or the base of the chamber, or perhaps 
even one end for some samples and the opposite end for others. 
The second specific aim of this study was to investigate changes in load-induced 
bone formation due to different scaffold preparation techniques involving in vitro 
preculture.  However, potential  confounds may exist impairing the ability to compare 
results between groups with different amounts of preculture.  Confocal analysis and 
quantification of DNA in the scaffolds seeded for in vivo implantation suggest that 
scaffolds seeded in the 1-week (Seeding #2) and no preculture (Seeding #3) groups 
received fewer cells and those cells present were less viable than scaffolds seeded for the 
8-week preculture (Seeding #1) group.  Additional samples from the 8-week preculture 
group and the no preculture group were continued on in vitro culture with osteogenic 
supplements.  After an additional eight weeks in culture, virtually no mineral was present 
on the scaffolds from Seeding Group #3.  There also may have been differences in the 
mechanical properties of scaffolds from different seeding groups.  While measures were 
taken to ensure an equivalent exposure of all constructs to an aqueous environment, the 
presence of serum proteins, ions, and cells in the longterm preculture group may have 
accelerated the polymer degradation process, impacting the mechanical properties of the 
constructs.   
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Overall, the in vivo data reflect a general trend of increasing mineral with longer 
preculture time; however the seeding disparity means the in vivo results from the 8-week 
preculture group can not directly be compared to the 1-week and no preculture groups.  
Despite this complication, there was a significant effect of scaffold preparation group 
even when the 1-week and no preculture groups were excluded, indicating a significant 
difference between the cell-free constructs and those with 8-weeks of preculture.  This 
difference may be attributable to the presence of cells and/or the preculture period.  
While it may be natural to assume that the effect of cells results from direct participation 
of the implanted MSCs in osteogenesis, it should also be acknowledged that the presence 
of the MSCs on the cell-seeded scaffold and even a subsequent immune response to those 
cells may also incite changes in neighboring host cells that contribute to osteogenesis. 
While preculture time may have a real effect on the mineralization of tissue-engineered 
polymeric constructs, no conclusion can be drawn based on this study. 
The variation in seeding groups can most likely be attributed to the length of 
exposure to PBS experienced by the PLDL prior to seeding the scaffold.  Because the 
stiffness of PLDL changes with exposure to an aqueous environment, all scaffolds 
regardless of length of preculture were exposed to an aqueous environment for an 
equivalent time.  Scaffolds in Seeding Group #1 were hydrated approximately 48 hours 
prior to seeding while scaffolds in Seeding Group #2 and #3 spent seven and eight weeks 
respectively in PBS prior to seeding with cells.  Although the saline was changed twice 
weekly to remove degradation byproducts, it is possible that accumulated degradation 
products from the polymer created an acidic environment that changed the surface 
chemistry of the scaffold affecting cell attachment and viability.  While attachment and 
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viability were not addressed, Kohn has previously shown that changes in the pH of the 
culture environment can affect changes in cell function including collagen synthesis and 
alkaline phosphatase activity [190].  Standard cytotoxicity tests, adhesion strength tests, 
and evaluations of surface chemistry could be performed in the future to characterize 
these suspected changes due to degradation of the polymer. 
The third aim of this work was to characterize the local stresses and strains 
experienced in both the polymer and the interstitial pore space to serve as guidelines for 
future applications of the subcutaneous loading technology.  Most of the polymer 
experiences a largest principal strain about -0.24% with strains in the marrow being about 
five times greater.  Stresses in the polymer concentrated around 1.6 MPa while stresses in 
the interstitial tissue were about two orders of magnitude smaller.  In general, these 
strains appear very large, but there are no examples in the literature for adaptive tissue 
strains in a polymer.  While Frost’s Mechanostat Theory would classify apparent strains 
in this region to be in the pathologic overload zone [34], several researchers have recently 
pointed out that cells do not respond to apparent level strains, but in fact require much 
higher strains [191, 192].  Finally, a comparison between stresses and strains in the top, 
middle, and bottom regions of the finite element models failed to demonstrate trends that 
mirrored the patterns of bone formation.  This does not necessarily mean that the 
demonstrated regional difference in mineralization in the loaded samples does not 
correlate with the tissue stresses or strains.  An underlying assumption of the finite 
element models constructed was that friction between the walls of the chamber and the 
bone construct was negligible.  This assumption may not be entirely valid since the 
samples fit closely in the chambers.   If present, frictional forces and possibly even tissue 
 
 163 
resistance from ingrowth at the chambers infiltration ports would result in a net force on 
the periphery of the construct in the opposite direction of the applied load, reducing both 
the stresses and strains in a graded manner such that the bottom region would be most 
affected by this possible discrepancy.  Therefore larger differences in the stresses and 
strains between the top and bottom regions may actually exist but are not well 
represented in the current finite element model.  However, without an accurate way to 
quantify the actual resistance due to friction and tissue ingrowth present in the system, 




CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions  
Through carefully devised experimental implant systems, the effects of controlled 
in vivo mechanical loading on bone grafts and bone graft substitutes were investigated.  
The use of experimental models employing controlled boundary conditions provided the 
ability to predict the local mechanical environment at the trabecular level for trabecular 
allografts and a cell-seeded tissue-engineered bone replacement construct subjected to 
applied mechanical compression.  The novel subcutaneous implant system designed to 
allow mechanical stimulation of three-dimensional constructs may also have potential as 
an in vivo bioreactor for the development of tissue-engineered bone constructs.  Such 
constructs may benefit both from the vascular in vivo environment and the applied 
mechanical loading.  This experimental model allows for a transition from purely 
academic studies of mechanical loading of bone toward a more clinically useful 
application; specifically, the enhanced development of tissue-engineered constructs for 
bone defect repair.    
A subcutaneous loading system was designed with several objectives.  The system 
allows for compression of a three-dimensional construct within a vascular envrironment 
while simultaneously controlling the necessary boundary conditions required to be able to 
easily model the local tissue stresses and strains imposed by the applied mechanical 
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loading.  This device also represents a first generation approach for an in vivo bioreactor 
for the subcutaneous development of tissue-engineered constructs for subsequent 
transplantation to an orthotopic defect site.  Such a bioreactor utilizing both the vascular 
in vivo environment and applied mechanical stimulation to developing tissue-engineered 
constructs may allow for the production of constructs with more mineralization in a more 
homogeneous arrangement.  This system may make the development of larger, stronger 
scaffolds capable of meeting the functional needs of an orthotopic site more feasible than 
those counterparts developed using in vitro bioreactors where cell expansion and matrix 
secretion are often limited to the periphery due to diffusional limitations.  By implanting 
them within chambers in the subcutaneous space, the constructs enjoy the advantage of 
an adequate blood supply offering nutrient and waste exchange from the interior of the 
construct.  Because the subcutaneous environment is more compliant than bone, a loaded 
implant here has less risk of disrupting its own vascular supply.   
A design was chosen that allows for simultaneous loading of multiple scaffolds in 
a single animal.  Overall, size and shape were also considerations in the design in an 
effort to reduce any discomfort to the animal.  The design implemented is a hybrid of 
custom and commercial parts that forms a novel system that may not be limited in scope 
to bone defect repair constructs, but could in fact be used as is or modified to investigate 
the benefits of in vivo mechanical preconditioning on a range of tissue-engineered 
constructs, including constructs for cartilage or tendon repair.  
The first primary conclusion of this thesis work is that applied mechanical 
compression of a subcutaneously implanted cell-seeded polymeric construct for bone 
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replacement results in significantly more mineralized matrix production on the construct 
than their nonloaded counterparts.  This research represents the first demonstration of 
increased bone formation with controlled in vivo mechanical loading of a cell-populated 
three-dimensional scaffold material.  Given that an effect of loading was demonstrated on 
a scaffold that is probably not ideally conducive to bone formation and seeded with 
relatively low cell seeding efficiencies, it is likely that loading would produce even more 
dramatic effects on a better suited scaffold with an abundance of viable cells.  This result 
has important implications for the use of mechanical stimulation in the development of 
tissue-engineered bone constructs and in designing tissue-engineered constructs to handle 
the mechanical challenges of a bone defect site. 
Another primary conclusion of this work was the generation of tissue level 
stresses and strains associated with load-induced increases in mineralization on cell-
seeded polymeric constructs.  Largest principal strain in the polymer were distributed 
about a modal value of -0.24% with strains in the marrow being about five times greater.  
Stresses in the polymer were distributed about a modal value of 1.6 MPa while stresses in 
the interstitial tissue were about two orders of magnitude smaller.  These data represent a 
useful reference for designing future experiments and serves as a potential target value to 
be achieved in the design of future tissue-engineered constructs.   
A secondary conclusion drawn from this work is that significantly more mineral is 
deposited on polymeric scaffolds seeded with cells and precultured for 8-weeks prior to 
implantation than their cell-free counterparts.  This information supports evidence from 
other researchers that the presence of cells enhances bone formation [127, 137, 
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138][193].  However, the 8-week preculture period may have also added to the effect 
shown. 
Finally, a significant decrease in bone formation with loading on a rabbit 
trabecular allograft was shown.  This result is at odds with published literature on the 
effects of mechanical loading on normal and repairing bone [7, 8, 100].  Similar 
experiments involving in vivo mechanical stimulation of canine de novo bone and the rat 
subcutaneous loading experiment detailed in Chapter 5 both resulted in increased bone 
formation with mechanical compression.  Differences in a variety of conditions make 
direct comparisons between these studies difficult since the studies involved three very 
different materials (de novo bone, trabecular allograft, and polymer) each with different 
compositions and mechanical properties.  Although each of the studies applied loads at 1 
Hz for 1800 cycles per session, the force magnitudes, number of loading sessions, and 
timing of sessions varied.  The canine study employed a 17 N load magnitude for eight 
weeks with daily loading.  The rabbit study used a 22 N load for four weeks of daily 
loading and finally, the rat study used a 13 N load for two weeks with loading sessions 
occurring three times per week.   
No clear explanation of these data is obvious, but the result most likely highlights 
the tightly controlled regulation of bone formation by mechanical signals and the 
importance of optimizing loading parameters such as force magnitude, frequency, and 
duration.  Possible micromotion or other disruptions of vascularity may have been a 
factor but cannot be confirmed. Furthermore, traditional investigations of the 
mechanosensitivity of bone involve established mature bone or bone repair in a fracture 
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site.  These studies may not directly translate to the response of osteoprogenitors and 
osteoblasts on the surface of natural or synthetic implant materials where these 
relationships may be altered by the non-native arrangement of cells and matrix.  It is 
currently not known if cell communication via a functional canalicular network is 
required for mechanoresponsiveness.  Additional studies are needed to determine the 
requisite loading parameters, level of cell and tissue maturity, and possibly other 
environmental variables to produce the ideal response to mechanical stimulation.  These 
parameters may in fact depend heavily on the cell source and scaffold chosen for a 
particular bone repair construct.   
 
6.2 Recommendations  
Tissue engineering is a discipline still in its infancy.  To generate tissue-
engineered constructs capable of meeting the functional demands of the native tissue, 
novel means of preparing tissue-engineered constructs must be explored.  The novel 
subcutaneous loading system presented here represents a first generation approach toward 
capitalizing on the advantages of the nourishing in vivo setting and the sensitivity of 
many cells and tissues to their local mechanical environment.  Specifically, this work 
demonstrates the potential this approach has to significantly improve the development of 
tissue-engineered constructs for bone defect repair. 
Being a first generation approach, there are several design improvements that 
could be made to the subcutaneous loading system.  The current loading apparatus 
demands hydraulic access, requiring either resident transcutaneous tubing or repeated 
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incisions to access the chamber.  The system should be redesigned to be fully 
implantable, not merely for convenience, but to reduce the risk of infection.  Such a 
design feature would be absolutely necessary for a clinical variant of this system.  Such 
designs might include radio controlled motors or piezoelectric materials or even the use 
of shape memory alloys.  Regarding the current research model for rats, the system would 
benefit from further miniaturization to improve the animal’s comfort.  Reducing the 
length of the implant would be particularly helpful and could be accomplished by custom 
connectors and manifolds.  The system is also currently limited to applying loads to 
moderately stiff scaffolds.  This limitation exists primarily due to friction between the 
chamber wall and the o-ring on the loading platen.  The necessary force to overcome 
friction and result in motion of the piston is sufficiently large to plastically deform many 
candidate scaffold materials.  A glass/Teflon interface may permit easier movement of 
the piston, allowing a wider range of materials to be loaded in the system. 
There are several studies using the novel subcutaneous loading system that could 
be performed in the future.  First, effects of loading and preculture time should be 
investigated given comparable cell number and viability between groups.  Given the 
change in mechanical stiffness that occurs in PLDL when exposed to an aqueous 
environment, samples from different preculture groups could be loaded to different levels 
resulting in an equivalent apparent strain in all samples.  Furthermore, the study might be 
repeated on a scaffold material whose stiffness is impervious to time spent in an aqueous 
environment.  In addition, parallel in vitro scaffolds should be cultured to determine if 
constructs prepared in vivo with loading have more mineral than scaffolds exclusively 
cultured in vitro for an equivalent time.  Furthermore, studies using different loading 
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reqimes investigating a variety of load magnitudes, frequencies, durations, and timing of 
the onset of loading may provide a better understanding of the optimal loading 
parameters. 
A series of experiments should be performed to not only access quantity of 
mineral formed, but also quality of mineralization and functional performance.  Samples 
prepared in vivo with and without loading should be mechanically tested to determine if 
the increases in mineralization translate into improved mechanical properties.  
Additionally, FTIR analysis could be used to compare the composition and quality of 
mineral formed with and without loading.  The quality of mineral formed in vivo could 
also be compared to that deposited in vitro on cell-seeded scaffolds.  Finally, the most 
important question to be answered is how well do constructs developed in an in vivo 
bioreactor with loading actually repair an orthopedic defect.  Current plans exist in our 
laboratory to perform such an evaluation using a rat segmental gap defect model. 
In conclusion, the use of a subcutaneous in vivo bioreactor to develop tissue-
engineered bone constructs must be put in perspective with current technology and 
anticipated developments in the field.  While this technology represents a potentially 
better approach to developing tissue-engineered constructs for bone defect repair than 
simply seeding the scaffolds with cells and implanting them directly or even preculturing 
the scaffolds in vitro without loading, it is not an ideal solution to the development of 
functionally competent tissue-engineered constructs.  In general, in vitro preparation of 
scaffolds is preferrable due to significantly lower costs, as well as reduced risk and 
discomfort for the patient.  Hopefully, new in vitro technologies employing perfusion and 
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mechanical loading, or perhaps some other technique, will address current diffusional 
limitations in vitro.  The required repeat surgical procedures associated with this method 
may be warranted in certain situation, especially when a large homogeneous graft is 
required.  Vacanti et.al. have previously successfully employed a multi-procedure 
technique to replace an avulsed human phalanx with tissue-engineered bone in a clinical 
setting [194].  The technique would probably be most successful when a vascular pedicle 
is incorporated into the subcutaneous developing construct to aid incorporation of a 
viable graft into the defect site.  Given the wide range of possible defect sites, it is 
appropriate that tissue engineers have a wide array of techniques for scaffold preparation 
available so that the best possible replacement scaffold can be offered for a given 








A.1 Rabbit Orthotopic Bone Chambers 
 





















A.2 Clamp for Bisecting Rabbit Chamber Biopsies 
 
Figure 67.  Machine Drawing of Clamp to Hold Rabbit Chamber Biopsies 
During Bisection with Isomet Saw 
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A.3 Rat Subcutaneous Loading Chamber 
 













Figure 71.  Compacted Assembly of Piston, Sample, and Base Platen in Rat 




A.4 Prototype Manifold for Rat Subcutaneous Loading Chambers  
 
Figure 72.  Machine Drawing of Prototype Manifold for Four Rat 




Figure 73.  Machine Drawing of Prototype Manifold for Four Rat 
Subcutaneous Chambers; Bottom View Shown 
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A.5 Platform Housing for Load Cell and Calibration Rat Subcutaneous Chamber 
 
Figure 74.  Machine Drawing of Platform Base with Circular Hole Pattern to 








Figure 76.  Machine Drawing of Platform Top with Center Hole to Hold a 
Rat Subcutaneous Chamber with the Base Removed 
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A.6 Tabletop Platform to Hold Rat Subcutaneous Chamber During Compression 
Testing 
 
Figure 77.  Machine Drawing of Tabletop Platform for Mechanical Testing 








B.1 Procedure to Implant Rabbit Hydraulic Bone Chamber 
Anesthesia was induced in the animals using an injectible cocktail of ketamine 
(18mg/kg), xylazine (9mg/kg), and acepromazine (0.4mg/kg) and maintained by 
isoflurane gas (0.5-2.0%) administered by mask.  The rabbit’s legs were shaved and 
prepped for surgery using a clorhexidine scrub, betadine, and isopropyl alcohol.  The 
animal was placed on the surgery table and the incision sites were carefully draped with a 
laporotomy drape to create a sterile field.  Two cc of Marcaine was injected 
subcutaneously over the incision site to provide additional local anesthetic.  After five to 
ten minutes, a one inch incision through skin and muscle was made over the medial side 
of the distal femur as shown in Figure 78.   
 
Figure 78.  Incision Site for Rabbit Hydraulic Bone Chamber 
After removing the periosteum on the surface of the condyle by scraping and 
cleaning with gauze, the cortex was scored with a 0.248” ID trephine using a trephine 
guide (Figure 79) to help grip the surface and keeping the trephine teeth flush against the 
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bone surface.  The trephine was backed out and the cortex popped off using a pointed 
biopsy tool.   
 
Figure 79.  A Pneumatic Drill with Trephine and Trephine Guide was Used to Score 
the Bone Surface to Remove the Cortex 
A 7mm hole was drilled to a depth of ½” along a vector that angles slightly distal 
as the drill travels medial to lateral, making sure to avoid the intercondylar notch.  Both 
the trephine and drill bit were powered by a hand-held pneumatic drill.  The hole was 
then tapped with a M8x1.0 tap being extremely careful not to strip the bone threads.  
Chambers were assembled using ethylene propylene o-rings on the cap (dash 010) and on 
the piston (dash 060).  Piston o-rings received a thin film of silicon lubricant and pistons 
were placed in the chambers using a positioning screw that fits in the top of each piston.  
An assembled chamber was threaded into the hole.  If the implant was a loaded chamber, 
the barb was aligned to point superiorly and slightly anterior to the long axis of the bone.  
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The barb was also wrapped with Teflon tape to prevent tissue growth in the barb.  The 
implanted chamber cap was wiped with betadine.  Figure 80 shows how an implanted 
nonloaded chamber sits against the bone’s surface.  Vicryl sutures (size 2-0) joined the 
muscle margins underneath the barb and close to the chamber in addition to superficial 
sutures to join the skin margins over the chamber cap. 
 
Figure 80.  Position of Implanted Hydraulic Bone Chamber in Rabbits 
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B.2 Procedure for a Non-Terminal Biopsy of the Rabbit Hydraulic Bone Chamber 
Anesthesia was induced in the animals using an injectible cocktail of ketamine 
(18mg/kg), xylazine (9mg/kg), and acepromazine (0.4mg/kg) and maintained by 
isoflurane gas (0.5-2.0%) administered by mask.  The rabbit’s legs were shaved and 
prepped for surgery using a clorhexidine scrub, betadine, and isopropyl alcohol.  The 
animal was placed on the surgery table and the incision sites were carefully draped with a 
laporotomy drape to create a sterile field.  Two cc of Marcaine were injected 
subcutaneously over the incision site to provide additional local anesthetic.  After five to 
ten minutes, a one inch incision through skin and muscle was made over the HBC.  The 
cap was removed from the chamber as well as the piston in loaded chambers.  The tissue 
inside the chamber was extracted using a thin-walled device called a kerchunker shown 
in Figure 81.  Once the tissue is inside the biopsy device, a thin platen resting inside the 
device was used to push out the tissue when a screw was inserted in the top of the device.  
Frozen allografts were placed in the chambers before the pistons and caps were replaced.  
The incision site was closed with 2-0 vicryl suture.   
 
Figure 81.  Thin-Walled Extraction Device 
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B.3 Procedure to Implant Subcutaneous Loading Tubing in Rabbits 
Polyurethane tubing from Cole-Parmer (Part #P-95625-00; working pressure = 
100 psi, burst pressure = 200-300 psi) with an inner diameter of 1/16” and an outer 
diameter of 1/8” was used.  Twenty inch lengths of tubing were prepared by bonding a 
¾” x 3/2” strip of acrylic art felt (Hancock Fabrics)  3 inches from one end of the tubing 
using a long-term implant grade 2-part silicone adhesive (NuSil MED1-4213) as shown 
in Figure 82.  The ¾” edge was bonded along the length and allowed to cure ten minutes 
at 70C, then the length of the felt strip was wrapped around the tubing and bonded with 
more silicone adhesive and cured for an additional ten minutes at 70C.  The tubing was 
then gas sterilized. 
 
Figure 82.  Bonded Felt Cuff on Polyurethane Tubing 
Anesthesia was induced in the animals using an injectible cocktail of ketamine 
(18mg/kg), xylazine (9mg/kg), and acepromazine (0.4mg/kg) and maintained by 
isoflurane gas (0.5-2.0%) administered by mask.  An intraoperative dose of an antibiotic 
(Baytril, 7 mg/kg) was given at this time.  The rabbit’s legs were shaved and prepped for 








working from the incision site outward.  In addition, the distal half of the abdomen was 
shaved and cleansed as well as the butt on the side with the loaded chamber.  A 4” circle 
was shaved and prepped between the rabbit’s shoulder blades.  The animal was placed on 
his back on the surgery table on top of sterile towels leaving plenty of room on the table 
near the head and all shaved areas were sprayed with betadine.  A non-sterile assistant 
held up the rabbit’s legs while a sterile surgeon wrapped the feet in sterile drape towels.  
With the rabbit’s legs still held up, a sterile drape was placed flat beneath the rabbit and a 
second drape towel was used to “diaper” the rabbit to keep fur out of the sterile field.  
Additional drapes were used to cover the middle, top, and sides of the rabbit.  Finally, a 
large laporotomy drape was placed over the rabbit exposing only the rabbit’s legs.  The 
incision sites were carefully draped with a laporotomy drape to create a sterile field.   
Two cc of Marcaine was injected subcutaneously over the incision site to provide 
additional local anesthetic.  After five to ten minutes, a one inch incision through skin 
and muscle was made over the medial side of the distal femur.  Using the animal as a 
visual reference, the tubing length was trimmed from the end opposite the felt cuff.  This 
end of the tubing was then placed over the loaded chamber barb using a serrated hemostat 
that had a hole drilled through the jaw interface to fit the tube diameter to grip the tubing 
tightly.  With the loaded chamber cap loosened, a 20 cc syringe with a 16 gage needle 
was used to fill the tubing and upper plenum of the chamber with sterile 0.7% saline.  
Once all bubbles were flushed from the tubing and chamber, the cap was tightened.  The 
opposite end of the tubing was melted closed with the heat from a butane-powered 
soldering iron to keep the lumen of the tubing clean during subsequent steps.  With the 
standard incision at the medial side of the distal femur open, a second incision was made 
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on the lateral side of the leg on the proximal end of the femur about two inches proximal 
to the chamber.  A stainless steel sloped nozzle was placed over the felt cuff of the tubing 
to facilitate smoother movement through the subcutaneous tissue as shown in Figure 83.  
From the proximal incision, a hemostat was tunneled subcutaneously to the distal incision 
and used to pull the tubing from the distal to the proximal incision wrapping the tubing 
around the rabbit’s leg.  As the tubing was pulled beneath the skin, it was wiped with 
betadine soaked gauze.  The distal incision over the chamber was closed with vicryl 
suture.   
 
Figure 83.  Diagram of Tools Used to Route Tubing Subcutaneously in Rabbits 
At this point, the rabbit was carefully turned on its side such that the leg with the 
loaded chamber is on top.  The mask was checked to make sure the animal was still 
receiving isoflurane and the area between the shoulder blades was prepped with a 
surgical scrub brush again.  A hole was cut in the laparotomy drape to expose the area 
between the shoulder blades.  A third incision about ½” long was made 1.5” caudal to the 
shoulder blades along the midline of the back.  A long yeoman was routed 
subcutaneously from the incision on the back to the proximal leg incision.  The tubing 
was grasped in the yeoman’s teeth and then pulled through the subcutaneous tunnel being 
careful to avoid kinks in the tubing.  Again, the tubing was wiped with betadine-soaked 
gauze as it was pulled beneath the skin.  The proximal leg incision was closed with vicryl 
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suture and silk suture was used to anchor the felt cuff to the subcutaneous tissue at the 
incision on the back.  Finally, a sharp 13 g x 3.5” stainless steel hypodermic needle was 
used to tunnel about 1” proximally from the back incision and puncture the skin.  A thin 
stainless steel surgical guide wire was routed through the lumen of the needle and used to 
pull the tubing from the back incision through the tiny puncture wound between the 
shoulder blades.  The incision on the back was closed with vicryl suture.  No sutures were 
applied at the actual exit site to eliminate the potential of the suture to wick infection 
inside.   
During recovery, a polypropylene luer connector with a 1/16” hose barb (Cole-
Parmer #A-06359-25) was inserted in the exposed tubing end and capped with a 
polypropylene male luer-lok connector (Cole-Parmer #A-30504-22).  After the animal 
had obtained sternal recumbency, an Elizabethan collar was placed on each rabbit to 
protect the tubing from bites and scratches.  A sterile transparent polyurethane wound 
covering from Johnson & Johnson was applied over the tubing exit site.  The dressing 
was checked daily and changed as needed.  One person held the rabbit still by keeping 
one hand on the rabbit’s rump and one hand over the rabbit’s eyes.  Another person 
isolated the exit area with sterile drape towels and removed the old dressing.  Wearing 
sterile gloves, this person then cleansed the area with Betadine or chlorhexidine and 
sterile gauze working outward in a circular fashion.  A new dressing was applied over the 
exit site leaving the luer connectors exposed.  Rabbits in Group #3 of the frozen allograft 
study, also received daily application of a silver-impregnated glass powder (Giltech 




B.4 Procedure for Implantation of Subcutaneous Rat Loading Device 
B.4.1 Surgical Materials 
Hardware 
Autoclave: 
• 4mm rat chambers (custom) 
• 4mm pistons (custom) 
• 4mm platens (custom) 
• Beswick manifolds (#MX-1010-303) 
• Nipples, 10-32 (Beswick # MN-1010-303) 
• Plugs, 10-32 (Beswick # MSP-1000-303) 
• Adjustable elbow barbs, 10-32 to 1/16” (Beswick # SMLS-1012-303) 
• 1-72 piston screws (McMaster #92196A068) 
• O-ring lubricant (Chemplex 710 Silicone compound from McMaster-Carr) 
• 5/32” dowel pins (McMaster #90145A488) 
• Wrench 
• Screwdriver (separate packet) 
• Tubing holder or hemastat 
• Forceps 
• 1/16” plastic barbs/FL 
• 10cc syringe 
• 16 g needle 
• saline bag 
 
Gamma-Irradiation: 
• (.085x.036") BN o-rings (Apple Rubber custom order) 
 
Ethylene Oxide Sterilization: 
• 5” lengths of PUR tubing (1/8” OD, 1/6” ID) (CP # 95625-00) 
 
PLDL samples 
Sterile petri dishes, 100mm and 35mm 






• Adson-Brown forceps 
• Russian forceps 
• Needle-nose forceps 
• 2 blade holders, #7 
• Paper Scissors 
• Skin scissors  
• 13g needles 
• SST wire 
• Needle holder 
• Hemastats (2) 
• Wound clipper 
• Clip remover 
• Wound Clips 
 
Towel Trays 
• Blue surgical towels 
• 4x4 gauze 
• 2x2 gauze 
 
Other disposables 
• silk 4-0 suture  
• vicryl 3-0 suture  
• 4x4 gauze, non-sterile 
• 2x2 gauze, non-sterile 
• #10 blades (surgery days)  
• #11 blades (loading days)  
• IOBAN  
• drape towels, 2 per pack  
• 500ml bottles of sterile water  
• saline for injection, 250ml bottles  
• half drapes  
• 10cc syringes  
• 16 g needles  
• gloves, sterile 
• wound clips  
• Glass bead sterilizer 
• Sterile towels, cloth 




B.4.2 Assembly Instructions for Subcutaneous Rat Loading Device 
Loaded Chambers 
1. Insert the longer end of the 10-32 nipple into a rounded port of the 4-way 
manifold.  Repeat on the other end. 
2. Add an elbow barb to one of the remaining ports, making sure that the barb lies in 
plane with the manifold.   
3. Add a cap to the remaining port. 
4. Insert a platen into the base of a chamber. 
5. Insert the appropriate PLDL scaffold. 
6. Put an o-ring on a piston.  Add a small amount of silicone lubricant and wipe off 
excess on gauze.  Immediately discard gauze.  Try not to get lubricant on your 
gloves or other instruments. 
7. Using the 1-72 screw, insert the piston into chamber on top of PLDL.  Remove 1-
72 screw. 
8. Use a dowel pin to confirm that piston sits firmly against the PLDL. 
9. Attach the chamber to the appropriate end of the manifold.  PLDL scaffolds 
designated top, go on the side of the manifold with the barb. 
10. Repeat steps 4-9 for the second chamber. 
11. Attach a piece of tubing to the barb.  Attach a plastic barb/luer to the other end of 
the tubing. 
12. Confirm that all joints of the assembly are tight EXCEPT the cap. 
13. Using a 10cc syringe filled with saline, fill the implant.  While fluid is exiting 
from the cap, tighten it down with a screwdriver. 
14. Apply a moderate amount of pressure by hand to the syringe and watch the 
implant carefully for leaks.  If leaks occur, reassemble using different chambers 
and/or pistons. 
15. Store implant in 100mm petri dish with alpha-MEM until surgeon is ready. 
16. Surgeon will cut the tubing to length and hand back to you to heat seal.  Have a 
non-sterile assistant hold the heat sealer in front of you.  When plastic gets 
gummy, use a hemastat to clamp the end shut and hold until cooled.  Confirm 
seal. 





1. Insert the longer end of the 10-32 nipple into a rounded port of the 4-way 
manifold.   
2. Repeat on the other end 
3. Add caps to the remaining ports. 
4. Insert a platen into the base of a chamber.  
5. Insert the appropriate PLDL scaffold. 
6. Insert a spacer.  If out of spacers, use pistons with no o-ring. 
7. Use a dowel pin to confirm that PLDL and spacer sit firmly against base. 
8. Attach the chamber to the appropriate end of the manifold/nipple assembly.  
PLDL scaffolds designated top, go on the side of the manifold with the etched 
mark ‘X’. 
9. Repeat for second chamber. 
10. Confirm that all joints of the assembly are tight. 




B.4.3 Surgical Procedure for Implanting Subcutaneous Rat Loading Device 
Anesthesia was induced using 4% isoflurane and maintained with 1-2% isoflurane 
via mask. The rat’s back was shaved and scrubbed.  The animal was transferred to a 
surgical table and the back was draped and covered in Ioban, a sterile antimicrobial film.  
Under sterile conditions, a 1.5” incision was made just to the right of the midline and 
beginning about 1.5” caudal to the center of scapulae.  By blunt dissection, a small pouch 
was created in the subcutaneous space to receive the implant.  The free end of the 
attached polyurethane tubing (Cole-Parmer # 95625-00) was heat-sealed using a hemostat 
heated in the glass-bead sterilizer.  A stainless steel 13g x 3.5” hypodermic needle was 
used to create a route for the tubing running from just caudal and proximal to the cephalic 
end of the incision to the center of the scapulae.  Stainless steel surgical wire was used to 
keep the tubing path open. The implant was placed in the pouch inserting the tubing 
along the path created by the needle.  Care was taken to ensure the implant lies flat on its 
side with the elbow barb close to the midline and pointed toward the head.  If necessary, 
the pouch was enlarged just enough to pull the skin margins together over the implant.  
Silk suture (size 3-0) were used to pull the underlying issue around 1) the port holes on 
both chambers, 2) both nipple connectors, and 3) the elbow barb as shown in Figure 84.  
Then 3-0 vicryl suture was used to close the skin margins over the entire implant.  The 
closure was reinforced with metal wound clips.  NewSkin with Metronidazole 
(100mg/ml) was applied topically over wound clips to act as an additional sealant and 
prevent the animal from biting the incision.  Wound clips were removed after 10-14 days.  
Surgical instruments were rinsed in sterile water and placed in glass bead sterilizer 




Figure 84.  Placement of Silk Sutures to Anchor Rat Subcutaneous Loading Device 
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B.5 Procedure for Exposing Implanted Tubing for Loading Sessions in Rats 
On the first day of loading, anesthesia was induced using 4% isoflurane and 
maintained with 1-2% isoflurane via mask.  If necessary, the back was shaved.  The area 
was then cleansed with chlorhexidine and isopropyl alcohol.  Originally, a local 
anesthetic (lidocaine) was also applied to the skin just over the end of the tubing, but was 
eventually abandoned since four animals failed to recover from anesthesia.  The lidocaine 
may have caused the anesthesia to be too deep.  Furthermore, the additional local 
anesthetic did not seem to be necessary.  A small incision about 3/4” was made 
approximately between the shoulder blades over the end of the implanted tubing using a 
#11 blade.  The end of the tubing was pulled through the incision and a sterile 
polypropylene luer connector with a 1/16” hose barb (Cole-Parmer #A-06359-25) was 
inserted in the exposed tubing end.  The tubing was wrapped with sterile gauze to cover 
the open incision on the back.   Figure 85-B shows the location of the incision and the 
tubing just after it has been pulled through the incision, while Figure 85-C shows the 





Figure 85.  Steps to Expose Tubing for Rat Loading Procedure; A) Anesthesia 
Induction, B) Incision and Exposure of Tubing, C) Addition of Connector, and D) 
Re-implantation of Tubing and Wound Closure 
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The rat was then removed from the isoflurane supply and restrained in a thin 
plastic cone restrainer once the rat was sternally recumbent.  The rat was placed in a 
open-topped plastic box with a dark cloth over the head to help keep the animal calm.  
My experience was that the animal would remain very calm and relaxed in the restrainer 
if the cloth covers the eyes, even if the animal is not sedated.  A hole was clipped in the 
restrainer to allow the tubing to exit the restrainer.   
 
Figure 86.  Thin Plastic Cone Restrainers Used During Rat Loading Procedures 
One ml tuberculin syringes were filled with sterile saline and a 5”-length of PTFE 
microbore (0.012x0.030") tubing (Cole-Parmer #EW-06417-11) was slipped over its 27g 
needle.  The microbore tubing was threaded into the implanted tubing until it reached the 
implanted hardware.  Applying pressure to the syringe, the tubing was slowly backfilled 
with saline to ensure that all air bubbles were removed from the implanted tubing.  The 
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implanted tubing was then attached to the external solenoid-driven loading system 
(Figure 34 and Figure 35).  Care was again taken to make sure no bubbles were 
introduced to the animal’s tubing or the system tubing.  The saline in the system was then 
pressurized cyclically between 20-200 psi in a sinusoidal pattern at 1 Hz for 30 minutes.  
The tubing was then disconnected from the system and the animal removed from the thin 
plastic cone restrainer and anesthesia induced again at 4% isoflurane.  The tubing and 
incision area were cleansed with diluted betadine solutions (10% and 50%).  A sterile 
polypropylene male luer-lok connector (Cole-Parmer #A-30504-22) capped the luer 
connector on the tubing.  The tubing including connectors was then pushed back under 
the animal’s skin and the wound closed with wound clips (Figure 85-D). 
The procedure was repeated for subsequent loading sessions, opening the same 
site.  A fresh incision was not necessary since the wound did not have sufficient time to 
heal between loading sessions.  Loading occurred roughly every other day for three times 
per week for 2 weeks.  After the last loading session, the tubing was clipped short 
removing the connector and cap and heat sealed with a hemostat heated in a glass bead 
sterilizer.  The site was then thoroughly washed with betadine and closed permanently 
with wound clips.  Clips were removed in 10-14 days after the site healed completely.  
All instruments used in this procedure were autoclaved and were repeatedly resterilized 
with a glass bead sterilizer throughout the procedure even though a fully sterile 




LOADING PROCEDURE FOR RABBIT HYDRAULIC BONE CHAMBER STUDIES 
 
 209 
C.1 Standard Loading Procedure for Rabbit HBCs 
1. Take off cover and set IV stand w/ bag on table. 
2. Turn on top MOS and oscilloscope.  Turn on voltmeter while pressing its blue button 
to prevent automatic timed turn-off. 
3. Check that signal generator is set to 1 Hz. 
4. Turn manifold valve to 9 o’clock position.  Check cylinder for bubbles.  Move 
solenoid back and forth several times.  Be sure that you end with the solenoid pushed 
almost all the way in, but not with the black rubber seal sticking. 
5. Turn manifold valve to 12 o’clock and check that all loading lines are free of bubbles.  
Especially check near the connectors.  
6. Turn chamber valve to 3 o’clock.  Open chamber cap and let all bubbles escape from 
the loading line and its connections. 
7. Using 4-40 screw, lift the piston off the brass rod connected to load cell and then 
press “Rel” on the voltmeter.  Then gently push piston down until the piston just 
barely contacts the brass rod, but is enough for the load cell to be responsive to touch. 
8. With water brimming the top of the chamber, replace the cap being extremely careful 
not to change the position of the chamber relative to the plate of the test stand (i.e. 
make sure that the chamber doesn’t get screwed in any more or any less to avoid an 
artificial preload; use the angle of the barb as your check).  Make sure voltmeter still 
reads zero.  Close the chamber valve by turning to 6 o’clock. 
9. Open manifold cap and allow bubbles to escape from the manifold.  Press “/tare” on 
the pressure meter.  Replace the manifold cap.  Turn the manifold valve to 3 o’clock. 
10. Turn on bottom MOS.  Note:  Solenoid then begins its actuation.  It will be a static 
pressure if the button labelled “gate 1S, range 200K” is pushed and the pressure will 
be dynamic if the button labelled “ gate 10S, range 2” is pushed in on the top row of 
buttons on the frequency generator.  Turning the DC offset and amplitude knobs 
makes system pressure adjustments.  The knobs are 10 turn potentiometers so that 
you have better control of the system’s response. 
11. Check system for any leaks or unusual sounds. 
12. Adjust system to about the anticipated load range (0-5 lb)).  Cycle for 20 minutes.  
Record operating conditions. 
13. Turn chamber valve to 6 o’clock.  Turn off system and reset solenoid to full volume. 
14. Turn dynamic range down to ~ 10-20 psi.  You don’t want it to be zero, because you 
may lose pressure when you turn system on to the rabbit due to any air bubbles 
trapped in his line. 
15. Take rabbit out of cage and put him in a basket.  Check for bubbles in his tubing.  If 
you see any, run the microbore tubing that fits a 27 gage needle through the luer 
connector into the rabbit’s tubing.  Be sure that there is pressure on the needle’s 
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syringe at all times to force water out of the microtubing.  Feed the microtubing all 
the way to the rabbit’s chamber.  You will feel resistance.  Then slowly back out the 
microtubing allowing the forced water to fill the space taken by any bubbles.  You 
will see bubbles coming out of the rabbit’s tubing.  Usually, this only has to be done 
the first day of loading, but always check the rabbit’s exposed tubing for bubbles 
every day. 
16. Connect the rabbit’s tubing to the system’s loading line.  Be sure to fill both 
connectors with saline first to prevent bubbles. 
17. Turn each of the valves to the rabbits to 12 o’clock one at a time while watching the 
oscilloscope to make sure the pressure doesn’t drastically drop.  Turn the valve to the 
load cell to 3 o’clock.  Adjust the pressure up to the desired load range.  You can use 
the scope’s cursors to easily define the load range for you visually.  Use the min/max 
button on the voltmeter to check the range of the actual applied load.  Note the time. 
18. Cycle for 30 minutes.  Note any abnormalities and make small adjustments to keep 
the pressure within the defined range. Be sure to fill out loading record. 
19. At the end of 30 minutes, reduce the pressure to ~ 20 psi then switch to a static 
pressure and zero the load.  Do not go negative, but you may have slight positive 
pressure.  Sometimes, it simply isn’t possible to exactly zero the system.  If tweaking 
the knobs makes no difference on the oscilloscope, simply stop there.  Then, turn the 
chamber valve to 6 o’clock.  Switch system back to a dynamic 10-20 psi. 
20. Disconnect the rabbit from the system and recap his line.   
21. Repeat steps #15-20 for other rabbits. 
22. To shut down, turn off bottom MOS, then turn off scope and finally the top MOS.  
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C.2 Dealing with Anomalies Experienced During Loading Rabbit HBCs 
A rabbit turns around and bites the tubing. 
The system will immediately stop actuation because the solenoid will push the plunger to 
the emergency light stops in an effort to maintain pressure. 
1. You should immediately close all valves to loading lines and the load cell.  Flip 
the bottom MOS off.  Note the time. 
2. Remove the damaged load line and replace it with a new one from the cart. 
3. Turn manifold valve to 9 o’clock position.  Check cylinder for bubbles.  Move 
solenoid back and forth several times.  Be sure that you end with the solenoid 
pushed almost all the way in, but not with the black rubber seal sticking. 
4. Turn manifold valve to 12 o’clock and turn the new line valve to 3 o’clock and 
allow the new line to fill with saline.  Close line valve to 6 o’clock.  Open 
manifold cap and allow bubbles to escape from the manifold.  Press “/tare” on the 
pressure meter.  Replace the manifold cap.  Turn the manifold valve to 3 o’clock 
5. For extra measure turn manifold valve back to 9 o’clock and back again to 3 
o’clock to release any residual pressure to the saline bag. 
6. Reconnect line to offending rabbit. 
7. Flip bottom MOS back on.  Repeat step #17.  Continue loading for the remaining 
time. 
 
System gradually bleeds out and begins “knocking” light stops. 
1. This usually occurs about half way through the 30 min session when using high 
loads (such as 5 lb) with multiple rabbits.  Because the system is working at its 
upper limit, even tiny water losses (especially around the seal on the cylinder) 
may cause the system to try to push past the light stops. 
2. You may hear on occasional knock, but wait til knocking is nearly every cycle.  
Then turn pressure down to below 20 psi and turn off system.  You need to refill 
cylinder.  You may follow instructions outlined for a damaged line, just omit 
changing and refilling of the damaged line.  
 
Internal leak in rabbit. 
1. This may seem similar to either of the two previous anomalies, but cannot be 
corrected by simply resetting the system.  If there is a drastic pressure drop and no 
evidence of damaged lines, this may be the case. 
2. First try refilling cylinder as for A&C.  Then when you turn on system, watch the 
system response to an individual rabbit.  You need to determine which one is 
leaking so that you may exclude him from further loading and continue with the 
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others.   If you can’t tell the offender and the same thing happens again right 
away, stop and disconnect rabbits and run microbore tubing to eliminate any 
bubbles from lines.  Attach a saline-filled syringe with a luer lock to the end of 
rabbit’s tubing and try gently compressing the fluid.  It should resist and plunger 
should bounce back when you stop.  If you can actually force fluid out of the 
syringe with no recovery, that rabbit has an internal leak and can receive no more 
loading.  He should go on antibiotics immediately and receive surgery ASAP to 
correct the leaking tubing.  If after removing bubbles, the system works, then 
continue loading there may just have been too much compliance in the rabbit’s 











1. SuperScript II Rnase H- Reverse Transcriptase Kit from Invitrogen 
(Cat. No. 18064-014, store at –20) 
2. Oligo DT (12-18)  (500ug/ul) from Invitrogen (Cat. No.  18418-015; store at –20) 
3. 10mM dNTP mix (Promega C1145) 
4. Purified sample RNA 
5. Rnase Zap 
6. Rnase free water 
7. 1.5 ml microcentrifuge tubes, Rnase-free, Dnase-free, sterile 
8. PipetteMan 
9. 100 ul and 1000ul filtered pipette tips 
10. vortexer 
11. microfuge 
12. SpeedVac (Savant DNA 120) 
13. Water Bath set to 42C 
14. Heat block set to 70C 
15. ice bucket 
 
Procedure: 
1. Treat all surfaces with Rnase Zap 
2. Thaw at least 4ug of RNA for each sample. Keep on ice when possible.  
3. Aliquot 4 ug RNA into microcentrifuge tubes.  If the volume of RNA is less than 
11 ul, bring volume up to 11 ul with DEPC H2O.  If the volume of RNA is greater 
than 11 ul, dry the RNA down to 11 ul in the SpeedVac.  Tip:  If volume is very 
large, divide a given sample’s volume into multiple tubes to decrease the amount 
of time the RNA spends at room temperature. 
4. Thaw Oligo DT (12-18), dNTPs, SuperScript II enzyme, the accompanying 5x 
First Strand Buffer, and .1M DTT.  Vortex and brief spin. 
5. Add 1 ul Oligo to each and place in heat block for 10 min.  
6. Immediately move RNA to ice. Centrifuge to collect contents 
7. Make Master Mix.  Combine in the following order:   
a. 4ul/ reaction x __reaction = ___ ul 5x buffer 
b. 2ul/ reaction x __ reaction = ___ul DTT 
c. 1ul/ reaction x __ reaction = ___ul dNTPs  
Vortex and spin. 
8. Add 7 ul Master mix to each tube.  Vortex and brief spin. 
9. Place samples in water bath for 2 min. 
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10. Add 1 ul RT enzyme to each tube.  Vortex and brief spin. (Was a fresh aliquot 
used? _______) 
11. Place samples in water bath for 50 min. 
12. Transfer tubes to heat block for 15 min. Brief chill and centrifuge to collect 
contents. 
13. (Optional) Add 80 ul DEPC H2O to each tube to dilute to workable volume (i.e. 
use 5 ul or 1/20 reaction volume per PCR reaction).  Vortex and brief spin. 




D.2  Protocol Worksheet for Radioactive PCR  
 
Materials Needed 
1. Qiagen’s HotStarTaq Kit (Cat. # 203203 for 250 units or #203205 for 1000 units; 
store –20C); Kit includes 10x PCR buffer, 5x Q-soln (typically do not use), 
25mM MgCl2, and HotStarTaq DNA polymerase at 5 units/ul. 
2. 10mM dNTP mix (Promega C1145) 
3. Primers, both forward and reverse at 10 pmol/ul (Primers obtained as lyophilate 
from IDT and are resuspended to 100 pmol/ul with successive 1:10 dilutions later) 
4. HOT P-32 (Amersham #PB10205-250uCi or # PB10205-500uCi; 10mCi/ml;  
3000 Ci/mmol; store at –20C) {If P-32 is two weeks old, it may be necessary to 
double P-32 used and adjust water accordingly.} 
5. 6x loading buffer (xylene cyanol and bromophenol blue in glycerol base) 
6. Rnase free water 
7. 1.5 ml microcentrifuge tubes 
8. PipetteMan 
9. 100 ul and 1000ul filtered pipette tips 
10. PCR plate base and optional retainer 
11. PCR tubes 
12. vortexer 
13. microfuge 
14. ice bucket 
 
Procedure: 
1. PCR set up should be done on the DNA bench behind the radioactive shield.  Use 
tips, pipettors, water, etc. that are restricted to that area.  Turn on dosimeter.   
Check that waste containers are available. 
2. Thaw PCR Buffer, MgCl2 (if you need more than 1.5 mM Mg in the reaction), 
Taq, primers for each gene target, dNTPs, and P-32.   
3. Prepare Plate Layout Table 12.  Always include an open water (NIL) control to 
check for aerosol contamination and a closed water control to check for Master 
Mix contamination. You may also include RNA controls to check for genomic 
DNA contamination and an “RT” control to check for contamination in the RT 
Master Mix.  Allow for duplicate reaction tubes for experimental samples.  Place 





Table 12.  Working Plate Layout (12x8 Grid) 
PLATE LAYOUT 
 
4. If cDNA was not diluted 5x at end of RT, go ahead and add 80 ul water to the 20 
ul RT reaction volume now.  Place 5 ul (1/20 reaction volume) cDNA into each of 
the appropriate tubes.   
5. Place 5 ul water in the NIL controls.   
6. Place RNA in control tubes based on following info. 
What is the mass of RNA used in the RT reaction?  ________________ 
What is the mass of RNA per PCR control? (above/20) 
__________________________ 
Assuming 4 ug of cDNA were used in the RT reaction, place 0.2 ug (1/20 of RNA 
used in RT) RNA into each of the RNA controls.  Work out volumes needed 




Table 13.  Worksheet for Adjusting Sample Volume for PCR Reaction 
A B C D E 








Water to be 
Added;  (5-D) 
     
     
     
 
7. Cover PCR plate and set aside momentarily. 
8. Determine total number of reactions. Add a few more for mistakes. Prepare a 1:10 
dilution of P-32 for this number of samples:  Vol P-
32:__________________________;  Volume water: _______________________ 
9. Prepare Master Mixes as detailed in Table 14.  There will be a separate Master 
Mix for each primer.  Note:  hGAP works best at 1.5 mM MgCl2, rabCOLI works 
best at 2.0 mM, and OPN works best at 3.0mM.  Volumes are in ul.  Place check 
marks beside each ingredient from which you used a fresh aliquot. 
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Table 14.  Worksheet for Preparing PCR Master Mixes 
 
TARGET     
# samples per 
master mix 
    
Ingredient 1.5mM 2.0mM 2.5mM 3.0mM 
Buffer 5 x # = 5 x # = 5 x # = 5 x # = 
MgCl2 0 x # = 1 x # = 2 x # = 3 x # = 
DNTPs 1 x # = 1 x # = 1 x # = 1 x # = 
Fwd primer  2 x # = 2 x # = 2 x # = 2 x # = 
Rev primer 2 x # = 2 x # = 2 x # = 2 x # = 
Taq 0.5 x # = 0.5 x # = 0.5 x # = 0.5 x # = 
Water 33.5 x # = 32.5 x # = 31.5 x # = 30.5 x # = 
P-32 (1:10 
dilution) 
1 x # = 1 x # = 1 x # = 1 x # = 
TOTAL 45 x # = 45 x # = 45 x # = 45 x # = 
 
10. Add 45 ul of the appropriate master mix to each sample of that gene target.  
Pipette up and down to mix. 
11. Place capped tubes in preheated thermocycler block set for the given cycle pattern 
below. 
15’ @ 95;  {30” @ 94; 30” @ Ta; 30” @ 72};   10’@72; hold at 4 
Repeat backeted steps for total of 22 cycles.   
Ta varies from primer to primer.   
(Use 59 for hGAP, 57 for OPN and 61 for rabCOLI.) 
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Record Ta for each primer: __________________________________ 
12. At end of cycle remove tubes to the radioactive gel area in the fume hood.  Add 5 
ul of 6x loading buffer to each tube.  Pipette to mix. 
13. Return to thermocycler and run program DYESTORE or DYEGEL to bind the gel 
to the DNA.  Cycles hold DNA at 65 for 10 minutes, and then return to either 4 or 
22 degrees respectively.  (You want you PCR product at room temperature when 
loading gel. 
14. Either continue to running the gel or store PCR product at –20C. 
 





Pico-Green Assay For Double-Stranded Dna On Cell-Seeded Ha/Tcp Or Pldl  
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Report Abstract:  
This method describes how to predict the number of cells on a three dimensional 
scaffold using PicoGreen, a fluorescent dye that binds specifically to dsDNA.  Cells are 
lysed in the presence of a detergent using scraping and sonication to release the dsDNA 
into suspension.   Samples are centrifuged to remove debris and the supernatant exposed 
to Pico-Green fluorochrome.  Fluorescent intensity is measured by a fluorescence plate 
reader set to excite the samples at 502 nm and collect emissions at 523 nm (closest setting 
usually will be 480/520nm).  Unknowns are read side by side with standardized samples 
of known DNA amounts and relative fluorescence intensities are used to predict the 
number of cells in the unknown samples.  This assay for dsDNA provides a simple, very 
sensitive technique for determining the number of cells within a cell-seeded construct. 
Why use Pico-Green vs. Hoechst 33258? 
Pico-Green can detect much lower levels of dsDNA.  Hoechst can detect only 
10ng/ml dsDNA, while Pico-Green can quantify levels as low as 25pg/ml.  Furthermore, 
Pico-Green has a much wider dynamic range.  While the Hoechst assay requires two dye 
concentrations to obtain a dynamic range of two orders of magnitude, the Pico-Green 
assay only requires one dye solution to obtain a dynamic range of four orders of 
magnitude.  Also, the assay remains linear in the presence of many contaminants, 
although there will often be an offset involved (see product literature to find the effect of 
different contaminants).  Finally, the Hoechst assay is often sensitive to contaminating 
ssDNA and RNA. 
 
Useful Note:  The average cell has 7.7 pg DNA. 
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1. Materials and Reagents 
1.1. Pico-Green dsDNA Quantitation Kit (Molecular Probes, Cat. No. P-7589) 
including the Pico-Green dsDNA quantitation reagent, Lambda DNA standard 
(100ug/ml), and a 20x TE buffer (200mM Tris-HCL, 20mM EDTA, pH 7.5) 
1.2. 1M Tris-HCl (Life Technologies # 15567-027) 
1.3. 1% Triton-X100 in Ca-free PBS  (Sigma X-100) 
1.4. Ca-free PBS (Life Technologies #14190-136) 
1.5. 96-well Black Plates with Clear Bottom (Corning Costar Corp., Cat. No. 3603) 
1.6. Disposable serological pipettes, 25 ml (VWR) 
1.7. Pipette tips, 1-200 µl (VWR) 
1.8. Pipette tips, 200-1000 µl (VWR) 
1.9. 1.5 ml microcentrifuge tubes (Eppendorf) 
1.10. 48-well plate for dilutions (optional) 
1.11. aluminum foil 
1.12. Sharpie marker 
2. Equipment 
2.1. Fluorescence  Plate Reader  
2.2. Beckman Microfuge E 
2.3. Pipet-Aid (Drummond ) 
2.4. Pipetman, 2-20 µl  (P20) 
2.5. Pipetman, 20-200 µl  (P200) 
2.6. Pipetman, 200-1000 µl  (P1000) 
2.7. 8-channel Pipettor (FinnPippette) 
2.8. Repeator Pipettor (FinnPippette) 
 
3. Procedure  
3.1. Prepare Samples (Volumes per well assumes you are using 10cm2 dishes or a 6 
well plate.) 
3.1.1. Prepare TTH solution:  Add 10 ml 1M Tris-HCl + 20 ml 1% Triton + 
200 ml PBS to make a .1% Triton solution in 50 mM Tris-HCL.  Keep 
cold. 
3.1.2. Working buffer:  10% serum-free media, 90% TTH. 
3.1.3. Rinse scaffold with 1ml PBS.   
3.1.4. For HA/TCP, place scaffold in a 1.5 ml microcentrifuge tube.  Add 1ml 
buffer (media + TTH) and crush with an eppendorf pestle.  Transfer to a 
5ml tube.   
3.1.5. For PLDL, mince scaffold and place in a 5ml tube.  Add 1ml buffer 
(media + TTH). 
3.1.6. Sonicate all samples 10 seconds.  Transfer to a 1.5ml centrifuge tube.  




4. Prepare Standards (may be done at time of scaffold seeding) 
4.1. Prepare as many ladders as needed for the experiment.  In this case, prepare 
an MSC-ladder, and MOP-ladder, a PLDL+MSC ladder, and a 
HA/TCP+MSC ladder.  For scaffold plus cell ladders, as an equivalent mass 
of the scaffold material to the cell suspension. 
4.2. Prepare the following cell solutions in Table 15 using a 10e6/ml solution of 
each cell type.  Volumes are ul. Prepare in 5ml tubes.  Add crushed HA/TCP 
or minced PLDL as needed. 
Table 15.  Relative Volumes (µL) Of Cell Suspension, Media, And TTH Required 
For Each Solutioni In The Cell Ladder. 
 Blank 0.20M 0.4M 0.6M 0.8M 1.0M 
Cell Suspension 0 20 40 60 80 111 
Additional Media 100 80 60 40 20 0 
TTH 900 900 900 900 900 999 
 
Mass of HA/TCP: ____________ Mass of PLDL:_____________ 
4.3. (Optional) Prepare three serial dilutions of the 1e6/ml cell solution also. Use 
111ul of the more concentrated solution plus 999ul of buffer (media + TTH).  
Label these as 0.1M, 0.01M, and 0.001M.  . 
4.4. Sonicate 10 seconds.  Transfer to a 1.5ml microcentrifuge tube. Freeze at –
80C. 
 
5. Plate Set-up 
5.1. Thaw samples and standards.  Spin 30 seconds in microfuge. 
5.2. Prepare Working Reagent by mixing 19 parts ddH2O with 1 part 20x-TE 
buffer, then add a tenth part of the Pico-Green Reagent.  Vortex.  Protect 
from light. {PG Reagent takes a long time to thaw, even from RT.} 
 EXAMPLE 
Total WR volume:____________________ 10 ml 
ddH2O volume: _____________________ 9.5 ml 
20x-TE volume: _____________________ 500 ul 
PG volume: _________________________  50 ul 
5.3. Diagram sample and standard layout on plate cover.   
5.4. In plate, mix 100ul sample (or standard or blank) and 100 ul working reagent.  
Pipette to mix or use a shaker plate for 30 seconds. Incubate 5 minutes.  Read 




Finite Element Modeling Procedures for Rabbit Trabecular Bone 
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F.1 Determination of the Tissue Modulus of Rabbit Trabecular Bone 
 
Sample XII was chosen as a representative sample to model to determine tissue modulus.  
It had good architecture (a good right cylinder without many holes) and it’s bone volume 
fraction was close to 36% (the average of the Whitaker samples loaded and nonloaded, n 
= 18).  Developed model and applied a distributed 18.17N compressive load on top 
surface, constrained the cylindrical surface in the x and y directions, and the bottom 
surface of the cylinder in the z direction.  Guess 5000 MPa for tissue modulus and then 
acquired the model’s output for ezz apparent.  Used linear relationship to determine 
actual tissue modulus for the polymer. 
 
PREP FOR FE MODEL 
• Contoured original file (c0000994.isq at 16 um resolution) using 405 pixel circles 
from slice 52-441.  x1/y1 = 280/322; x2/y2 = 684/726.  Picked best segmentation 
by eye.  Gaussian filter (sigma = 1.2, support = 2) and threshold = 143.   
/isq in c0000994.isq 
/gobj_mask in c0000994.gobj 
/gauss_seg in seg        1.2/2/143 
/vox seg 
BVF = 51022620/15468663 = 0.3032 
/write seg m1015_p405_t143_seg.aim 
copy c0000994.isq to m1015.isq  
 
• Created a coarsened model with resolution of 32 microns, otherwise model would 
be too big for iplfe. 
/isq in m1015.isq 
/noipscale in sca  
-downscale 2 2 2 
-upscale  1 1 1 
/from_aim_to_isq sca m1015_s2.isq 
 
• Renamed m1015_s2.isq to c0000994.isq in root directory so the contouring 
program will recognize it.  Opened contouring program and created new contours.  
Many slices were out of range since it expects more slices.  New gobj: 203pixel 
circles on slices 26-224. x1/y1 = 140,161 and x2/y2 = 342/363.  Saved and 
renamed to m1015_s2_p203.gobj 
 
• In ipl, masked the rotated aim file with the new gobj file before component 
labeling to remove unconnected elements which could compromise the finite 
element model.  Performed a bounding box cut to minimize the zero space.  
Examined new aim for overall dimensions. 
 
/isq in m1015_s2.isq 
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/gobj_maskaimpeel_ow in m1015_s2_p203.gobj 
/gauss_seg in seg        1.2/2/143 
/cl26_rank seg cl 
/bounding_box_cut 
  -input                     cl 
  -output                    bb 
  -z_only                    false 
  -border                    3 0 0 ß on this model I had to add a border to make it square 
!> out dim:   203   203   199 
/write bb m1015_s2_p203_t143_cl_bb.aim  * 
 
** This is the file used as input to the fe program. 
 
• On a pc computer, created a boundary condition file (.bcd) using dimensions of 
_bb.aim.  See cyl_coords .xls.  Saved the last worksheet as cyl_coords.prn (space 
delimited text).  Opened .prn in Notepad, added the header information (making 
sure to edit the total number of boundary conditions in line 3.  Saved as _bb.txt 
and FTPed the document to microCT computer in the working directory and 
renamed the file _bb.bcd. 
 
 
RUNNING FE MODEL 
$ iplfe 
/read in m1015_s2_p203_t143_cl_bb.aim 
  /fe_solve3 
  -in                        in 
  -fea_file_name               m1015_s2_p203_t143_cl_bb   ß include dir if not 
in current working dir 
  -problem_nr                100 
  -scale_factor              1.817000E+01 
  -output_option             1 
  -tolerance_force           1.000000E-04 
  -tolerance_displ           1.000000E-04 
  -max_nr_iter               20000 
  -restart_option            1 
  -comp_val_mat_001          127 
  -Ymodulus_mat_001          5.000000E+03 
  -Poissonr_mat_001          3.000000E-01 
  -comp_val_mat_002          0 
  -Ymodulus_mat_002          1.000000E+04 
  -Poissonr_mat_002          3.000000E-01 
  -comp_val_mat_003          0 
  -Ymodulus_mat_003          1.000000E+04 




ESTIMATING TMOD FROM RESULTS 
 $iplfe 
/fe_post 
  -post_file_name            m1015_s2_p203_t143_cl_bb.post 
  -output                    ezz 
  -variable_nr               3 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
 
Read m1015_s2_p203_t143_cl_bb.poslist to get that (ezz)app = -0.0051433 
 
TMOD = 5000 MPA x  (-0.0051433) 
             (-0.00397)   ß  resultant displ amplitude from mech tests 
 
TMOD = 6478 MPa or 6.48 GPa 
 
 
Always check that this makes sense.  This stiffness is higher than the guess in 
the original model (5000 MPa) so we would expect less deformation when 
TMOD = 6480 MPa is used which makes sense since the model predicted 
more deformation than actually occurred in the mechanical tests when a force 




F.2 Modeling of Two Representative Rabbit Trabecular Bone Allografts 
 
Samples 19L and 14R were chosen as representative samples.  These samples were 
scanned on Ralph Mueller’s microct20 at 34 micron resolution.  The starting files were 
“rabbit-tibia_series04_19l_compl.aim” and “rabbit-tibia_series04_19l_compl.aim”.  The 
header info says that they were thresholded at 250 with a Gauss filter (sigma/support = 
1.2/2) and then component labeled.   But it also said that the element size was 75mm! 
Used /header_geo_set to change element size to .034x.034x.034 and then renamed files 
to 19l_cl.aim and 17l_cl.aim 
 
Prep 19l 
• Rotated cl.aim -1 degrees about x-axis and 4.5 degrees about y axis to straighten 
up the sides.   Reset header position.  
 
/read in 19l_cl.aim 
/turn3d 
  -input                     in 
  -output                    out 
  -turnaxis_angles           0.000 90.000 90.000 
  -turnangle                 -1 
/turn3d 
  -input                     out 
  -output                    r 
  -turnaxis_angles           90.000 0.000 90.000 
  -turnangle                 4.5 
/write r 19l_clr.aim 
/header_geo_set r    
   -position -1 -1 0 
/write r 19l_clrp.aim 
/from_aim_to_isq r 19l_clrp.isq 
 
• Renamed 19l_clrp.isq to c0000xxx.isq in root directory so contouring program 
will recognize the file.  Opened contouring program.   Many slices were out of 
range since the program expects more slices.  New gobj: 186 pixel circles on 
slices 25-213 x1/y1 = 165/177 and x2/y2 = 350/362.  Saved and renamed to 
19l_clrp.gobj 
 
• In ipl, masked the rotated aim file with the new gobj file before component 
labeling to remove unconnected elements which could compromise the finite 
element model.  Performed a bounding box cut to minimize the zero space.  
Examined new aim for overall dimensions. 
 
/aim in 19l_clrp.aim 
 
 230 
/gobj_maskaimpeel_ow in 19l_clrp.gobj 
/cl26_rank in cl 
/bounding_box_cut cl bb 
/exa bb geom. 
!> dim                               186     186     189 
!> off                                 0       0       0 
!> pos                               165      177     24 
!> element size in mm             0.0340  0.0340  0.0340 
!> phys dim in mm                 6.3240  6.3240  6.3240 
/write bb 19l_clrp_bb.aim 
 
• On a pc computer, created a boundary condition file (.bcd) using dimensions of 
_bb.aim.  See cyl_coords.xls.  Saved the last worksheet as cyl_coords.prn (space 
delimited text).  Opened .prn in Notepad, added the header information (making 
sure to edit the total number of boundary conditions in line 3.  Saved as _bb.txt 
and FTPed the document to microCT computer in the working directory and 
renamed the file _bb.bcd. 
 
Prep 14R 
• Repeated steps above for 19L with the following differences. 
• Rotated cl.aim -3 degrees about x-axis and 4.5 degrees about y axis to straighten 
up the sides.   Reset header position.  
• Reneamed 14r_clrp.isq to c0000xxx.isq in root directory so contouring program 
will recognize the file.  Opened contouring program and created  new contours.  
New gobj: 187 pixel circles on slices 21-203 x1/y1 = 156/178 and x2/y2 = 
342/364.  Saved and renamed to 14r_clrp.gobj 
 
Ran FEM models for 19l and 14r as shown for p19l below.  
$ iplfe 
/read 
  -name                      in 
  -filename                  19L_CLRP_BB.AIM;1 
/fe_solve3 
  -in                        in 
  -fea_file_name             19L_CLRP_BB 
  -problem_nr                100 
  -scale_factor              2.22400E+01 
  -output_option             1 
  -tolerance_force           1.000000E-04 
  -tolerance_displ           1.000000E-04 
  -max_nr_iter               20000 
  -restart_option            1 
  -comp_val_mat_001          127 
  -Ymodulus_mat_001          6.480000E+03 
  -Poissonr_mat_001          3.000000E-01 
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  -comp_val_mat_002          0 
  -Ymodulus_mat_002          1.000000E+04 
  -Poissonr_mat_002          3.000000E-01 
  -comp_val_mat_003          0 
  -Ymodulus_mat_003          1.000000E+04 
  -Poissonr_mat_003          3.000000E-01 
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F.3 Post-Processing of Two Representative Rabbit Trabecular Bone Allografts 
The following batch file contains IPL commands necessary to create .aim files coded 
with each of the four output parameters: åzz,  åpl, VMS, and SED and histograms of these 





$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$   seg_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEG.AIM" 
$   gobj_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + ".GOBJ" 
$   histo_ezz = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZ.TAB" 
$   histo_epl = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPL.TAB" 
$   histo_vms = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMS.TAB" 
$   histo_sed = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SED.TAB" 
$   ezz_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZ.AIM"  
$   epl_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPL.AIM" 
$   vms_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMS.AIM" 
$   sed_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SED.AIM" 
$ 
$   show log org_file 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$   ipl_scanco_prog 
 
/fe_post 
  -post_file_name            org_file 
  -output                    ezz 
  -variable_nr               3 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
/fe_post 
  -post_file_name            org_file 
  -output                    epl 
  -variable_nr               24 
  -loadcase_nr               1 
  -output_option             1 
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  -interpol_option           1 
  -averaging_option          0 
/fe_post 
  -post_file_name            org_file 
  -output                    vms 
  -variable_nr               42 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
/fe_post 
  -post_file_name            org_file 
  -output                    sed 
  -variable_nr               45 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
/write ezz "ezz_file 
  -compress_type             bin 
  -version_020               true 
/write epl "epl_file 
  -compress_type             bin 
  -version_020               true 
/write vms "vms_file 
  -compress_type             bin 
  -version_020               true 
/write sed "sed_file 
  -compress_type             bin 
  -version_020               true 
/histo ezz 
  -fileout_or_screentab      "histo_ezz 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/histo epl 
  -fileout_or_screentab      "histo_epl 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
 /histo vms 
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  -fileout_or_screentab      "histo_vms 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/histo sed 
  -fileout_or_screentab      "histo_sed 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 






Finite Element Modeling Procedures for PLDL 
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G.1 Determination of PLDL Tissue Modulus  
P25 was chosen as a representative sample to model.  The model was developed with a 
distributed compressive force of 11.89 N on the top surface.  The cylindrical surface was 
constrained in the x and y directions, and the bottom surface of the cylinder in the z 
direction.  A guess of 5000 MPa for tissue modulus was used to determine the model’s 
output for åzz apparent and a linear relationship used to determine the actual tissue 
modulus for the polymer. 
 
PREP FOR FE MODEL 
• Copied c0000286a_g81_t28_seg.aim (previously segmented with a Gaussian 
filter set to a sigma of 0.8 and a support of 1 and threshold of 28) to p25_seg.aim 
• Rotated p25_seg.aim -9 degrees about x-axis and -5 degrees about y axis to 
straighten up the sides.  New file is p25_segr.aim 
 
/read 
  -name                      in 
  -filename                  p25_seg.aim 
/turn3d 
  -input                     in 
  -output                    out 
  -turnaxis_angles           0.000 90.000 90.000 
  -turnangle                 -9.000000 
/turn3d 
  -input                     out 
  -output                    r 
  -turnaxis_angles           90.000 0.000 90.000 
  -turnangle                 -5.000000 
/write r p25_segr.aim 
  -compress_type             bin 
  -version_020               true 
 
• Created an .isq file from the rotated .aim file, so that a contour file can be created.  
Since the rotation process sometimes creates negative z-coordinates, first check to 
make sure the z-position in the .aim file header is positive or the contouring 
program won’t be able to read in the appropriate slices since it expects slices to 
start at zero.  If not reset z-position to zero using the header_geo_set command. 
 
/examine r geom 
!> dim                               180     197     225 
!> off                                 0       0       0 
!> pos                               128     245      19 
!> element size in mm             0.0300  0.0300  0.0300 




  -aim_name                  r 
  -isq_filename              p25_segr.isq 
  -square_flag               false 
  -original_position         true 
 
• Copied r25_segr.isq to c00000285.isq and opened it in the contouring program.  
Created a right cylinder .gobj file.  In this case, I omitted 3 slices with too little 
bone to adequately apply forces to on top and 3 slices on bottom for same reason.  
Slices 43-214.  The diameter of circular contours is 136 pixels and x1/y1 position 
is 152/223 and x2/y2 position is 287/408.  Saved contours as c0000285.gobj and 
then copied to p25_segr.gobj. 
• In ipl, masked the rotated aim file with the new gobj file before component 
labeling to remove unconnected elements which could compromise the finite 
element model.  Performed a bounding box cut to minimize the zero space.  
Examined new aim for overall dimensions. 
 
/read in P25_SEGR.AIM;1 
/gobj_maskaimpeel_ow 
  -input_output              in 
  -gobj_filename             P25_SEGR.GOBJ;1 
  -peel_iter                 0 
/cl26_rank_extract 
  -input                     in 
  -output                    cl 
  -first_rank                1 
  -last_rank                 1 
  -connect_boundary          false 
  -value_in_range            127 
/bounding_box_cut 
  -input                     cl 
  -output                    bb 
  -z_only                    false 
  -border                    0 0 0 
/examine bb geom.  
/write bb p25_segr_bb.aim  ** 
** This is the file used as input to the fe program. 
 
• On a pc computer, created a boundary condition file (.bcd) using dimensions of 
p25_segr_bb.aim.  See cyl_coords p25.xls.  Saved the last worksheet as 
cyl_coords.prn (space delimited text).  Opened .prn in Notepad, added the header 
information (making sure to edit the total number of boundary conditions in line 
3.  Saved as p25_segr_bb.txt and FTPed the document to microCT computer in 




Running FE Model 
$ iplfe 
/read in P25_SEGR_BB.AIM;1 
/fe_solve3 
  -in                        in 
  -fea_file_name             P25_SEGR_BB 
  -problem_nr                100 
  -scale_factor              1.189000E+01 
  -output_option             1 
  -tolerance_force           1.000000E-04 
  -tolerance_displ           1.000000E-04 
  -max_nr_iter               20000 
  -restart_option            1 
  -comp_val_mat_001          127 
  -Ymodulus_mat_001          5.000000E+03 
  -Poissonr_mat_001          3.000000E-01 
  -comp_val_mat_002          0 
  -Ymodulus_mat_002          1.000000E+04 
  -Poissonr_mat_002          3.000000E-01 
  -comp_val_mat_003          0 
  -Ymodulus_mat_003          1.000000E+04 
  -Poissonr_mat_003          3.000000E-01 
 
ESTIMATING TMOD FROM RESULTS 
 /iplfe 
/fe_post 
  -post_file_name            P25_SEGR_BB.POST 
  -output                    ezz 
  -variable_nr               3 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
 
Read p25_segr_bb.poslist to get that (åzz)app = -0.0034625 
 
TMOD = 5000 MPA x  (-0.0034625) 
                        (-0.0204)   ß displacement from mechanical tests 
TMOD = 849 MPa  
 
• Always check that this makes sense.  This stiffness is lower than the guess in the 
original model (5000 MPa) so we would expect more deformation when TMOD = 
849 MPa is used which makes sense since the model did not deform as much as 




G.2 Modeling of Three Representative PLDL Samples 
Samples p25, p26, and p93 were chosen and modeled as representative PLDL 
samples.  Deformations within the tissue space are important, so both the polymer (or 
“bone”) and the tissue (or “marrow”) were modeled.  In addition, a metal plate was 
modeled on the end of the sample that the force is applied since the difference in moduli 
of the two materials could result in large deformation errors near this boundary.  Created 
an .aim file that has polymer (127), tissue (10), plate (5) and empty space (0) as well as 
individual .aim files of the polymer, tissue, and plate.  The empty space is the corners of 
the cube that are outside the right cylinder.  The plate was modeled as a disk that is a 
single layer of elements thick.  A distributed force of 13.3 N was applied to the plate to 
match the actual loading conditions of the rats in vivo.  The polymer was assigned a 
tissue modulus of 849 MPa based on the procedure outlined in Appendix G.1.  The plate 




• Copied p25_segr_bb.aim to p25_segr_bb2_bone.aim 
• Created .aim file with bone and marrow. 
 
/read in P25_SEGR_BB2_bone.AIM  
/set_value 
  -input                     in 
  -value_object              127 
  -value_background          10 
/gobj_maskaimpeel_ow 
  -input_output              in 
  -gobj_filename             P25_SEGR.GOBJ;1 
  -peel_iter                 0 
/write in p25_segr_bb2.aim     ß represents “bone” and “marrow” 
 
• Created .aim with marrow only. 
 
/read in P25_SEGR_BB2_bone.aim 
/set_value 
  -input                     in 
  -value_object              10 
  -value_background          127 
/gobj_maskaimpeel_ow 
  -input_output              in 
  -gobj_filename             P25_SEGR.GOBJ;1 
  -peel_iter                 0 




• Created .aim with plate, bone, and marrow by first creating a second gobj exactly 
as before but including one extra slice on top (i.e. slices 42-214) and saved as 
p25_ps.gobj.  Also saved a .gobj file with just slice 42 as p25_plate.gobj.  Then in 
ipl, created an aim of just the plate and then concatenated that file to the aim of 
the bone and marrow listed above.  Another bounding box cut is required.  
 
/read in P25_segr.aim 
/set_value 
  -input                     in 
  -value_object              127 
  -value_background          127 
/gobj_maskaimpeel_ow 
  -input_output              in 
  -gobj_filename             P25_plate.GOBJ;1 
  -peel_iter                 0 
/set_value 
  -input                     in 
  -value_object              5 
  -value_background          0 
/read sample p25_segr_bb2.aim 
/concat 
  -input1                    in 
  -input2                    sample 
  -output                    both 
  -common_region_only        false 
  -add_not_overlay           true 
  -make_edge                 false 
  -shift_ofin2               0 0 0 
  -turnangle                 0.000000 
  -turnpoint_global          -1 -1 
/bounding_box_cut 
  -input                     both 
  -output                    bb 
  -z_only                    false 
  -border                    0 0 0 
/gobj_maskaimpeel_ow 
  -input_output              bb 
  -gobj_filename             P25_ps.GOBJ;1 
  -peel_iter                 0 
/histo bb p25_ps.tab 





• On a pc computer, created a boundary condition file (.bcd) using dimensions of 
_ps.aim.  Saved as _ps.txt and FTPed the document to microCT computer in the 
working directory and renamed the file _ps.bcd. 
 
Prep P26 
• Copied c0000286b_g81_t28_seg.aim (previously segmented with a Gaussian 
filter set to a sigma of 0.8 and a support of 1 and threshold of 28) to p26_seg.aim 
• Rotated p26_seg.aim +14 degrees about x-axis and +6 degrees about y axis to 
straighten up the sides.  New file is p26_segr.aim 
• Created an .isq from the rotated aim so that you can create a contour file.  Since 
the rotation process sometimes creates negative z-coordinates, first check to make 
sure the z-position in the .aim file header is positive or the contouring program 
won’t be able to read in the appropriate slices since it expects slices to start at 
zero.  If not reset z-position to zero using the header_geo_set command and save 
as _segrp.aim. 
 
/read in P26_SEGR.AIM;1 
/examine in geom 
!> dim                               184     220     235 
!> off                                 0       0       0 
!> pos                               141      33     -20 
!> element size in mm             0.0300  0.0300  0.0300 
!> phys dim in mm                 5.5200  6.6000  7.0500 
/header_geo_set 
  -input                     in 
  -off_new                   -1 -1 -1 
  -pos_new                   -1 -1 0 
  -el_size_mm_new            -1.000 -1.000 -1.000 
!> New Pos      141       33        0 
/write in p26_segrp.aim      
/from_aim_to_isq r p26_segrp.isq 
 
• Copied r26_segrp.isq to c00000285.isq and opened it in the contouring program.  
Created a right cylinder gobj file.  In this case, I omitted 3 slices with too little 
bone to adequately apply forces to on top and 10 slices on bottom for same 
reason.  Contoured slices 34-194 using circular contours with a diameter of 138 
pixels and x1/y1 position of 164/74 and x2/y2 position of 301/211.  Saved 
contours as c0000285.gobj and copied to p26_segrp.gobj. 
• In ipl, masked the rotated aim file with the new gobj file before component 
labeling to remove unconnected elements which could compromise the finite 
element model.  Performed a bounding box cut to minimize the zero space.  
Examined new aim for overall dimensions. 
 
/read in P26_SEGRp.AIM;1 
/gobj_mask in P26_SEGRp.GOBJ;1 
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!% -> Set 2409204 of total ? 
/cl26_rank_extract in cl 
!%  Total number of disjoint components: 217   
!%  Label      1:             99.87 %    
/bounding_box_cut cl bb 
/examine bb geom 
!> dim                               136     136     159 
!> off                                 0       0       0 
!> pos                               165      74      34 
!> element size in mm             0.0300  0.0300  0.0300 
!> phys dim in mm                 4.0800  4.0800  4.7700 
/write bb p26_segrp_bb.aim 
 
• Copied p26_segrp_bb.aim to p26_segrp_bb2_bone.aim 
• Created .aim with bone and marrow. 
 
/read in  P26_SEGRp_BB2_bone.AIM  
/set_value in 
  -value_object              127 
  -value_background          10 
/gobj_maskaimpeel_ow in P26_SEGRp.GOBJ;1 
/write bb p25_segr_bb2.aim     ß represents “bone” and “marrow”, will be fe 
input 
 
• Created .aim with marrow only. 
 
/read in P26_SEGRp_BB2_bone.aim 
/set_value in 
  -value_object              10 
  -value_background          127 
/gobj_maskaimpeel_ow in P26_SEGRp.GOBJ;1 
/write in p25_segr_bb2_mar.aim     ß represents “marrow”,  
 
• Created .aim with plate, bone, and marrow by first creating a second gobj exactly 
as before but including one extra slice on top (i.e. slices 42-214) and saved as 
p25_ps.gobj.  Also saved a .gobj file with just slice 42 as p25_plate.gobj.  Then in 
ipl, created an aim of just the plate and then concatenated that file to the aim of 
the bone and marrow listed above.  Another bounding box cut is required.  
 
/read in P25_segr.aim 
/set_value 
  -input                     in 
  -value_object              127 




  -input_output              in 
  -gobj_filename             P25_plate.GOBJ;1 
  -peel_iter                 0 
/set_value 
  -input                     in 
  -value_object              5 
  -value_background          0 
/read sample p25_segr_bb2.aim 
/concat 
  -input1                    in 
  -input2                    sample 
  -output                    both 
  -common_region_only        false 
  -add_not_overlay           true 
  -make_edge                 false 
  -shift_ofin2               0 0 0 
  -turnangle                 0.000000 
  -turnpoint_global          -1 -1 
/bounding_box_cut 
  -input                     both 
  -output                    bb 
  -z_only                    false 
  -border                    0 0 0 
/gobj_maskaimpeel_ow 
  -input_output              bb 
  -gobj_filename             P25_ps.GOBJ;1 
  -peel_iter                 0 
/histo bb p25_ps.tab 
/write bb p25_ps.aim ß represents “bone” and “marrow” and “plate”, will be 
fe input 
 
• On a pc computer, created a boundary condition file (.bcd) using dimensions of 
_ps.aim.  Saved as _ps.txt and FTPed the document to microCT computer in the 
working directory and renamed the file _ps.bcd. 
 
Prep P93 
• Repeat steps for P26 with the following differnces 
• Copied c0000287c_g81_t28_seg.aim (previously segmented with a Gaussian 
filter set to a sigma of 0.8 and a support of 1 and threshold of 28) to p93_seg.aim 
• Rotated p93_seg.aim -1 degrees about x-axis and +7 degrees about y axis to 
straighten up the sides.  New file is p93_segr.aim 
• P93 did not need repositioning. 
• Contouring:  In this case, I omitted 2 slices with too little bone to adequately 
apply forces to on top and 1 slice on bottom for same reason.  Slices 40-195.  
Diameter of circular contours is 140 pixels and x1/y1 position is 308/163 and 
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x2/y2 position is 447/302.  Saved contours c0000287.gobj and copied to 
p93_segr.gobj. 
 
Run FEM models for p25, p26, and p93 as shown for p25 below.  
$ iplfe 
/read in P25_PS.AIM;1 
/fe_solve3 
  -in                        in 
  -fea_file_name             P25_PS 
  -problem_nr                100 
  -scale_factor              1.33000E+01 
  -output_option             1 
  -tolerance_force           1.000000E-04 
  -tolerance_displ           1.000000E-04 
  -max_nr_iter               20000 
  -restart_option            1 
  -comp_val_mat_001          127 
  -Ymodulus_mat_001          8.490000E+02 
  -Poissonr_mat_001          3.000000E-01 
  -comp_val_mat_002          10 
  -Ymodulus_mat_002          1.000000E-01 
  -Poissonr_mat_002          3.000000E-01 
  -comp_val_mat_003          5 
  -Ymodulus_mat_003          1.200000E+07 




G.3 Post-Processing of Three Representative PLDL Samples 
G.3.1 Generation of Output Files for Materials 1 & 2 
• Run ad_fe_pc1.com on *.post file to create output aims.  Note that the output 
lumps material 1 (polymer) and material 2 (interstitial tissue) and material 3 
(plate) together.  
• Manually reset headers on all four output aims to match the position of the input 
aim.  åzz example below where x y z refer to the position of the input aim for the 
finite element model.  For some reason, all the iplfe output .aims are shifted by 1 
voxel in all three directions. 
• /read out _ezz.aim 
• /read in _bb2.aim 
/examine in geom 
/examine out geom. 
/header_geo_set 
-input                     out 
-off_new                   -1 -1 -1 
-pos_new                   x y z 
-el_size_mm_new            -1.000 -1.000 -1.000 
/write out _ezzr.aim 
• Run ad_fe_pc2.com on *.post file to create aims that include the output 
parameters for bone and marrow individually.  Also histograms of same data. 
• Run ad_fe_pc_statb.com on *.post file to see output statistics for bone.  Record 
values on spreadsheet. 
• Run ad_fe_pc_statm.com on *.post file to see output statistics for marrow.  
Record values on spreadsheet. 





G.3.2 IPL Batch Files Used to Generate Output for Materials 1 & 2 
The following batch file contains IPL commands necessary to create .aim files coded 
with each of the four output parameters: åzz,  åpl, VMS, and SED.  These .aim files contain 
output for both Material 1 and Material 2.  To execute the following batch file, type the 





$!  IPL Batch for post-processing angel's fe models with 2 materials for preculture study. 
$!  Step 1  
$! 
$!  IPL Batch Scanco 
$! 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$   ezz_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZ.AIM"  
$   epl_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPL.AIM" 
$   vms_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMS.AIM" 
$   sed_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SED.AIM" 
$ 
$   show log org_file 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$   ipl_scanco_prog 
 
/fe_post 
  -post_file_name            org_file 
  -output                    ezz 
  -variable_nr               3 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
/fe_post 
  -post_file_name            org_file 
  -output                    epl 
  -variable_nr               24 
  -loadcase_nr               1 
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  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
/fe_post 
  -post_file_name            org_file 
  -output                    vms 
  -variable_nr               42 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
/fe_post 
  -post_file_name            org_file 
  -output                    sed 
  -variable_nr               45 
  -loadcase_nr               1 
  -output_option             1 
  -interpol_option           1 
  -averaging_option          0 
 
/write ezz "ezz_file 
  -compress_type             bin 
  -version_020               true 
/write epl "epl_file 
  -compress_type             bin 
  -version_020               true 
/write vms "vms_file 
  -compress_type             bin 
  -version_020               true 
/write sed "sed_file 
  -compress_type             bin 






The following batch file contains IPL commands necessary to create .aim files coded 
with each of the four output parameters: åzz,  åpl, VMS, and SED separated by material 
designation.  Histograms of each .aim are also created.  To execute the following batch 




$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Step 2 -- to be run after ad_fe_pc1 and after the headers are 
$!  repositioned. 
$! 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$   bone_gobj_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_bone.aim" 
$   marrow_gobj_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_mar.aim" 
$   ezz_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR.AIM"  
$   epl_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR.AIM" 
$   vms_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR.AIM" 
$   sed_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR.AIM" 
$   ezzb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR_BONE.AIM"  
$   eplb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR_BONE.AIM" 
$   vmsb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR_BONE.AIM" 
$   sedb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR_BONE.AIM" 
$   ezzm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR_MAR.AIM"  
$   eplm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR_MAR.AIM" 
$   vmsm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR_MAR.AIM" 
$   sedm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR_MAR.AIM" 
$   histo_ezzb = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR_BONE.TAB" 
$   histo_eplb = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR_BONE.TAB" 
$   histo_vmsb = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR_BONE.TAB" 
$   histo_sedb = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR_BONE.TAB" 
$   histo_ezzm = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR_MAR.TAB" 
$   histo_eplm = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR_MAR.TAB" 
$   histo_vmsm = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR_MAR.TAB" 
$   histo_sedm = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR_MAR.TAB" 
$ 
$   show log org_file 
$ 




$   ipl_scanco_prog 
 
!    This section generates a _ezz_bone.aim and _ezz_bone.tab of histogram data 
!    for material 1 (bone) and a _ezz_marrow.aim and _ezz_marrow.aim 
!    for material 2 (marrow). 
 
/read 
  -name                      ezz 
  -filename                  "ezz_file 
/gobj_maskaimpeel_ow 
  -input_output              ezz 
  -gobj_filename             "bone_gobj_file 
  -peel_iter                 0 
/write ezz "ezzb_file 
  -compress_type             bin 
  -version_020               true 
/histo ezz 
  -fileout_or_screentab      "histo_ezzb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/read 
  -name                      ezz 
  -filename                  "ezz_file 
/gobj_maskaimpeel_ow 
  -input_output              ezz 
  -gobj_filename             "marrow_gobj_file 
  -peel_iter                 0 
/write ezz "ezzm_file 
  -compress_type             bin 
  -version_020               true 
/histo ezz 
  -fileout_or_screentab      "histo_ezzm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
 
 
!    This section generates a _epl_bone.aim and _epl_bone.tab of histogram data 
!    for material 1 (bone) and a _epl_marrow.aim and _epl_marrow.aim 
!    for material 2 (marrow). 
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/read 
  -name                      epl 
  -filename                  "epl_file 
/gobj_maskaimpeel_ow 
  -input_output              epl 
  -gobj_filename             "bone_gobj_file 
  -peel_iter                 0 
/write epl "eplb_file 
  -compress_type             bin 
  -version_020               true 
/histo epl 
  -fileout_or_screentab      "histo_eplb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/read 
  -name                      epl 
  -filename                  "epl_file 
 
/gobj_maskaimpeel_ow 
  -input_output              epl 
  -gobj_filename             "marrow_gobj_file 
  -peel_iter                 0 
/write epl "eplm_file 
  -compress_type             bin 
  -version_020               true 
/histo epl 
  -fileout_or_screentab      "histo_eplm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
 
  
!    This section generates a _vms_bone.aim and _vms_bone.tab of histogram data 
!    for material 1 (bone) and a _vms_marrow.aim and _vms_marrow.aim 
!    for material 2 (marrow). 
 
/read 
  -name                      vms 




  -input_output              vms 
  -gobj_filename             "bone_gobj_file 
  -peel_iter                 0 
/write vms "vmsb_file 
  -compress_type             bin 
  -version_020               true 
/histo vms 
  -fileout_or_screentab      "histo_vmsb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/read 
  -name                      vms 
  -filename                  "vms_file 
/gobj_maskaimpeel_ow 
  -input_output              vms 
  -gobj_filename             "marrow_gobj_file 
  -peel_iter                 0 
/write vms "vmsm_file 
  -compress_type             bin 
  -version_020               true 
/histo vms 
  -fileout_or_screentab      "histo_vmsm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
 
 
!    This section generates a _sed_bone.aim and _sed_bone.tab of histogram data 
!    for material 1 (bone) and a _sed_marrow.aim and _sed_marrow.aim 
!    for material 2 (marrow). 
 
/read 
  -name                      sed 
  -filename                  "sed_file 
/gobj_maskaimpeel_ow 
  -input_output              sed 
  -gobj_filename             "bone_gobj_file 
  -peel_iter                 0 
/write sed "sedb_file 
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  -compress_type             bin 
  -version_020               true 
/histo sed 
  -fileout_or_screentab      "histo_sedb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
 
/read 
  -name                      sed 
  -filename                  "sed_file 
/gobj_maskaimpeel_ow 
  -input_output              sed 
  -gobj_filename             "marrow_gobj_file 
  -peel_iter                 0 
/write sed "sedm_file 
  -compress_type             bin 
  -version_020               true 
/histo sed 
  -fileout_or_screentab      "histo_sedm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 






The following batch file contains IPL commands necessary to display statistical 
information for each output .aim file for Material 1 (polymer phase “bone”).  To execute 




$   if p1 .EQS. ""  
$  THEN  
$  write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$   define   org_file    'p1' 
$   ezzb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR_BONE.AIM"  
$   eplb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR_BONE.AIM" 
$   vmsb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR_BONE.AIM" 
$   sedb_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR_BONE.AIM" 
$   show log org_file 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$   ipl_scanco_prog 
/read 
  -name                      ezzb 
  -filename                  "ezzb_file 
/examine 
  -input                     ezzb 
  -item                      stat 
/read 
  -name                      eplb 
  -filename                  "eplb_file 
/examine 
  -input                     eplb 
  -item                      stat 
/read 
  -name                      vmsb 
  -filename                  "vmsb_file 
/examine 
  -input                     vmsb 
  -item                      stat 
/read 
  -name                      sedb 
  -filename                  "sedb_file 
/examine 
  -input                     sedb 





The following batch file contains IPL commands necessary to display statistical 
information for each output .aim file for Material 2 (interstitial phase “marrow”).  To 




$   if p1 .EQS. ""  
$  THEN  
$   write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$   define   org_file    'p1' 
$   ezzm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EZZR_MAR.AIM"  
$   eplm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_EPLR_MAR.AIM" 
$   vmsm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_VMSR_MAR.AIM" 
$   sedm_file = p1 - F$PARSE(p1,,,"VERSION") - ".POST" + "_SEDR_MAR.AIM" 
$   show log org_file 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$   ipl_scanco_prog 
/read 
  -name                      ezzm 
  -filename                  "ezzm_file 
/examine 
  -input                     ezzm 
  -item                      stat 
/read 
  -name                      eplm 
  -filename                  "eplm_file 
/examine 
  -input                     eplm 
  -item                      stat 
/read 
  -name                      vmsm 
  -filename                  "vmsm_file 
/examine 
  -input                     vmsm 
  -item                      stat 
/read 
  -name                      sedm 
  -filename                  "sedm_file 
/examine 
  -input                     sedm 





G.3.3 Regional Analysis of Tissue Parameters  
• Run ad_fe_pc_regb_xxp.com where xx = 25, 26, or 93 on _bone.aim in the 
respective directories including _ezzr_bone.aim (& eplr_bone.aim, etc) to 
generate aims and histograms for the top 25%, middle 50%, and bottom 25%.  
Histograms reflect the full data set. 
• Run ad_fe_pc_regm_xxp.com where xx = 25, 26, or 93 on _mar.aim  in directory 
including _ezzr_mar.aim (& eplr_mar.aim, etc) to generate aims and histograms 
for the top 25%, middle 50%, and bottom 25%.  Histograms reflect the full data 
set. 
• Run ad_fe_pc_regstat.com on _xxx_bone.aim or xxx_mar.aim where xxx = ezz, 
epl, vms, or sed.  Run multiple times to get top, middle, bottom stats for each 
parameter in bone and in marrow. 
• Run ad_fe_pc_histo_bone_r.com on _xxx_bone.aim to create histograms with a 
reduced data set including 0-95th percentile for VMS and SED and 5th to 95th 
percentile for ezz and epl. 
• Run ad_fe_pc_histo_mar_r.com on _xxx_mar.aim to create histograms with a 
reduced data set including 0-95th percentile for VMS and SED and 5th to 95th 
percentile for ezz and epl. 
• Run ad_fe_pc_vivo.com on the _seg.aims for every measurement in the 8-week 
preculture loaded group (m2354-59, 2476-77) to determine the distribution of 
bone volume for the top 25%, middle 50%, and bottom 25%.  Repeat to determine 
the distribution of bone volume for the top 10%, middle 80%, and bottom 10%.  




G.3.4 IPL Batch Files Used to Generate Regional Output of Tissue Parameters  
The following batch file contains IPL commands necessary to separate the tissue 
response output for Material 1 (polymer phase “bone”) into zones (top 25%, middle 50%, 
and bottom 25%).  To execute the following batch file, type the following command in a 




$!       
$!         _/_/_/  _/_/_/    _/         
$!          _/    _/    _/  _/           Image Processing Language   
$!         _/    _/_/_/    _/  
$!        _/    _/        _/             (c)  Andres Laib, Scanco Medical AG 
$!     _/_/_/  _/        _/_/_/_/             
$!         
$!       
$! 
$!  IPL Batch FOR POST-PROCESSING ANGEL'S FE MODELS WITH 2 
MATERIALS. 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Divides resultant data into top, middle, and bottom regions. 
$!   
$!  Written for p25 which has a z-dim of 173 voxels and z-pos of 41. 
$!  The first slice is a metal plate.  Then the sample is  
$!  Divided into top 43 slices, middle 86 slices, and bottom 43 slices. 
$! 
$!  The 'p1' org_file here is _bone.aim 
$! 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$   ezz_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE.AIM"  
$   epl_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE.AIM" 
$   vms_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE.AIM" 




$   ezzt_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE_TOP.AIM"  
$   eplt_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_TOP.AIM" 
$   vmst_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_TOP.AIM" 
$   sedt_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_TOP.AIM" 
$   ezzm_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE_MID.AIM"  
$   eplm_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_MID.AIM" 
$   vmsm_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_MID.AIM" 
$   sedm_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_MID.AIM" 
$   ezzb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE_BOT.AIM"  
$   eplb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_BOT.AIM" 
$   vmsb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_BOT.AIM" 
$   sedb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_BOT.AIM" 
$   histo_ezzt = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE_TOP.TAB" 
$   histo_eplt = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_TOP.TAB" 
$   histo_vmst = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_TOP.TAB" 
$   histo_sedt = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_TOP.TAB" 
$   histo_ezzm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE_MID.TAB" 
$   histo_eplm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_MID.TAB" 
$   histo_vmsm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_MID.TAB" 
$   histo_sedm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_MID.TAB" 
$   histo_ezzb = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EZZR_BONE_BOT.TAB" 




$   histo_vmsb = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_BOT.TAB" 
$   histo_sedb = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_BOT.TAB" 
$ 
$   show log org_file 
$! 
$  z_dim          := 172 
$  z_dim_top      := 43 
$  z_dim_mid      := 86 
$  z_dim_bot      := 43 
$   
$  z_pos_top      := 1 
$  z_pos_mid      := 44 
$  z_pos_bot      := 130 
$ 
$! 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$! 
$   ipl_scanco_prog 
 
!   ****EZZ**** 
/read 
  -name                      out 
  -filename                  "ezz_file 
 
/sub_get 
  -input                     out 
  -output                    top 
  -pos                       -1 -1 "z_pos_top 
  -dim                       -1 -1 "z_dim_top 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              top 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo top 
  -fileout_or_screentab      "histo_ezzt 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write top "ezzt_file 
  -compress_type             bin 
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  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    mid 
  -pos                       -1 -1 "z_pos_mid 
  -dim                       -1 -1 "z_dim_mid 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              mid 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo mid 
  -fileout_or_screentab      "histo_ezzm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write mid "ezzm_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    bot 
  -pos                       -1 -1 "z_pos_bot 
  -dim                       -1 -1 "z_dim_bot 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              bot 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo bot 
  -fileout_or_screentab      "histo_ezzb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write bot "ezzb_file 
  -compress_type             bin 





  -input                     top 
  -item                      geom 
/examine 
  -input                     mid 
  -item                      geom 
/examine 
  -input                     bot 
  -item                      geom 
 
!   ****EPL**** 
/read 
  -name                      out 
  -filename                  "epl_file 
 
/sub_get 
  -input                     out 
  -output                    top 
  -pos                       -1 -1 "z_pos_top 
  -dim                       -1 -1 "z_dim_top 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              top 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo top 
  -fileout_or_screentab      "histo_eplt 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write top "eplt_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    mid 
  -pos                       -1 -1 "z_pos_mid 
  -dim                       -1 -1 "z_dim_mid 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              mid 
  -gobj_filename             org_file 




  -fileout_or_screentab      "histo_eplm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write mid "eplm_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    bot 
  -pos                       -1 -1 "z_pos_bot 
  -dim                       -1 -1 "z_dim_bot 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              bot 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo bot 
  -fileout_or_screentab      "histo_eplb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write bot "eplb_file 
  -compress_type             bin 
  -version_020               true 
 
/examine 
  -input                     top 
  -item                      geom 
/examine 
  -input                     mid 
  -item                      geom 
/examine 
  -input                     bot 
  -item                      geom 
 
!   ****VMS**** 
/read 
  -name                      out 
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  -filename                  "vms_file 
 
/sub_get 
  -input                     out 
  -output                    top 
  -pos                       -1 -1 "z_pos_top 
  -dim                       -1 -1 "z_dim_top 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              top 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo top 
  -fileout_or_screentab      "histo_vmst 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/write top "vmst_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    mid 
  -pos                       -1 -1 "z_pos_mid 
  -dim                       -1 -1 "z_dim_mid 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              mid 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo mid 
  -fileout_or_screentab      "histo_vmsm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/write mid "vmsm_file 
  -compress_type             bin 





  -input                     out 
  -output                    bot 
  -pos                       -1 -1 "z_pos_bot 
  -dim                       -1 -1 "z_dim_bot 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              bot 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo bot 
  -fileout_or_screentab      "histo_vmsb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/write bot "vmsb_file 
  -compress_type             bin 
  -version_020               true 
 
/examine 
  -input                     top 
  -item                      geom 
/examine 
  -input                     mid 
  -item                      geom 
/examine 
  -input                     bot 
  -item                      geom 
 
!   ****SED**** 
/read 
  -name                      out 
  -filename                  "sed_file 
 
/sub_get 
  -input                     out 
  -output                    top 
  -pos                       -1 -1 "z_pos_top 
  -dim                       -1 -1 "z_dim_top 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              top 
  -gobj_filename             org_file 




  -fileout_or_screentab      "histo_sedt 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/write top "sedt_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    mid 
  -pos                       -1 -1 "z_pos_mid 
  -dim                       -1 -1 "z_dim_mid 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              mid 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo mid 
  -fileout_or_screentab      "histo_sedm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/write mid "sedm_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    bot 
  -pos                       -1 -1 "z_pos_bot 
  -dim                       -1 -1 "z_dim_bot 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              bot 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo bot 
  -fileout_or_screentab      "histo_sedb 
  -from_val                  -1 
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  -to_val                    -1 
  -nr_bins_in_tab            50000 
  -dt_type                   auto 
  -count_zeros               no 
/write bot "sedb_file 
  -compress_type             bin 
  -version_020               true 
 
/examine 
  -input                     top 
  -item                      geom 
/examine 
  -input                     mid 
  -item                      geom 
/examine 
  -input                     bot 
  -item                      geom 
 





The following batch file contains IPL commands necessary to separate the tissue 
response output for Material 1 (polymer phase “bone”) into zones (top 25%, middle 50%, 
and bottom 25%).  To execute the following batch file, type the following command in a 
DecTerm window.  The following example is for sample p26.  Due to similarity to 




$!       
$!         _/_/_/  _/_/_/    _/         
$!          _/    _/    _/  _/           Image Processing Language   
$!         _/    _/_/_/    _/  
$!        _/    _/        _/             (c)  Andres Laib, Scanco Medical AG 
$!     _/_/_/  _/        _/_/_/_/             
$!         
$!       
$! 
$!  IPL Batch FOR POST-PROCESSING ANGEL'S FE MODELS WITH 2 
MATERIALS. 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Divides resultant data into top, middle, and bottom regions. 
$!   
$!  Written for p26 which has a z-dim of 162 voxels and z-pos of 32. 
$!  The first slice is a metal plate.  Then the sample is  








$  z_dim          := 161 
$  z_dim_top      := 40 
$  z_dim_mid      := 81 
$  z_dim_bot      := 40 
$   
$  z_pos_top      := 1 
$  z_pos_mid      := 41 








The following batch file contains IPL commands necessary to separate the tissue 
response output for Material 1 (polymer phase “bone”) into zones (top 25%, middle 50%, 
and bottom 25%).  To execute the following batch file, type the following command in a 
DecTerm window.  The following example is for sample p93.  Due to similarity to 




$!       
$!         _/_/_/  _/_/_/    _/         
$!          _/    _/    _/  _/           Image Processing Language   
$!         _/    _/_/_/    _/  
$!        _/    _/        _/             (c)  Andres Laib, Scanco Medical AG 
$!     _/_/_/  _/        _/_/_/_/             
$!         
$!       
$! 
$!  IPL Batch FOR POST-PROCESSING ANGEL'S FE MODELS WITH 2 
MATERIALS. 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Divides resultant data into top, middle, and bottom regions. 
$!   
$!  Written for p93 which has a z-dim of 157 voxels and z-pos of 39. 
$!  The first slice is a metal plate.  Then the sample is  








$  z_dim          := 156 
$  z_dim_top      := 39 
$  z_dim_mid      := 78 
$  z_dim_bot      := 39 
$   
$  z_pos_top      := 1 
$  z_pos_mid      := 40 







The following batch file contains IPL commands necessary to separate the tissue 
response output for Material 2 (interstitial phase, “marrow”) into zones (top 25%, middle 
50%, and bottom 25%).  The code is very similar to ad_fe_pc_regb_xxp.com (where xx = 
25, 26, or 93) and for that reason, only code for p25 is shown and the code below has 
been truncated.  The necessary commands are shown to process åzz only.  The commands 
may be repeated for åpl, VMS, and SED.  To execute the batch file, type the following 




$!       
$!         _/_/_/  _/_/_/    _/         
$!          _/    _/    _/  _/           Image Processing Language   
$!         _/    _/_/_/    _/  
$!        _/    _/        _/             (c)  Andres Laib, Scanco Medical AG 
$!     _/_/_/  _/        _/_/_/_/             
$!         
$!       
$! 
$!  IPL Batch FOR POST-PROCESSING ANGEL'S FE MODELS WITH 2 
MATERIALS. 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Divides resultant data into top, middle, and bottom regions. 
$!   
$!  Written for p25 which has a z-dim of 173 voxels and z-pos of 41. 
$!  The first slice is a metal plate.  Then the sample is  
$!  Divided into top 43 slices, middle 86 slices, and bottom 43 slices. 
$! 
$!  The 'p1' org_file here is _mar.aim 
$! 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$ 
$   ezz_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + "_EZZR_MAR.AIM"  
$   epl_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + "_EPLR_MAR.AIM" 
$   vms_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_VMSR_MAR.AIM" 
$   sed_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + "_SEDR_MAR.AIM" 




$   eplt_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EPLR_MAR_TOP.AIM" 
$   vmst_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_VMSR_MAR_TOP.AIM" 
$   sedt_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_SEDR_MAR_TOP.AIM" 
$   ezzm_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EZZR_MAR_MID.AIM"  
$   eplm_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EPLR_MAR_MID.AIM" 
$   vmsm_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_VMSR_MAR_MID.AIM" 
$   sedm_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_SEDR_MAR_MID.AIM" 
$   ezzb_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EZZR_MAR_BOT.AIM"  
$   eplb_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EPLR_MAR_BOT.AIM" 
$   vmsb_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_VMSR_MAR_BOT.AIM" 
$   sedb_file = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_SEDR_MAR_BOT.AIM" 
$   histo_ezzt = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EZZR_MAR_TOP.TAB" 
$   histo_eplt = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EPLR_MAR_TOP.TAB" 
$   histo_vmst = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_VMSR_MAR_TOP.TAB" 
$   histo_sedt = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_SEDR_MAR_TOP.TAB" 
$   histo_ezzm = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EZZR_MAR_MID.TAB" 
$   histo_eplm = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EPLR_MAR_MID.TAB" 
$   histo_vmsm = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_VMSR_MAR_MID.TAB" 
$   histo_sedm = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_SEDR_MAR_MID.TAB" 
$   histo_ezzb = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EZZR_MAR_BOT.TAB" 
$   histo_eplb = p1 - F$PARSE(p1,,,"VERSION") - "_MAR.AIM" + 
"_EPLR_MAR_BOT.TAB" 








$   show log org_file 
$! 
$  z_dim          := 172 
$  z_dim_top      := 43 
$  z_dim_mid      := 86 
$  z_dim_bot      := 43 
$   
$  z_pos_top      := 1 
$  z_pos_mid      := 44 
$  z_pos_bot      := 130 
$ 
$! 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$! 
$   ipl_scanco_prog 
 
!   ****EZZ**** 
/read 
  -name                      out 
  -filename                  "ezz_file 
 
/sub_get 
  -input                     out 
  -output                    top 
  -pos                       -1 -1 "z_pos_top 
  -dim                       -1 -1 "z_dim_top 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              top 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo top 
  -fileout_or_screentab      "histo_ezzt 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write top "ezzt_file 
  -compress_type             bin 





  -input                     out 
  -output                    mid 
  -pos                       -1 -1 "z_pos_mid 
  -dim                       -1 -1 "z_dim_mid 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              mid 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo mid 
  -fileout_or_screentab      "histo_ezzm 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write mid "ezzm_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     out 
  -output                    bot 
  -pos                       -1 -1 "z_pos_bot 
  -dim                       -1 -1 "z_dim_bot 
  -global_pos_flag           false 
/gobj_maskaimpeel_ow 
  -input_output              bot 
  -gobj_filename             org_file 
  -peel_iter                 0 
/histo bot 
  -fileout_or_screentab      "histo_ezzb 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write bot "ezzb_file 
  -compress_type             bin 
  -version_020               true 
 
/examine 
  -input                     top 
 
 272 
  -item                      geom 
/examine 
  -input                     mid 
  -item                      geom 
/examine 
  -input                     bot 







The following batch file contains IPL commands to display statistical information on the 
tissue response of either Material 1 (polymer phase, “bone”) or Material 2 (interstitial 
phase, “marrow”) for different zones (top 25%, middle 50%, and bottom 25%).  To 
execute the following batch file, type the following command in a DecTerm window. 
@{file_path}ad_fe_regstat.com {file_path}*_xxx_bone.aim  OR 
@{file_path}ad_fe_regstat.com {file_path}*_xxx_mar.aim 
where xxx = ezz, epl, vms, or sed 
 
ad_fe_pc_regstat.com 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$   define   org_file    'p1' 
$   top_file = p1 - F$PARSE(p1,,,"VERSION") - ".AIM" + "_TOP.AIM"  
$   mid_file = p1 - F$PARSE(p1,,,"VERSION") - ".AIM" + "_MID.AIM" 
$   bot_file = p1 - F$PARSE(p1,,,"VERSION") - ".AIM" + "_BOT.AIM" 
$   show log org_file 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$   ipl_scanco_prog 
 
/read 
  -name                      top 
  -filename                  "top_file 
/read 
  -name                      mid 
  -filename                  "mid_file 
/read 
  -name                      bot 
  -filename                  "bot_file 
/examine 
  -input                     top 
  -item                      stat 
/examine 
  -input                     mid 
  -item                      stat 
/examine 
  -input                     bot 
  -item                      stat 





The following batch file contains IPL commands to create histograms  of the stresses and 
strains in the polymer with a reduced data set including 0-95th percentile for VMS and 
SED and 5th to 95th percentile for ezz and epl.  To execute the following batch file, type 
the following command in a DecTerm window. 
@{file_path}ad_fe_pc_histo_bone_r.com {file_path}*_bone.aim  OR 
 
ad_fe_pc_histo_bone_r.com 
$!       
$!         _/_/_/  _/_/_/    _/         
$!          _/    _/    _/  _/           Image Processing Language   
$!         _/    _/_/_/    _/  
$!        _/    _/        _/             (c)  Andres Laib, Scanco Medical AG 
$!     _/_/_/  _/        _/_/_/_/             
$!         
$!       
$! 
$!  IPL Batch FOR POST-PROCESSING ANGEL'S FE MODELS WITH 2 
MATERIALS. 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Reprocessing regional histogram data to exclude top 
$!  5% of vms and sed voxels and the top 5% and bottom 5% 
$!  of epl voxels.   
$! 
$!  The org file is _BONE.aim  
$! 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$   eplt_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_TOP.AIM" 
$   vmst_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_TOP.AIM" 
$   sedt_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_TOP.AIM" 
$   eplm_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_MID.AIM" 
$   vmsm_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_MID.AIM" 




$   eplb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_BOT.AIM" 
$   vmsb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_BOT.AIM" 
$   sedb_file = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_BOT.AIM" 
$   histo_eplt = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_TOP_R.TAB" 
$   histo_vmst = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_TOP_R.TAB" 
$   histo_sedt = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_TOP_R.TAB" 
$   histo_eplm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_MID_R.TAB" 
$   histo_vmsm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_MID_R.TAB" 
$   histo_sedm = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_MID_R.TAB" 
$   histo_eplb = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_EPLR_BONE_BOT_R.TAB" 
$   histo_vmsb = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_VMSR_BONE_BOT_R.TAB" 
$   histo_sedb = p1 - F$PARSE(p1,,,"VERSION") - "_BONE.AIM" + 
"_SEDR_BONE_BOT_R.TAB" 
$ 
$   show log org_file 
$! 
$   e_from      := -22000 
$   e_to        := +1000 
$   v_from      := 0 
$   v_to        := 11 
$   s_from      := 0 
$   s_to        := 81000 
$! 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$! 




  -name                      top 
  -filename                  "eplt_file 
/read 
  -name                      mid 




  -name                      bot 
  -filename                  "eplb_file 
/mult_constant_ow 
  -in_out                    top 
  -factor                    1000000.000000 
/mult_constant_ow 
  -in_out                    mid 
  -factor                    1000000.000000 
/mult_constant_ow 
  -in_out                    bot 
  -factor                    1000000.000000 
/histo top 
  -fileout_or_screentab      "histo_eplt 
  -from_val                  "e_from 
  -to_val                    "e_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/histo mid 
  -fileout_or_screentab      "histo_eplm 
  -from_val                  "e_from 
  -to_val                    "e_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/histo bot 
  -fileout_or_screentab      "histo_eplb 
  -from_val                  "e_from 
  -to_val                    "e_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
 
/read 
  -name                      top 
  -filename                  "vmst_file 
/read 
  -name                      mid 
  -filename                  "vmsm_file 
/read 
  -name                      bot 
  -filename                  "vmsb_file 
/histo top 
  -fileout_or_screentab      "histo_vmst 
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  -from_val                  "v_from 
  -to_val                    "v_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/histo mid 
  -fileout_or_screentab      "histo_vmsm 
  -from_val                  "v_from 
  -to_val                    "v_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/histo bot 
  -fileout_or_screentab      "histo_vmsb 
  -from_val                  "v_from 
  -to_val                    "v_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
 
/read 
  -name                      top 
  -filename                  "sedt_file 
/read 
  -name                      mid 
  -filename                  "sedm_file 
/read 
  -name                      bot 
  -filename                  "sedb_file 
/mult_constant_ow 
  -in_out                    top 
  -factor                    1000000.000000 
/mult_constant_ow 
  -in_out                    mid 
  -factor                    1000000.000000 
/mult_constant_ow 
  -in_out                    bot 
  -factor                    1000000.000000 
/histo top 
  -fileout_or_screentab      "histo_sedt 
  -from_val                  "s_from 
  -to_val                    "s_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 




  -fileout_or_screentab      "histo_sedm 
  -from_val                  "s_from 
  -to_val                    "s_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/histo bot 
  -fileout_or_screentab      "histo_sedb 
  -from_val                  "s_from 
  -to_val                    "s_to 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 





The following batch file contains IPL commands to create histograms  of the stresses and 
strains in the interstitial tissue with a reduced data set including 0-95th percentile for 
VMS and SED and 5th to 95th percentile for ezz and epl.  Since the file is so similar to 
ad_fe_pc_histo_bone_r.com, the file has been truncated and sections omitted.  To execute 
the following batch file, type the following command in a DecTerm window. 
@{file_path}ad_fe_pc_histo_mar_r.com {file_path}*_mar.aim  
 
ad_fe_pc_histo_mar_r.com 
$!       
$!         _/_/_/  _/_/_/    _/         
$!          _/    _/    _/  _/           Image Processing Language   
$!         _/    _/_/_/    _/  
$!        _/    _/        _/             (c)  Andres Laib, Scanco Medical AG 
$!     _/_/_/  _/        _/_/_/_/             
$!         
$!       
$! 
$!  IPL Batch FOR POST-PROCESSING ANGEL'S FE MODELS WITH 2 
MATERIALS. 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  Reprocessing regional histogram data to exclude top 
$!  5% of vms and sed voxels and the top 5% and bottom 5% 
$!  of epl voxels.   
. 
. 




$   show log org_file 
$! 
$   e_from      := -186000 
$   e_to        := +3620 
$   v_from      := 0 
$   v_to        := 3 
$   s_from      := 0 







The following batch file contains IPL commands to determine the distribution of new 
bone volume between top, middle, and bottom zones.  The size of these zones may be 
changed by editing the z_* parameters in the variable assignment portion of the code.  To 
execute the following batch file, type the following command in a DecTerm window. 
@{file_path}ad_fe_pc_vivo.com {file_path}*_seg.aim  OR 
 
ad_fe_pc_vivo.com 
$!  Prepared for the pre-culture study models of rMSCs on PLDL. 
$!  To be used to analyze the zones of the actual in vivo samples 
$!  Divides bone volume data into top, middle, and bottom regions. 
$!   
$!  Must edit z_dim, z_dim_top, z_dim_mid, and z_dim_bot  
$!  for each file. 
$! 
$!  The 'p1' org_file here is _seg.aim 
$! 
$   if p1 .EQS. ""  
$  THEN  
$ write sys$output "Give C0001234.aim ! Exit" 
$  exit 
$   endif 
$ 
$   define   org_file    'p1' 
$   top_file = p1 - F$PARSE(p1,,,"VERSION") - "_SEG.AIM" + "_TOP.AIM" 
$   mid_file = p1 - F$PARSE(p1,,,"VERSION") - "_SEG.AIM" + "_MID.AIM" 
$   bot_file = p1 - F$PARSE(p1,,,"VERSION") - "_SEG.AIM" + "_BOT.AIM" 
$   histo_top = p1 - F$PARSE(p1,,,"VERSION") - "_SEG.AIM" + "_TOP.TAB" 
$   histo_mid = p1 - F$PARSE(p1,,,"VERSION") - "_SEG.AIM" + "_MID.TAB" 
$   histo_bot = p1 - F$PARSE(p1,,,"VERSION") - "_SEG.AIM" + "_BOT.TAB" 
$ 
$   show log org_file 
$! 
$  z_dim          := 280 
$  z_dim_top      := 28 
$  z_dim_mid      := 224 
$  z_dim_bot      := 28 
$  z_pos_mid      := 28 
$  z_pos_bot      := 252 
$ 
$   ipl_scanco_prog := $um:ipl_scanco_fe.exe 
$   ipl_scanco_prog 
 
/read 
  -name                      seg 





  -input                     seg 
  -output                    top 
  -pos                       -1 -1 -1 
  -dim                       -1 -1 "z_dim_top 
  -global_pos_flag           false 
/histo top 
  -fileout_or_screentab      "histo_top 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            200 
  -dt_type                   auto 
  -count_zeros               no 
/write top "top_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     seg 
  -output                    mid 
  -pos                       -1 -1 "z_pos_mid 
  -dim                       -1 -1 "z_dim_mid 
  -global_pos_flag           false 
/histo mid 
  -fileout_or_screentab      "histo_mid 
  -from_val                  -1 
  -to_val                    -1 
  -nr_bins_in_tab            500 
  -dt_type                   auto 
  -count_zeros               no 
/write mid "mid_file 
  -compress_type             bin 
  -version_020               true 
 
/sub_get 
  -input                     seg 
  -output                    bot 
  -pos                       -1 -1 "z_pos_bot 
  -dim                       -1 -1 "z_dim_bot 
  -global_pos_flag           false 
/histo bot 
  -fileout_or_screentab      "histo_bot 
  -from_val                  -1 
  -to_val                    -1 
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  -nr_bins_in_tab            200 
  -dt_type                   auto 
  -count_zeros               no 
/write bot "bot_file 
  -compress_type             bin 
  -version_020               true 
 
/examine 
  -input                     top 
  -item                      geom 
/examine 
  -input                     mid 
  -item                      geom 
/examine 
  -input                     bot 
  -item                      geom 
 
/voxgobj_scanco_param 
  -input                     top 
  -gobj_filename             gobj_from_log 
  -peel_iter                 -1 
  -region_number             0 
/voxgobj_scanco_param 
  -input                     mid 
  -gobj_filename             gobj_from_log 
  -peel_iter                 -1 
  -region_number             0 
/voxgobj_scanco_param 
  -input                     bot 
  -gobj_filename             gobj_from_log 
  -peel_iter                 -1 
  -region_number             0 
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